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Proper T-cell activation and effector function are essential for effective immunity. 
T-cell antigen receptor (TCR) signals are known to regulate the outcome of differentiation, 
but the mechanisms remain unclear. Recent work from our lab demonstrates that the Src 
family protein tyrosine kinase, p56Lck, is able to specifically link TCR signals to 
activation of the Mitogen Activated Protein Kinase (MAPK) pathway through the function 
of its SH3 domain. The MAPK pathway is known to be involved in T-cell activation 
downstream of TCR ligation and has previously been implicated in T-helper type 2 (Th2) 
effector function. We have utilized an Lck SH3 mutant knock-in mouse line (Lck W97A) 
to investigate the potential role of this regulatory signaling mechanism in determining T-
lymphocyte activation and effector function. Our results demonstrate that the Lck SH3 
   xxiv 
 
domain function is required for normal activation of T-lymphocytes following TCR 
stimulation as indicated by significantly reduced proliferation, IL-2 production, and CD69 
induction in Lck W97A T-cells. Biochemical studies confirm that activation of the MAPK 
pathway is selectively altered in Lck W97A T-cells as P-ERK1/2 induction is significantly 
reduced but phospho-PLCγ1 induction and calcium mobilization is unaffected.  In vivo 
experiments demonstrate a specific and significantly impaired Th2 immunity in Lck W97A 
mice, with reduced serum levels of IgG1, IgE and IL-4 following immunization with DNP-
KLH, or infection with the helminth Nippostrongylus brasiliensis. Th1 immunity does not 
appear differentially regulated in Lck W97A mice as serum levels of IgG3 and IgG2b are 
similar to WT following immunization with DNP-KLH, as well as serum levels of IFN-γ1 
following immunization with heat-killed Brucella abortus. In vitro differentiation studies 
confirm that Lck W97A T-lymphocytes are able to be directed to the Th2 phenotype, as 
indicated by intracellular staining for IL-4, with significantly increased levels of IFN-γ 
under Th2 differentiating conditions compared to WT. These data indicate that the Lck 
SH3 domain regulates activation of T-lymphocytes by affecting MAPK pathway induction 
and demonstrate a novel and critical role for Lck in the regulation of Th2-type immunity. 
The Lck SH3 domain has also been implicated in the pathogenesis of Plasmodium, 
the causative agent of malaria. The role of the mosquito vector on malaria pathogenesis is 
not well understood. Initial studies examining the role of vector salivary gland proteins on 
cells of the innate immune system indicate that Anopheles stephensi saliva is able to 
enhance macrophage activation and phagocytosis as well as enhance macrophage Ag-
presentation to T-lymphocytes in an in vitro model. 










I. Innate and Adaptive Immunity. 
The body’s immune system is an intricate collaboration between highly adapted and 
specialized cells working together to mitigate and suppress invasion by pathogens. It is the 
exquisite partnership between these immune cells and responses of the innate and adaptive 
branches of the immune system that enable efficient and protective host immunity. The 
innate immune system is part of the host’s first-line of defense against infection and 
includes antigen presenting cells (APCs) such as macrophages, dendritic cells and mast 
cells, which target infectious agents in a non-specific manner. These cells are able to 
process and present antigenic peptides derived from extra- and intracellular pathogens on 
the cell surface in the context of major histocompatibility complexes (MHC) in order to 
engage and prime cells of the adaptive immune system, such as T- and B-lymphocytes. 
The purpose of adaptive immunity is to provide specific and robust host protection from 
acute and recurring infections. T-cells are able to directly kill infected cells expressing 
foreign peptides on their surface by releasing cytotoxins, and function to assist the priming 
and activation of B-cells to produce antigen-specific antibodies. T-cells govern the cellular 
immune responses of adaptive immunity, whereas the humoral responses are mainly 
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controlled by B-cells and their secreted immunoglobulin (Ig) isotypes. B-lymphocytes also 
have membrane-bound Ig that can bind bacterial and viral antigenic epitopes on cell 
surfaces, further initiating B-cell activation and enhancing the immune responses to 
infection. Once activated, B-cells can differentiate into specialized cells termed plasma 
cells, which are able to secrete Ig that functions to tag foreign substances for neutralization 
or phagocytosis. Frequently, the Ig-targeted antigenic epitope is part of a functionally 
critical protein on the foreign agent required for invasion of the host, such as molecules 
required for adhesion to target cells (Rhoades). Binding to this type of epitope is termed 
neutralization. 
A.   B- and T-Cell Subsets. The tailored Ag-specific response of adaptive 
immunity relies, in part, on the proper development and activation of naïve lymphocytes. 
Although T-and B-cells both originate in the bone marrow as hematopoietic stem cells, 
they have divergent developmental programs, and distinct functions with regard to 
immunity. Whereas B-cells complete their development in the bone marrow, T-cells 
complete their development and maturation in the thymus. The designation of “B”- and 
“T”-lymphocytes is of note here, as T-cells are named as a result of the organ in which 
they mature, the Thymus. However, B-cells are named due to the organ in which they were 
originally discovered to develop, the avian-specific Bursa of Fabricius. 
Following both naïve T-cell exodus from the thymus, and B-cell migration from the 
bone marrow, the naïve lymphocytes interact with cells of the innate immune system while 
circulating through the lymph organs in search of an antigenic match precursory to 
activation. T-cells are able to interact and engage APCs through surveillance of the 
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lymphatic system and secondary lymphoid organs, such as the spleen and lymph nodes. 
APC priming and activation of naïve T-lymphocytes is facilitated by ligation of the 
primary T-cell activating receptor, the T-cell antigen receptor (TCR), with MHC/peptide 
complexes on the APC surface. MHC class I and class II molecules, with cognate peptide, 
bind the class I binding protein CD8 or Class II binding protein CD4, respectively, on the 
surface of T-lymphocytes. This ligation induces and assists activation signals through the 
TCR, resulting in clonal expansion of the activated T-cell, cytokine secretion, and 
acquisition of effector function. The ability of T-cells to properly differentiate between self 
and foreign antigenic (Ag) peptides in the context of MHC is critical for understanding the 
processes leading to proper T-cell immunity and the improper response to self antigens 
leading to autoimmunity (Deng). 
Once a T-cell has been activated and gained effector function, it has several 
possible fates. Either the cell can perform its primary immune function immediately, or it 
can segregate into a separate and long-lived population of “memory” cells. Memory cells 
are a reservoir of primed immune sentinel cells that are available to respond rapidly and 
with robust function upon secondary infection. 
CD4+ and CD8+ T-cells comprise the two major subgroups within the T-
lymphocyte population. In addition to their selective ability to bind MHC class II 
molecules, CD4+ T-helper (Th) cells are able to secrete various immune cytokines as well 
as bind and activate B-cells. Th-activated B-lymphocytes produce Ag-specific antibodies, 
the primary component of the humoral immune response. The other major group of T-
lymphocytes, the CD8+ cytotoxic T-cells, recognize MHC class I molecules that have 
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bound cytosolic peptide (ie; viral), and, once primed, are able to cytolytically kill infected 
cells through the release of cytotoxins or through Fas-FasL interactions. This Ag-specific 
cellular immune response is important for the control and clearance of virally infected 
immune cells. 
Another important T-lymphocyte subgroup is the regulatory T-cells (Treg). T-regs 
are a smaller but very important T-cell subgroup that acts to regulate T-cell mediated 
immunity as well as control auto-reactive T-cells. T-reg development in the thymus is 
regulated by the activity of the Foxp3 transcription factor, and express CD4+CD25+ on 
their cell surface. Although the mechanisms of T-reg suppression are the focus of intense 
study, it is known that they are able to secrete immunosuppressive TGF-β and IL-10 to 
control the scope of immune responses. 
 
II. Immunity and the Activation and Function of T-Lymphocytes: A Role for the Src 
Family PTK, Lck. 
In order to fully understand and manipulate the activity of T-lymphocytes, it is critical 
to examine the mechanisms that govern their development, activation, differentiation, and 
effector function. The Src family of non-receptor protein tyrosine kinases (PTKs) is of 
imminent value to this end, as they are involved in, and critical for, many of these 
processes (Thomas). 
A. The Discovery of Src. A pioneer in the field of Src PTKs was Dr. Peyton Rous, 
who discovered the ability of the (now named) Rous Sarcoma Virus (RSV) to cause cancer 
in hens in 1911. Dr. Rous was later awarded the Nobel Prize in Physiology or Medicine in 
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1966 for his work, and became the first scientist to demonstrate that a virus is capable of 
inducing cancer (Nobel). Although Dr. Rous was unaware of the host cellular gene src in 
this infection model, his work was a major advancement for our understanding of the 
importance that this family of proteins plays in the immune system. It would not be until 
1976, that Michael Bishop and Harold Varmus identified that it was, in fact, the cellular 
gene, “sark” (src), that was hijacked by the RSV to cause cancer (Stehelin). This body of 
work was the first to identify the Src PTKs, and classify them as proto-oncogenes. Bishop 
and Varmus were awarded the Nobel Prize in Physiology or Medicine in 1989 for their 
work with src, and an increased study of the nine Src PTK family members, which include: 
Src, Blk, Fgr, Fyn, Hck, Lck, Lyn, Yes, and Ykr, would follow their discovery. 
Furthermore, one of the first properties of these kinases was discovered when mutations or 
over-expression lead to certain types of cancers (Potts, Stehelin). Of particular importance 
to the study of T-lymphocyte activation and function are the Src PTK family members, 
Lck and Fyn, as they are critical signaling components of the TCR. 
B. The Src PTKs, P56Lck and p59Fyn. The lymphocyte cell kinase, Lck, was 
first discovered in 1985 by Jamey Marth (Marth), and subsequently, both Lck and Fyn 
have been shown to be critical for TCR signal transduction (Appleby, Goldsmith, Stein, 
Straus’92). In order to understand how Lck is involved in signaling through the TCR, it is 
necessary to understand the TCR structural components. The TCR is a hetero-oligomeric 
structure on the T-cell surface. Signaling via this receptor is required for T-lymphocyte 
activation. Ligand binding to this receptor is facilitated by heterodimeric immunoglobulin-
like clonotypic chains (αβ, and/or γδ), which are noncovalently complexed with three pairs 
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of disulfide-linked molecules, termed the CD3 complex. The CD3 complex is comprised 
of γ-ε and δ-ε heterodimers and a disulfide-linked homodimer (ζζ, or ζ linked to its 
alternatively spliced form, the η chain). These CD3 subunits contain cytoplasmic tails 
essential for Ag-stimulated signaling downstream of ligand binding to the TCR (Frank). As 
the TCR has no intrinsic kinase activity, it is dependent on the recruitment and function of 
the Src family of PTKs, located within the cell, to propagate TCR-induced intracellular 
signals leading to T-cell activation, differentiation and function. (Fig. 1). Following TCR 
and co-receptor (CD4 or CD8) engagement with peptide/MHC complexes on the surface of 
an antigen presenting cell, Lck is able to facilitate signal transduction via binding to 
phospho-tyrosine residues located within immunoreceptor tyrosine-based activation motifs 
(ITAM) within the CD3-associated zeta chains (Straus ’96). Once bound and activated, 
Lck is able to further phosphorylate tyrosine resides within the ITAM motifs, which 
promotes the binding of the Syk family member, ZAP-70, and subsequent propagation of 
activating signals. Lck activity is governed by several proteins, including the C-terminal c-
Src kinase (csk) and CD45. Csk is localized at the T-cell membrane by association with the 
transmembrane scaffold protein, PAG1, and is thus able to continually phosphorylate Lck 
at its inhibitory tyrosine residue (Tyr505). Following TCR ligation PAG1 is de-
phosphorylated, releasing csk, and enabling CD45 de-phosphorylation of Lck at the 
inhibitory tyrosine residue. (DeFranco) 
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Although Lck and Fyn expression is similar in both CD4+ and CD8+ thymocyte 
populations (Olszowy), Fyn is more highly expressed in peripheral T-cells (Denny’00). 
And though Lck and Fyn are both able to initiate tyrosine phosphorylation of the TCR, 
studies using the Lck deficient T-cell line, J.CaM1, have shown that the Fyn-specific 
phosphorylation pattern of TCR CD3 subunits and TCR zeta chains is distinct from that of 
Lck. Moreover, Fyn-specific phosphorylation of the Zeta-chain-associated protein kinase 
(ZAP-70), a Syk family PTK involved in proximal TCR signaling, is reduced compared to 
that induced by Lck. Subsequent activation of these J.CaM1 cells was also reduced, as 
indicated by reduced levels of IL-2 following TCR induced cell activation, resulting in a 
phenotype of partial T-cell activation compared with cells which rely solely on Lck 
activity. (Denny’00). Furthermore, Fyn null mice exhibit only partially dampened TCR 
signaling, whereas Lck null mice are almost completely lacking in peripheral T-cells due to 
severely arrested thymocyte development, with those cells that are found in the periphery 
having significantly impaired proliferation in response to TCR cross-linking (Stein, 
Molina). Examination of mice lacking both Lck and Fyn demonstrate a complete lack of 
αβT-cell development (Van Oers ‘96b). Therefore, the roles of these two Src PTKs are 
distinct with regard to T-cell development and proximal TCR signaling events and are not 
completely redundant, even though they perform similar roles in the processes that lead to 
T-lymphocyte activation. 
C. The Roles of Lck and Fyn in T-Cell Signaling. As Lck is associated with both 
the CD4 and CD8 co-receptors on T-lymphocytes, ligation of the TCR and co-receptors 
with cognate MHC/peptide complexes on APCs localizes and couples the co-receptor-
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associated Lck with the TCR enabling intracellular signaling cascade initiation.  This 
concept is supported by work by Glaichenhaus et al, where the association between CD4 
and Lck was found to be critical for T-cell activation. However, further examination of this 
model has indicated that while this interaction is necessary, it may not be the only kinase 
critical for this process (Veillette’89a-b, Luo, Sefton). (Fig. 1). While TCR ligation 
requires Lck for complete T-lymphocyte activation, it has been shown that tumors, such as 
Hodgkin’s Lymphoma, are able to affect cellular immunity by inhibiting the function of 
this kinase. The mechanism of this suppression is believed to be a result of elevated 
secretion of prostaglandin E2 (PGE2) with the onset of this form of lymphoma, which has 
been shown to inhibit CD4+ activation by negatively regulating TCR and T-cell co-
stimulatory (CD28) signaling via the inactivation of Lck (Chemnitz). Understanding the 
role that these signaling molecules play in the cellular response to co-stimulation is very 
important, not only as co-stimulation is responsible for lowering the threshold for signals 
received via the TCR to induce an intracellular signaling response and cytokine secretion 
(Viola), but for understanding the ability of specific receptor complexes to congregate and 
initiate various intracellular pathways leading to differential cell outcomes/fates. The 
ligation and association of particular co-receptors and co-stimulatory molecules permits the 
selective induction of distinct signal pathways which enables the regulation of various 
signaling cascades for divergent activation responses to different stimuli. For example, the 
ligation of CD28 with its ligands B7-1 or B7-2 (activating ligands on B-cells) has been 
shown to induce signaling required for immunogenicity and T-cell mediated rejection of 
weakly immunogenic tumors (Chen). As with many regulatory pathways in vivo which 
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have multiple responses, data has also shown that blocking CD28 engagement in vivo 
inhibits the development of autoimmune diseases (Cross, Lenschow, Perrin) and donor-
specific tolerance to allogeneic organ transplants (Turka). The specific mechanisms by 
which these pathways are governed by signaling molecules are able to exquisitely direct 
the activation state and functional outcomes of the cells which they control. Moreover, Lck 
has been shown to associate with MHC class I–binding killer-cell immunoglobulin like 
receptors (KIR) on the surface of natural killer (NK) and T-cells (Moretta, Lanier). KIR 
receptors are type 1 membrane glycoproteins of the Ig superfamily. KIR receptor 
engagement acts to downregulate NK and T-cell cytotoxic effector function and cytokine 
production (Moretta). Lck has been shown to phosphorylate tyrosine residues of the KIR 
cytoplasmic tails. This phosphorylation promotes the association of PI3-K and its 
subsequent activation of the anti-apoptotic kinase AKT, resulting in a positive cell signal 
promoting cell survival, possibly as a consequence of insufficient viral or tumor 
MHC/peptide complex recognition. (Marti, Cannon). CD2 is found on the surface of NK 
and T-cells, and functions as a co-stimulatory molecule on the surface of the latter. This 
molecule is important for its ability to reverse anergy in T-lymphocytes following B7 
blockage (Boussiotis), and has a dual function as an adhesion molecule (Wang). Moreover, 
this receptor is able to interact with the inhibitory receptor CD5 (Carmo, Castro) and 
modulate signaling at the cell surface via this interaction (Carmo, Teh). Lck has been 
shown to bind the cytoplasmic tail of CD2 via SH3 domain interactions (Bell), and has 
recently been shown to be important for the localization of CD2 to lipid raft microdomains 
in non-stimulated T-cells (J.CaM1) (Nunes). CD2 null mice do not appear to have any 
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significant alterations in their T-lymphocyte compartment or function (Killeen). Thus, Lck 
may act to regulate signaling cascades downstream of a variety of cell surface receptors in 
response to stimuli in order to enhance or inhibit cellular functions, even if these functions 
are not perhaps critical for their function. 
Intracellular signaling following surface receptor engagement results in the 
association of various signaling proteins that interact to determine cell activation, as well 
as cell fate. Th2 T-lymphocytes (differentiated CD4+ T-cells) are critical mediators of 
allergic responses and provide essential functions for immunity to helminthic parasites 
such as the secretion of immune cytokines and assistance to B-cells to provide Ag-specific 
imunoglobulins. As IL-4 is a critical mediator of Th2 immunity, a deficit in this interleukin 
is of significant importance to the induction of a protective IgE response, and host 
immunity to parasite infection. Heyeck et al. have shown that Lck is able to phosphorylate 
a critical conserved tyrosine residue of Itk, and that this phosphorylation leads to specific 
activation of Itk and the induction of Itk kinase activity. Moreover, studies using a 
dominant-negative Lck transgenic mouse have shown that Th2 T-cell differentiation is 
selectively inhibited both in vitro and in vivo (Yamashita ’97) compared with that of Th1. 
Lck signaling has also been shown to influence the downstream MAPK pathway proteins 
Erk1/2, which have also been shown to be critical for controlling IL-4R function and Th2 
cell differentiation (Skapenko, Yamashita ’99) by positively regulating STAT6 activity and 
IL-4 transcription (So). The importance of Lck, therefore, involving its role as a critical 
regulator of early TCR signaling events, its requirement for TCR and co-stimulatory 
signals necessary for T-cell activation, and intracellular protein associations during cell 
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signaling which are able to alter effector T-lymphocyte function and differentiation, is of 
great value to further understand and use these mechanisms to target and treat infection and 
immune dysregulation. 
Lck is of particular interest to our lab, and is expressed in T-cells as well as NK 
cells, brain neurons, and B1 B-cells. Although I have touched on some of the aspects of 
Lck involvement in NK and T-cell activation and differentiation/function, its role in 
neurons and B1 B-cells is not as well understood. 
Lck appears to be localized to the photoreceptor cell bodies in the outer nuclear 
layer and outer plexiform layer of the adult mouse retina. Neuronal dependence on Lck has 
been examined using mice lacking functional Lck (Lck KO). These mice present with 
partial retinal detachment with retinal infoldings and rosette formation similar to 
retinopathy of prematurity (ROP), a retinal injury frequent in human infants caused by 
oxygen-induced retinopathy (Omri). Furthermore, embryonic stem (ES) cells treated with 
retinoic acid (to enhance neuronal differentiation) in conjunction with inhibitors of Src 
family kinases blocks the terminal differentiation process of the excitatory neural 
phenotype (Theus). As ES cell differentiation into neuronal cells is a proposed treatment 
for various central nervous system (CNS) disorders, the regulation of Lck in this process is 
of great clinical importance. 
B1 B-cells are a small subset of the B-lymphocyte population found in the spleen, 
lung, as well as peritoneal and pleural cavities, and are responsible for producing high 
levels of IgM. These cells have polyspecific receptors (low affinity for many different 
antigens) that have a preference for common bacterial polysaccharides. Splenic B1 B-cells 
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are devoid of Lck, but are induced to express Lck once in the peritoneum. Lck has recently 
been shown to be important for B-cell receptor (BCR) hypo-responsiveness, and, as such, 
Lck is believed to be important for the cell fate of B1 B-cells (Dal Porto).  
There are also studies reporting the importance of Lck in the ability of lymphocytes 
to maintain homeostatic balance within the periphery of a host animal. Homeostatic 
proliferation is a term used to describe the phenomenon by which lymphocytes are able to 
proliferate to fill a deficit in cell numbers in order to reach homeostatic balance within the 
host. Using a tetracycline-inducible system for regulating Lck levels in mice, Seddon et al. 
showed that in the absence of Lck, there was a defect in TCR-driven homeostatic 
proliferation of peripheral T-cells when in a lymphopoenic animal host- and that Lck was 
absolutely critical for this process. Lck was not, however, found to be essential for the 
long-term survival of peripheral T-cells, as Lck and Fyn had redundant roles in this process 
(also requiring IL-7) (Seddon). In order to better understand how Lck and its binding 
partners communicate with respect to T-cell development, activation and function, it is 
important to study the particular structural components of Lck, and understand how these 
domains interact to facilitate the specific roles and functions of Lck in these processes. 
D. The Structure of Src. There is a conserved domain homology between Src 
PTK family members. The conserved domains of the Src PTKs are the SH3, SH2, catalytic 
(tyrosine kinase) domain (which includes the activation loop and an autophosphorylation 
site), and a short C-terminal tail (which contains a secondary site for auto-
phosphorylation). As components of the TCR have no intrinsic kinase activity, the 
recruitment and activities of three classes of PTKs are essential for TCR function: Src 
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family members Lck and Fyn, Syk family members ZAP-70 and Syk, and Itk-Btk family 
member Itk) (Rawlings, Rudd ’94, Weiss ’94). A crystal structure for Src has been 
determined (Xu), but as of yet, there is no complete crystal structure for Lck. There are, 
however, isolated and compound crystal structures for the SH3 and SH2 domains of Lck 
(Boggon, Eck), (Fig. 2), and the kinase domain (Yamaguchi). 
The N-terminal segment of SRC PTKs is attached to a variable unique domain and 
is important for the localization of the protein to the membrane as well as proximal 
association with various membrane-bound receptors. This occurs, in part, as the N-
terminus can be modified by the covalent attachment of myristic and palmytic acid 
moieties. Myristic acid moieties can be cotranslationally added to glycine residues 
(position 2 in Lck) and Lck and Fyn are able to undergo further modification by 
palmitoylation at distinct cysteine residues antecedent to the unique domain. 
Palmitoylation of cysteine 3, and either cysteine 5 (Lck) or cysteine 6 (Fyn)) (Koegl, 
Paige), as well as cysteines 20 and 23, contributes to localization of Lck or Fyn within the 
cell (Shaw’90, Turner,). It is of note that Lck and Fyn maintain unique and distinct 
localizations within cells. This difference has been attributed to the function of additional 
protein-specific domain interactions unique to each of the Src PTKs (Ley, Lin). Lck is 
found at higher concentrations near the plasma membrane, whereas Fyn has greater affinity 
for the centrosomal and mitotic structures. The unique domain of Lck also plays a role in 
its reversible association with the T-cell co-receptors CD4 and CD8, both of which are 
important for T-cell activation (Abraham, Rudd‘88, Shaw, Veillette’88), via formation of a 
dicysteine motif in the unique domain with two cysteine residues (20 and 23)  
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(Rudd’88, Veillette’88) in each of the cytoplasmic domains of the co-receptors (Turner). 
Approximately 30-60% of total Lck is found associated with these receptors (Luo, 
Rudd’88, Veillette’88,’89). Further work has also demonstrated that GPI-anchored 
proteins can lead to the activation of T-cells (Robinson, Shenoy-Scaria’92, Su), and that 
this is made possible, in part, by the association of Lck with glycophosphatidylinositol 
(GPI)-anchored proteins via palmitylation and myristylation of the N-terminus of Lck 
(Shenoy-Scaria‘93). 
The SH2 domain consists of a central β-sheet flanked by single α-helixes on each 
side, and is able to engage ligands via binding with tyrosine residues. The ability of the 
Lck SH2 domain to bind to phosphotyrosines, and subsequently enable the 
phosphorylation of various tyrosine residues within ITAM motifs of the TCR zeta chains is 
critical for the propagation of activating signals upon TCR ligation. There are three ITAM 
motif repeats within each of the TCR zeta chains, as well as a single motif in each of the 
CD3 molecules (γ, δ, and ε) (Weiss ’94). ITAM tyrosine phosphorylation provides, in turn, 
a docking site for the secondary signaling protein, ZAP-70 (Iwashima ’94, Wange). Lck, 
being in proximity with ZAP-70, is able to bind and activate ZAP-70 via SH2 directed 
protein-protein interactions. (Chan, Duplay, Straus’92, ‘96). Activation of ZAP-70 leads to 
induction of the Ras/Raf pathway and downstream signaling cascades necessary for 
complete T-cell activation. The ability of the TCR to direct phosphoinositol (PI) pathway 
activation occurs rapidly upon TCR ligation. Phosphorylation of PLC-γ1 and the activation 
of PKC (serine/threonine kinase) in the PI pathway leading to the mobilization of 
intracellular calcium, have been shown to rely on Lck, and not Fyn, in T-cells (Lovatt), and 
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that this process requires the SH2 domain of Lck (Weber). Studies using mice lacking 
functional Lck show evidence that Lck is critical for T-cell development, and that TCR 
signaling is severely abrogated (Van Oers) with Zap-70 recruitment and downstream 
secondary signaling severely hampered. LAT, a downstream target of ZAP-70, is an 
adaptor molecule important for bringing signaling molecules together at the TCR including 
Grb2/SOS and resulting in downstream activation of Ras/Raf and the MAPK pathway 
protein, Erk. Another downstream molecule associated with ZAP-70 is SLP-76, an adaptor 
molecule involved in Itk activation and PI pathway induction. Therefore, defective ZAP-70 
function significantly affects both MAPK and PI pathway signaling cascades following 
TCR ligation. 
Data from Lck-null thymocytes has shown that Lck is critical for ITAM tyrosine 
phosphorylation, but that Fyn may be able to compensate to some degree in peripheral T-
cells (Van Oers). Taken together, these data demonstrate the critical role for Lck in TCR 
signal transduction. 
The C-terminal kinase domain of Src PTK family members functions to catalyze 
the phosphorylation of activating tyrosine residues on binding partners. The activating and 
inhibitory tyrosine residues responsible for the activation state of the Src protein itself are 
found in this domain (Abraham, Cooper). Lck further relies on low affinity intramolecular 
interactions between the C’-terminal phosphorylated inhibitory tyrosine (Tyr-505) and the 
SH2 domain, coupled with SH3 domain binding of the linker region, which results in a 
stabilized “closed” (or “autoinhibited”) conformation of the protein (Erpel, Sicheri, 
Superti-Furga, Williams, Xu). This inactive form of Lck is due to the fact that the 
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activating tyrosine (Tyr-394) is structurally occluded, and the C-lobe of the kinase domain 
is displaced (which contains a catalytically important glutamine residue). High affinity 
ligand binding to either the SH3 or SH2 domain, or de-phosphorylation of the inhibitory 
tyrosine, releases the intramolecular constrictions in favor of an active conformation of the 
protein (Brown, Erpel). 
E. Activation and Function of Lck. Several major modes of regulation are 
depicted in (Fig. 3) and are outlined in detail here. Direct activation of Lck is believed to 
occur by de-phosphorylation of the inhibitory tyrosine (Tyr-505) by CD45 (leukocyte 
common antigen), a transmembrane glycoprotein of the leukocyte-specific receptor-like 
protein tyrosine phosphatase (RPTP) family. Kinase activity involving CD45 in vitro has 
been shown to require Lck; and this association does not require the association of 
CD45/Lck with the TCR (Koretzky). Subsequent de-phosphorylation of Tyr-505 on Lck 
by CD45 renders the protein in a “primed” or “active” conformation (Hermiston, 
Mustelin’89, ‘90). Conversely, inhibition of Src PTK activity occurs as a result of 
phosphorylation of the inhibitory tyrosine residue (Tyr-505-on Lck) by the protein C-
terminal Src kinase (Csk) (Hermiston, Okada, Sondhi). Furthermore, the ubiquitin ligase, 
Cbl, is able to bind Lck via its SH3 domain and target it for lysosomal degredation as part 
of a negative feedback mechanism following TCR ligation and CD4 co-receptor 
engagement (Rao). In another negative feedback-type mechanism of regulation, activated 
Lck is able to phosphorylate and activate the tyrosine phosphatase, SHP-1, which is able, 
in turn, to mediate Lck inactivation. This is facilitated by T-lymphocyte ligands that induce 
activating signals through the TCR, and subsequently activate Lck and the MAPK pathway  
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signaling protein, Erk. Erk is able to phosphorylate Lck at serine 59, which prevents the 
association of Lck with SHP-1, and thus allows the activation of T-cells by activating 
ligands. (Germain). Therefore, viable activation signals received via the TCR, and the 
duration of that activation, compared with that of antagonizing signals, are able to be 
controlled by the interaction between Lck and SHP-1 (Stefanova ‘02, ‘03). Lck also 
contains an activating tyrosine located within the activation loop of the protein (Y394), 
which is able to be autophosphorylated following de-phosphorylation of Y505 (Brown, 
Williams). Moreover, Lck has been shown to be able autophosphorylate at this site upon 
the induction of the CD4 and CD28 accessory molecule stimulation in the absence of 
CD45 activity. This occurs following Lck recruitment by CD4 or CD28 to the T-cell/APC 
interface and CD28-induced anti-PY394 reactivity. (Holdorf ’02, Tavano). Furthermore, 
CD45 has been shown to negatively regulate CD44 mediated adhesion in T-cells, also 
requiring Src PTK activity (Li ‘01), and has recently been implicated as able to de-
phosphorylate the Lck activating tyrosine (Y394) following CD44 ligation (Wong). CD44 
ligation has been shown to activate Lck (Taher), so this new finding indicates that CD45 
inhibition of CD44 induced Lck activation is able to result in the inhibition of sustained 
Lck activation, and reduced actin rearrangement resulting in elongated T-cell spreading 
required during T-cell/APC engagements (Wong). 
F. The Role of Adaptor Protein Interactions. Adaptor proteins play a critical role 
in the organization of signaling clusters and molecules required for T-cell signaling 
through receptors, and function at many different levels to ensure proper  
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associations downstream of receptor ligation. The T-cell-specific adaptor protein (TSAd) is 
a critical adaptor molecule required for proper regulation of cytokine gene transcription. 
Cells lacking TSAd produce significantly reduced levels of IL-2, IL-4, and IFN-γ 
following TCR engagement (Drappa, Rajagopal). Marti et al. have shown that TSAd is 
able to activate Lck in peripheral T-cells. Although TSAd contributes to Lck activation, it 
is not sufficient for full Lck activation, and requires binding via both the SH3 and SH2 
domains of Lck (potentially by acting to release Lck from its autoinhibitory conformation). 
With the ability to affect the activation of Lck, Rlk, Itk, and MEKK2 (Rajagopal, Sun), as 
well as the ability to stimulate calcium mobilization, TSAd is able to affect multiple 
pathways leading to the transcription of cytokine genes. The Lck-interacting molecule 
(LIME) is an adaptor molecule involved in the regulation of T-cell activation following co-
receptor ligation with either CD4 or CD8. CD4 or CD8 ligation is able to activate LIME, 
whose function enables the proximal association of Csk and Lck (via binding to the Lck 
SH2 domain (Hur)), so that Csk is able to negatively regulate the activity of Lck following 
receptor engagement (Brdickova). The Lck SH3 domain has also been shown to recognize 
and bind scaffold proteins, such as SLP-76 (Sanzenbacher), which complexes and localizes 
various signaling proteins to enable the efficient transmission of activating signals 
downstream of receptor ligation. The linker for activation of T-cells (LAT, a 
transmembrane scaffolding protein) is able to recruit SLP-76 to the membrane, where the 
Syk family member, ZAP-70, is able to bind and phosphorylate these adaptor proteins 
(Wardenburg). Scaffolding molecules rely on the activity of tyrosine kinases, as they lack 
intrinsic kinase activity. SLP-76 and LAT interactions are important for T-cell activation, 
   25 
 
as they recruit phospholipase Cγ1 (PLCγ1), the guanine nucleotide exchange factor VAV, 
the Tec family kinase interleukin2-inducible T-cell kinase (Itk), and the Src family PTK, 
Lck (Jordan). With these proteins localized together, they are able to rapidly interact to 
release intracellular calcium stores and facilitate downstream activating signals required 
for complete T-cell activation. 
G. SH3 Domain Interactions. SH3 domains are important protein-protein binding 
domains, and are utilized by many proteins to facilitate functional interactions. To 
understand the specific requirements for the Src kinase, Lck, with regard to its SH3 
domain, it is important to further examine the structure of Lck and how these domains 
interact. Following the conserved SH2 domain, there is a two amino acid polypeptide 
linker region that connects the SH2 and SH3 domains in all nine of the Src PTKs (Eck), 
which is important for the aforementioned intramolecular interactions. Src SH3 domains 
are formed by five β-strands and contain two protruding loops (RT and n-Src loops) that 
border the hydrophobic and aromatic residues of the proline recognition site (Musacchio, 
Noble, Yu). This structure confers a binding orientation for class I ligands of the RxxPxxP 
motif (the class II ligands are named due to their opposing binding orientation to class I 
ligands) (Feng). This orientation is particularly sensitive to the position of a basic residue 
(usually arginine) relative to the core proline residues (Feng). Polyproline SH3 domain 
ligand binding occurs at the hydrophobic patch formed by the loops and at a point of 
contact between the β4 and β5 strands (Larson). Although the specific mechanisms and 
roles for interactions with the Lck SH3 domain have not yet been fully elucidated, several 
proteins known to be important for TCR signaling have been identified as binding partners 
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for the Lck SH3 domain, including: LckBP1 (identical to HS1; important for B- and T-cell 
selection) (Takemoto, Taniuchi), phosphatidylinositol-3-OH kinase (PI-3-kinase) (Prasad, 
Vogel), c-Cbl (adaptor molecule, ubiquitin ligase, lipid raft localization) (Hawash), and the 
T-cell co-stimulatory molecules, CD28 (Holdorf) and CD2 (Bell). 
In vitro studies have investigated the importance of the Lck SH3 domain with 
regard to T-cell activation using a J.CaM1 cell line containing an Lck SH3 domain mutant. 
This body of work has indicated that the Lck SH3 domain is critical for activation of the 
mitogen activated protein kinase (MAPK) pathway, as indicated by reduced Erk induction, 
but not for early TCR signaling events (including TCR zeta chain phosphorylation and 
ZAP-70 recruitment and activation) (Denny‘00, Patel), which rely more heavily on the 
function of the Lck SH2 and kinase domains. 
In order to further investigate the observed defect in Erk induction following TCR 
ligation in Lck W97A T-cells in vitro, Li et al. examined potential downstream signaling 
mediators leading to MAPK pathway activation. TCR/CD4 engagement leads to the 
association of Lck and Raf-1, and the subsequent activation of Raf-1 (Popik). Tyrosines 
340 and 341 are required for activation of Raf-1, and have been shown to be activated by 
Src kinases (Fabian). Li et al. have shown that defective Erk induction by TCR ligation of 
Lck W97A T-cells in vitro, occurs as a result of defective Lck activation of Tyrosines 
340/341 on Raf-1. 
Aside from a role for Lck in proximal TCR signaling events, it has also been 
implicated downstream of TCR signaling as a regulator of TCR/co-stimulation-induced 
lipid raft formation/recruitment to the TCR contact “cap”.  Lipid rafts are considered to be 
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microdomains rich in glycolipids, cholesterol, and saturated phospholipids, and are 
embedded with various cellular proteins (Simons). Previous work has indicated that T-cell 
co-stimulation is able to induce lipid raft recruitment to the TCR, enabling the association 
of various receptors and signaling molecules with the TCR (Moran, Tavano, Viola ’99). 
CD28 co-stimulation in T-cells has been shown to rely on the Lck SH3 domain in vitro 
(Holdorf). Moreover, the Lck SH3 domain has been implicated as an important mediator of 
TCR/CD28 co-stimulation-induced lipid raft aggregation as well as sustained TCR/CD28 
co-stimulation-induced protein tyrosine phosphorylation and IL-2 production (Patel). In 
order to study the role of the Lck SH3 domain in lipid-raft/immunological synapse 
formation, cells of the BI-141 T-cell hybridoma cell line were modified to contain a 
mutation in the Lck SH3 domain, ablating the function of this domain. Patel et al. found 
that the Lck SH3 domain was not only important for the recruitment of the TCR into lipid 
rafts in a co-stimulation-dependant fashion using this cell line model, but prolonged TCR 
engagement and signaling for this process is defective in T-cells lacking Lck SH3 domain 
function. 
Once lipid rafts aggregate in response to co-stimulation, a more compact synapse 
structure forms between immune cells. The lymphocyte function-associated antigen-1 
(LFA-1), a leukocyte integrin, binds to the inter-cellular adhesion molecule-1 (ICAM-1), 
to promote conjugate formation between T-cells and APCs in an Ag-dependent fashion. 
This interaction results from “inside-out” signaling downstream of surface receptor 
stimulation that alters the adhesive state of integrins. Actin accumulation and cytoskeletal 
reorganization occur following receptor ligation, to assist the interactions that occur at the 
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T-cell/APC binding site. A role for the Lck SH3 domain in this process has been shown by 
Morgan et al., who demonstrated that the Lck SH3 domain is required for conjugate 
formation, without relying on the activity/function of ZAP-70, implying a role for Lck to 
effect LFA-1-dependant conjugate formation via SH3 domain interactions independent of 
ZAP-70. Lck-deficient T-lymphocytes, and those having a mutation in the Lck SH3 
domain, both have significant defects in actin-remodeling and LFA-1 recruitment during 
T-/B-cell conjugate formation, irrespective of the function of the MAPK protein, Mek1 
(Morgan). In order to fully understand how Lck could be modulating conjugation, the 
effects of Lck on cytoskeletal reorganization have also been examined. The guanine 
nucleotide exchange factor (GEF), Vav-1, is an important regulator of Rho family 
GTPases, which are important for the process of actin remodeling. Defective Lck activity 
downstream of CD28 signaling has been implicated as having significantly negative effects 
on Vav-1-dependent Rac-1 activity and NF-AT activation, and thus, defective cytoskeletal 
remodeling and conjugate formation (Carey, Michel). Moreover, interference with Lck-
dependant activation of the Rho protein, CDC42, at the APC interface interrupts conjugate 
formation (Cannon’01). CDC42 is required for the activation of the Wiskott-Aldrich 
Synrome protein (WASp). Activation of WASp allows it to activate the Arp1/2 complex 
resulting in nucleation of F-actin. Dlgh1, a member of the membrane-associated guanylate 
kinases (MAGUK) family of molecular scaffolds, acts to bring together Lck, Zap-70 and 
WASp downstream of TCR/CD28 ligation to assist T-cell synapse formation and function. 
The SH3 domain of Lck has been shown to bind Dlgh1 and assist its localization at the 
membrane so that it can act as a scaffold for the secondary signaling molecules required 
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for antigen-induced actin polymerization and raft clustering (Round). Lck has therefore 
been proposed to play a role at two stages during TCR/CD28 signaling for synapse 
formation by positively affecting CDC42 function and Dlgh1 localization resulting in actin 
accumulation and synapse formation. 
While Lck has been implicated in signaling affecting various signaling cascades 
and protein-interactions, it has also been hypothesized as a critical mediator of pathogen 
invasion of immune cells. In order to examine the potential role that Lck may play in the 
pathogenesis of Plasmodium, it will be necessary for me to provide some background on 
malaria and what is known so far about infection by this protist. 
 
III. Immunity to Plasmodium. 
Malaria is considered to be an infection with the eukaryotic microorganism, 
Plasmodium, a genus of parasitic protozoa of the family Plasmodiidae. The genome of this 
organism consists of 14 chromosomes, one mitochondrion, and a plastid. Four species are 
known to infect humans, and more than 200-300 million people present with acute malaria 
infections each year. Infection by plasmodium is a leading cause of death in the tropics, 
claiming the lives of more than 3 million persons annually (Bjorkman), with the majority 
of these being children in sub-Saharan Africa. 9 out of 10 deaths from malaria are due to 
the highly fatal strain Plasmodium falciparum. 
 A. In the Beginning: The Foundation of Discovery. There is a long history that 
has lent itself to the study of malaria. Several major advances had their beginnings after 
Dr. Ronald Ross was awarded the Nobel Prize in 1902 for his work in 1898, demonstrating 
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the presence of Plasmodium in the midgut and salivary glands of the Culex mosquito. This 
work, combined with that of Dr. Giovanni Battista Grassi, who determined that only the 
Anopheles mosquito was able to transmit the human-infective plasmodium, and is also 
credited with the characterization of the complex plasmodium life-cycle, have provided 
critical insight for the life-and-death struggle against one of the world’s deadliest diseases. 
B. Plasmodium Life-Cycle and Pathology. There are two main stages of the life 
cycle of the parasite which requires two hosts: a female mosquito vector and a vertebrate 
host. Only female mosquitos are able to transmit the parasite, as only female mosquitos 
bite. This is believed to be due to the increased requirement for protein by the females, 
which rely on blood as well as the common nectar meals, in order to lay eggs. Following 
host infection, sporozoites are able to travel to the liver and rapidly infect hepatocytes. 
During the course of about a week, the hypnozoites (latent stage sporozoites) differentiate 
into the morphologically different merozoite stage, and rapidly replicate to such an extent 
(one sporozoite is believed to develop 30,000-40,000 merozoites) that they burst the 
hepatocytes (Nardin). Hypnozoite reactivation has been observed for P. malaria, P. ovale, 
and P. vivax, and can occur up to thirty years after initial infection of the host. Merozoites 
target and infect erythrocytes, where they take on a trophozoite form (ring form), and 
asexually divide during the schizont stage to such an extent that the red blood cells (RBC) 
swell and lyse, allowing renewed erythrocyte infection by the new merozoite population 
every 2-3 days (depending on the species of plasmodium), and result in the characteristic 
“cycles” of “malaria fever” (resulting form merozoite secreted molecules which stimulate 
the host inflammatory immune response) every 4-5 days. Splenomegaly is observed, as the 
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reticuloendothelial system tries to clear the infected RBCs, and the host presents with 
anemia, as the patient is deprived of their red blood cell population due to parasite 
infection. Some asexual parasites are able to take on gametocyte form (both male and 
female) that can be ingested by mosquitoes during a blood meal; and gametes can fertilize 
each other in the mosquito midgut to create motile zygotes termed ookinetes, that mature 
into sporozoites in the gut membrane and migrate to the salivary glands for infection of a 
new vertebrate host. Symptoms from an initial host infection can take approximately 1-2 
weeks to appear. 
Of the hundreds of species of plasmodium, only four are known to infect humans, 
and of these, only P. falciparum, and P. vivax are known to lead to fatality. The major 
cause of death is due to occlusion of brain microvessels by infected RBCs following P. 
falciparum infection (Miller). Specific immunity is acquired slowly, and is rarely long-
lived. Immunity to plasmodium is partly mediated by cytotoxic T-cell killing of infected 
hepatocytes and the subsequent induction of more specific Ag-induced T-cell proliferation 
and Ab-induced IFNγ production during the blood stage infection (Good ‘98, Miller). 
Several key antigens have been discovered to induce effector CD4+ and CD8+ T-cell 
function, including the sporozoite circumsporozoite protein (CS) (Plebanski ’97, ’99), the 
sporozoite thrombospondin related adhesive protein (TRAP) (Flanagan), and the P. 
falciparum-specific merozoite protein 1 (PfMEP1) (Newbold). These antigens are being 
intensively studied for their ability to induce immunity and protection against these stages 
of infection in the human host. No vaccine has successfully induced strong immunity using 
single antigens alone, even including those of CS (Good ‘98, Herrington, Nardin). 
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Although pre-erthyrocytic Ag-immunization can confer host protection from hepatocyte 
infection by plasmodium, it is only able to protect if there is sufficient induction of the 
CD8+ T-cell dependant IFN-γ response (Gilbert, Good ’99, Plebanski ’98, Schneider, 
Sedegah). The most effective vaccine candidate available is one that uses irradiated 
sporozoites to induce a strong CD8+ T-cell-dependant IFN-γ response (Good ’99). Aside 
from Ag-vaccines, there are plasmid DNA vaccines (Wang), non-replicating vector 
vaccines: Ty-particles/modified vaccinia virus Ankara (MVA) (Gilbert, Plebanski), and 
recombinant hepatitis B fusion protein particles in conjunction with MPL and QS-21 
adjuvants (Herrington) which all show great promise in Phase I and Phase II vaccine trials. 
Antigenic polymorphisms, poor antigen immunogenicity, parasite-induced 
immunosuppression, and the complex parasite life-cycle all contribute to the difficulty of 
effective vaccine development, and encourage the use of multi-factoral vaccine 
approaches. 
More recent work has indicated a critical interaction between the Plasmodium 
falciparum sporozoite TRAP protein (type 1 membrane protein important for motility and 
liver cell invasion) and the Src family tyrosine kinase, Lck, for proper localization and 
infection of sporozoites within hepatocytes (Akhouri). Furthermore, this association has 
been shown in the HepG2 liver cell line, and has illustrated the requirement for the SH3 
domain binding for this interaction (Akhouri). Experiments using TRAP null sporozoites 
have shown that these sporozoites are unable to infect mosquito salivary glands and the 
liver of the vertebrate host (Sultan). If an antagonizing agent were used to disrupt the Lck 
SH3 domain interaction with the sporozoite TRAP protein, it is possible that the 
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sporozoites would not be able to properly infect hepatocytes in a vertebrate host, and there 
would be no subsequent malaria infection following sporozoite entry into the host.  
Furthermore, previous work has shown that the Ixodes scapularis tick salivary protein, 
Salp15, is able to reduce T-cell activation by inhibiting Lck activity downstream of CD4-
assisted TCR signaling (Juncadella). Therefore, it is possible that salivary proteins are able 
to directly act on Lck activity, and may affect its ability to interact with the sporozoite 
TRAP protein. 
C. Vector Contributions to Plasmodium Pathology. Sporozoite infection models 
have, until recently, not included the role of the vector in the infection process. Extended 
use of malaria prophylactics such as Doxycycline, Tetracycline, and Larium, has resulted 
in the emergence of skin rashes that are subsequently treated with anti-histamines, such as 
Benadryl. A notable finding was that use of Benadryl, while it cleared the rashes on the 
patients, was, more importantly, able to induce some level of protection of the host against 
malaria. This led to comparisons between i.v. injection and bite-administered sporozoite 
delivery, where sporozoite infection via mosquito bite was found to be more infectious 
(Vaughan). Partially as a result of this research, there has been increased investigation into 
the role of mosquito saliva and cells of the innate immune system, such as mast cells, 
which secrete histamine (vasoactive amine), and how these interactions play a role in host 
immunity to malaria (Beghdadi, Demeure, Depinay, Furuta). Increased pathogen 
infectivity has been shown with many arthropod vectors (Titus), and so the role of salivary 
components and their effect on immune regulation and parasite infection are not novel 
undertakings. These modulating effects include mast-cell TNF production (Furuta), saliva-
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induced histamine release (Demeure, Depinay), and histamine binding to H1R and H2R to 
increase plasmodium susceptibility (Beghadadi).  
Several proteins present in mosquito saliva have been identified as critical inducers 
of inflammation at the site of mosquito bites aside from histamine, including the induction 
of neutrophil chemotactic factor (NCF) in Anopheles stephensi (Owhashi). Furthermore, 
Aedes aegypti mosquito saliva has been shown to inhibit T- and B-cell responses 
(Wanasen, Wasserman), which has potential for hampering immune responses to infection 
with plasmodium. Contrary evidence has also been proposed by Donovan et al., indicating 
that pre-exposure in vivo to mosquito saliva skews the immune response to a Th1-type 
immunity, resulting in elevated and protective levels of IL-12, IFN-γ, and inducible nitric 
oxide synthase in a murine model of Plasmodium yoelii infection. Earlier studies using 
pre-exposure of mice to Ixodes sacpularis tick saliva conferred resistance to Borrelia 
bergdorferi (Wikel). This was also found to be true with repeated exposure to sand fly 
bites and subsequent Leishmanis spp. (Kamhawi). 
 The quest for a vaccine against malaria is evolving to include both factors of the 
vector and host, as well as combined immunization strategies against multiple stages of the 
Plasmodium life-cycle. 
 
IV. Dissertation Objective. 
In order to fully understand the role of the Lck SH3 domain in T-cell development, 
activation and function in vivo, our laboratory created a novel animal model by designing a 
construct with a knock-in mutation of the lck allele with a critical amino acid change in the 
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Lck SH3 domain (W97A). This point mutation has previously been shown to ablate ligand 
binding (and function) of the SH3 domain (Denny’99, Patel). Lck is known to be involved 
in thymocyte signaling via the pre-TCR and TCR (Hashimoto, Levin, van Oers), but it was 
not until recently that a role for the Lck SH3 domain has been shown in vivo for this 
process. Data from our lab using thymocytes from Lck W97A mice has shown that 
ablation of Lck SH3 domain function in vivo results in defective development of CD4+ 
and CD8+ thymocytes, as well as reduced activation of the MAPK pathway (Erk 
activation), while early TCR signaling (including TCR zeta chain phosphorylation and 
ZAP-70 recruitment and activation) appear unaltered (Rudd‘06). 
The work of this thesis has expanded the investigation of the role of the Lck SH3 
domain in vivo with regards to peripheral T-lymphocytes in order to examine its relevance 
in T-cell activation and function, including in vivo immune responses to antigen and 
parasite infections. 
Moreover, novel reports have raised questions as to the relevance of Lck SH3 
domain function in the pathology of malaria. As there is currently no vaccine for malaria, it 
was the purpose of a brief internship during the course of this dissertation research to 
investigate malara and the role that the vector plays in host immunity, as well as to attempt 
to translate cell line data indicating a role for Lck SH3 domain in hepatocyte infection by 
sporozoites into ex vivo analysis of this hypothesis.








I. Animals and Media Reagents 
 A. C57BL/6 mice. C57BL/6 mice were obtained from the Jackson Laboratory (Bar 
Harbor, ME). Lck W97A mice, generated by our laboratory (described in Rudd ’06), were 
backcrossed to the C57BL/6 strain for 8 generations and maintained in specific pathogen 
free housing until use. Experimental mice were age and sex-matched. Mice were used 
between 6 and 12 weeks of age. All animal studies were reviewed and approved by the 
IACUC of Virginia Commonwealth University, Richmond, VA (Protocol #0508-3117). 
 B. OT-1 mice. OT-1 Tg mice were obtained from the Jackson Laboratory (Bar 
Harbor, ME). Lck W97A mice were backcrossed onto the OT-1 background for three 
generations and maintained in specific pathogen free housing until use. Experimental mice 
were age and sex-matched. Mice were used between 6 and 12 weeks of age. All animal 
studies were reviewed and approved by the IACUC of Virginia Commonwealth 
University, Richmond, VA (Protocol #0508-3117). 
C. OT-2 mice. OT-2 mice were obtained from the Jackson Laboratory (Bar 
Harbor, ME). Lck W97A mice were backcrossed to the OT-2 line for 5 generations and 
maintained in specific pathogen free housing until use. Experimental mice were age and 
   37 
 
sex-matched. Mice were used between 6 and 12 weeks of age. All animal studies were 
reviewed and approved by the IACUC of Virginia Commonwealth University, Richmond, 
VA (Protocol #0508-3117). 
D. Mice for Plasmodium Studies. C57BL/6, OT-1 and OT-2 mice were obtained 
from Charles River Laboratories International, Inc. (L'Arbresle Cedex, France) and 
maintained in aseptic housing until use. Experimental mice were age and sex-matched. 
Mice were used between 6 and 12 weeks of age. All animal studies reviewed and approved 
by the IACUC of the Institut Pasteur, 28 Rue Dr. Roux, Paris, France. 
E. Media Reagents. Dulbecco’s modified Eagle’s medium, 1x (DMEM) 
(Mediatech, Inc., Herndon, VA, Cat# 15-013-CM) was used throughout. Media was 
supplemented with 10% fetal bovine serum (HyClone, Logan, Utah, Cat# SH30071.03), 
5ml. of nonessential amino acid solution for MEM 100x (cellgro, Mediatech, Herndon, 
VA, Cat# 25-025-CI), 5ml. of penicillin, streptocmycin, L-Glutamine 100x (Invitrogen, 
San Diego, CA, Cat# 10378-016), and 50μM β-mercaptoethanol (Calbiochem, San Diego, 
CA, Cat# 444203). Stored at 4°C. NB: New β-mercaptoethanol was added every 6 weeks if 
entire solution was not used by this point. 
 
II. Analysis of Cell Surface Phenotype. 
Single cell suspensions were made from lymph nodes (inguinal, brachial, cervical, 
axillary) and spleen. Lymph node single cell suspensions were made by physical disruption 
of nodes through a nitex nylon mesh (Sefar America Inc., Kansas City, MO, Cat# 03-
100/32) in 2ml Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% 
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fetal bovine serum, L-glutamine, nonessential amino acids, penicillin, streptomycin, and 
50μM β-mercaptoethanol in 35mmx10mm cell culture dishes (Corning, Corning, NY, 
Cat#430165). Splenic preparations were used following RBC lysis (Ack Lysing Buffer, 
Quality Biological, Inc., Gaithersburg, MD, Cat#118-156-101). The surface antigens of 
primary murine lymphocytes were evaluated by flow cytometry following cell surface 
staining with 20μg/ml fluorochrome-conjugated antibodies recognizing CD4, CD8, TCRβ, 
CD90.2, CD69, CD25, CD44, and/or CD62L. All antibodies were obtained from BD 
Biosciences (San Diego, CA, CD4-PE L3T4, GK1.5: Cat#553730, CD8-FITC 53-6.7: 
Cat# 553031, Biotin anti-mouse CD8α (Ly-2, 53-6.7) Cat# 553028, TCRβ -FITC H57-
597: Cat#553171, CD90.2-PE 53-2.1: Cat# 553005, CD69-FITC H1.2F3: Cat# 557392, 
CD25-FITC (IL-2R α xhain, p55, 7D4) Cat# 553071, Biotin anti-mouse CD44 (Pgp-1, 
Ly-24, 1M7) Cat# 553132, CD62L-FITC (L-selectin, LECAM-1, Ly-22, MEL-14) Cat# 
553150, Streptavidin-PE-Cy7 (Sav-PE-Cy7) Cat# 557598. Cells were analyzed by 
FACS. 
 
III. In vitro Cell Stimulations for Proliferation and Cytokine Production. 
A. C57BL/6 mice. Single cell suspensions of primary murine lymphocytes were 
labeled with 2.5μM CFSE (Sigma, St. Louis, MO, Cat# 21888, 100mM stock dissolved in 
DMSO, store in light-proof vial). Briefly, cells were washed and resuspended in 1x PBS at 
a concentration of 5x106 cells/ml. An equal volume of CFSE in 1xPBS was added and 
slowly rotated every minute for five minutes (it is critical to never vortex the CFSE at any 
stage). Equal volume of ice cold FBS and ~10ml ice cold DMEM complete was added to 
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stop the reaction. Cells were spun at 309.66xg for 7 minutes, washed 1-2 times with ice 
cold DMEM complete and resuspended in room temperature DMEM complete and plated 
at 1.25x106 cells/ml with a total volume of 1 ml in 24 well tissue culture plates (Becton 
Dickinson, Franklin Lakes, NJ. Cat# 35-3047). In experiments where supernatants were 
harvested, T-cells were purified by negative selection using magnetic beads (Miltenyi 
Biotec, Auburn, CA. Cat# 130-090-861, used per manufacturer’s recommendations) before 
plating. Cells were stimulated with 0.1-10μg/ml bound or soluble anti-CD3 (145-2C11, 
BD Pharmingen, San Diego, CA, Cat#553058) and/or 1μg/ml anti-CD28 (BD Pharmingen, 
San Diego, 37.51, Cat# 557393) antibodies (with or without 10ng/ml phorbol-12-
myristate-13-acetate (PMA, Calbiochem, San Diego, CA, Cat# 524400). Cells cultured in 
DMEM complete were incubated at 37°C, 7.5%CO2 for 48 hours. For CFSE analysis, cells 
were stained with anti-CD90.2 for T-cell gating, and intensity of CFSE staining was 
analyzed by FACS. For IL-2 analysis, supernatants were harvested after 24 hours and 
analyzed using the OptEIA mouse IL-2 ELISA kit (BD Pharmingen, San Diego, CA, 
Cat#555148) per manufacturer’s protocol. Briefly, 96 well flat-well MaxiSorp plates 
(NUNC via Fisher Scientific, Pittsburgh, PA, Cat# (F96) 12-565-135) were coated with 
mIL-2 capture Ab O/N at 4°C. Wells were washed and blocked at RT for one hour. Culture 
supernatants were incubated at RT for two hours following which the working detector 
was added for 1 hour at RT and detected with substrate detection and ELISA reading. All 
substrates purchased with the kit or made following manufacturer’s recipe protocols. 
*handy reference for conversion of RPM to xg: 
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https://www.msu.edu/~venkata1.gforce.htm. Otherwise, formula used is g=(1.118x10-
5)RS2, where g is the gravitational force, R is radius of the rotor, and S is the RPM value. 
B. OT-1 mice. Single cell suspensions of primary murine lymphocytes from both 
Lck W97A and WT OT-1 Tg mice were labeled with 2.5μM CFSE, as described above. 
Splenocytes were harvested form WT OT-1 Tg mice and used following RBC lysis and 
irradiation by 2,000 RADS. Cells were plated in 24 well tissue culture plates at a 
concentration of 2x107cells/ml in 1ml of culture media with a LN:Spl ratio of 1:2. Plates 
were briefly centrifuged at 150xg for 5sec. before incubation at 37°C with 7.5%CO2. 
SIINFEKL peptide was used at doses of 0.003, 0.003, 0.03, 1, and 3μg/ml (Sigma 
Genosys, The Woodlands, TX, Peptide Cat#99058-1). Cells were harvested at 48 hours 
and analyzed by FACS as described above. 
 
IV. Activation Marker Induction. 
Single cell suspensions of primary murine lymphocytes were plated at 0.5x106 
cells/ml in 24 well tissue culture plates and incubated in DMEM complete with various 
doses of soluble anti-CD3 (2C11) for 4 hours at 37°C, 7.5%CO2. Cells were then stained 
with anti-CD90.2 and anti-CD69 conjugated fluorochromes (see reference above for 
product information) and analyzed by flow cytometry. 
 
V. TCR Signaling Analysis- Western Blot Protocol. 
Single-cell suspensions of primary murine T-lymphocytes were purified by 
negative selection (Miltenyi Biotec, Auburn, CA) and used at a concentration of 2-4 x 107 
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cells/ml in HEPES-buffered saline (25mM HEPES, 125mM NaCl, 5mM KCl, 1mM 
Na2HPO4, 1mM CaCl2, 0.5mM MgCl2, pH 7.4). 50μl cell suspension (~0.64x106 cell 
equivalents) was warmed at 37°C and stimulated with 3-5 μg/ml anti-CD3 antibody 
(2C11) for three minutes. Cells were lysed with 15μl 1%NP-40 with phosphatase and 
protease inhibitors (*) and insoluble material was removed by centrifugation at 300xg for 
10 minutes at 4ºC. Lysates were denatured by the addition of equal volume sodium 
dodecyl sulfate (SDS) sample buffer with β-Mercaptoethanol  (1ml 2x SDS-sample buffer, 
50μl 0.2% Bromophenol Blue) and incubation at 100°C for 3-4 minutes. Samples were 
analyzed by western blotting following SDS-gel electrophoresis and transfer to PVDF 
membrane Millipore Corporation, Bedford, MA, Immobilon-P, Cat#IPVH00010). Briefly, 
samples were run on an 8% polyacrylamide gel and run on a Bio Rad electrophoretic 
apparatus at constant current (12mAmp) and transferred onto an equilibrated PVDF 
membrane (equilibrated with MeOH and rinsed with 1xTBST) on a Bio Rad Trans-Blot-
SD, semi dry transfer machine at 24Volts for 35 minutes. The membrane was then blocked 
with either a filtered (Fisher Scientific, Pittsburgh, PA, 0.2μm syringe filter. Cat# 190-
2520) 3%BSA/1xTBST solution O/N at 4ºC for total mAbs or in a 2-5%milk/1xTBST 
solution for 15min.-1hr. RT and probed with phospho-mAbs O/N at 4ºC. Primary 
antibodies recognizing Lck (BD Biosciences, San Jose, CA, Cat#610098), PLC-γ1 (Cell 
Signaling, Danvers, MA, Cat#2822), P- PLC-γ1 (Biosource, Carlsbad, CA, P-PLCγ1 
Cat#44-696G), Erk (Cell Signaling Technology, Inc., Danvers, MA, p44/42 MAP 
Cat#9102), P-Erk, (Cell Signaling Technology, Inc., Danvers, MA, P-p44/42 MAP 
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Cat#9101S), 4G10 (Upstate, Charlottesville, VA, Cat#05-321), ZAP-70 (Cell Signaling 
Technology, Inc., Danvers, MA, Cat# 2705), P-ZAP-70 (Cell Signaling Technology, Inc., 
Danvers, MA, Tyr493, Cat# 2704), P38 (Cell Signaling Technology, Inc., Danvers, MA, 
Cat# 9212), P-P38 (Cell Signaling Technology, Inc., Danvers, MA, Thr180/Tyr182, Cat# 
9211S), P-LAT (Biosource, Camarillo, CA, Cat# 44-228), SLP-76 (Cell Signaling 
Technology, Inc., Danvers, MA, Cat# 4958), and CamKII (kind gift of Dr. Tombe’s 
Laboratory, VCU) were detected by incubation with primary antibodies and HRP-
conjugated secondary antibodies (Southern Biotech, Birmingham, AL, Cat# 1010-05 HRP-
Goat anti-mouse Ig (H+L) human adsorbed, Invitrogen, Carlsbad, CA, Cat# 65-6120 HRP-
Goat anti-rabbit IgG (H+L)) and detected using chemiluminescence (SuperSignal West 
Pico Chemiluminescent Substrate, Thermo Scientific, Rockford, IL, Cat# 34080). *for 1 
ml lysis buffer: 10μl 1M NAF, 10μl 40M Na3VO4, 10μl 100mM PMSF, 10μl 40mM 
EDTA, 10μl 1mg/ml leupeptin, 959μl 1% NP-40. 
 
VI. Calcium Mobilization. 
 Single-cell suspensions of primary murine T-lymphocytes were washed and 
resuspended in warm HEPES-buffered saline (25mM HEPES, 125mM NaCl, 5mM KCl, 
1mM Na2HPO4, 1mM CaCl2, 0.5mM MgCl2, pH 7.4) at a concentration of 3x106 
cells/1.5ml. 1.5μl Fura 2 (Fura-2, AM, Invitrogen, Eugene, OR, Cat# F1221) was added to 
cell suspension and placed in a 37°C incubator for 30min. 1.5ml HEPES was then added to 
the cell suspension and cells were spun at 269.75xg for 7min. Cells were washed again 
with 1.5 ml. HEPES, resuspended in a total volume of 1.35ml HEPES, and incubated at 
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37°C for 30min. 90μl of cell suspension was added to designated wells of a glass bottom 
plate (glass bottom 96-well plates No. 1.5, Uncoated, γ-irradiated, MatTek Corporation, 
Ashland, MA, Part No. P96G-1.5-5-F). 2μl stock biotin-anti-CD3α (2C11) was added to 
the negative control and stimulation wells. A separate 96-well reagent plate (Becton 
Dickinson, Franklin Lakes, NJ. Cat# 35-3047) with a base volume of 200μ HEPES was 
used to load the stimulations. Added to the reagent plate was: 1) warm HEPES alone for 
negative control, 2) 20μl stock Peroxidase labeled anti-biotin (Vector Laboratories, 
Burlingame, CA, Cat#SP-3010) to cross-link anti-CD3 mAb in stimulated samples, and 
2μl of a 1mM Ionomycin was added for the positive control. Automatic injections of 10μl 
from the reagent plate were added at a designated injection point and kinetic time points 
were taken using a NOVO Star plate reader (NOVO Star S/N 700-0122, BMG Labtech, 
Offenburg, Germany) at 10 flashes per time point. Ratiometric analysis was determined 
from the ratio of fluorescence at 340- and 380-nm excitation λ (emission 510-520 λ). 
 
VII. In vitro Conjugation. 
In order to examine conjugate formation between T-and B-cells, OT-2 LN T-cells 
were harvested from WT and W97A C57BL/6 mice. Splenocytes were harvested and lysed 
(previously described) from the spleens of OT-2 WT mice and placed at a concentration of 
3x106 cells/tube in 15ml Falcon polypropylene culture tubes (Fisher Scientific, Pittsburgh, 
PA, Cat#352059) (approx. volume 150ul/tube). 500μl 1xPBS was added to each tube and 
then spun at 309.66xg for 7min. Supernatants were aspirated and cells resuspended in 
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500μl 1xPBS. 25μl of a 10mg/ml ova stock (Sigma, St. Louis, MO, Chicken ovalbumin, 
Cat#A5503) solution was added per tube (500μl volume) into 4 of the 5 tubes (the 5th is a 
negative control). The tubes were then incubated at 37ºC for 1 hr (7.5%CO2). Following 
the incubation, the volume of each tube was split into two separate conical tubes A and B 
(250μl each): so that one half of the cell content is designated A and the other half 
designated B. The cells were then washed with 1ml 1xPBS. Cells were resuspended in 
200μl 1xPBS. 
1x106 LN from WT mice were added to the A series of tubes, and 1x106 cells from 
W97A C57BL/6 mice were added to the B series of tubes. This equals a T:APC ration of 
1:1.5. The tubes were pulse spun up to 500RPM and incubated at 37ºC for 5’, 10’, 15’, and 
30’ (7.5%CO2). When one set of tubes (A and B) were removed at the designated time 
interval, a 1:1 solution of 2% PAF was added and allowed to incubate at RT for 15’. The 
cells were subsequently washed with 1ml of a 0.5%BSA/PBS (BSA, Sigma, St. Louis, 
MO, Cat#A-3059) solution and spun at 1200RPM for 5’. Cells were resuspended in 0.5ml 
of the 0.5%BSA/PBS solution and stored at 4°C O/N. 
 The following day, the cells were stained by adding 230μl of the cells from each 
tube into Falcon FACS tubes (Fisher Scientific, Pittsburgh, PA, Cat#352008) and washed 
with 0.5ml 0.5%BSA/PBS solution. Following centrifugation at 1200RPM, cells were 
aspirated and resuspended in 30μl staining volume with the addition of 3μl B220-PE and 
3μl TCRβ-FITC flurorescent conjugated Abs for 20’ on ice in the dark (BD Biosciences 
Pharmingen, San Jose, CA, B220 (CD45R) RA3-6B2, Cat#553089, TCRβ, H57-597, 
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Cat#553171). Cells were then washed with 1ml 0.5%BSA/PBS and resuspended in 300μl 
1xPBS and analyzed by FACS for conjugate formation (double-staining for TCRβ and 
B220). 
 
VIII. Ag Immunization. 
A. DNP-KLH Ag Immunization. p56Lck W97A mice 4-6 weeks of age, sex- and 
age-matched with Jackson C57BL/6 wild type (WT) mice, were injected sub-cutaneously 
(s.c.) at the base of the neck with a 22G1” needle (BD, Franklin Lakes, NJ, Cat#305155) 
containing 100μg di-nitrophenol-keyhole limpet hemocyanin (DNP-KLH, Calbiochem, 
San Diego, CA, Cat# 324121) reconstituted in sterile de-ionized H2O in a 50/50 solution 
with Titer Max Gold adjuvant (Sigma, St. Louis, MO. T2684-127K1534, CAS 145380-33-
2), mixed using glass syringes, on day 0. A boost was performed on day 14 by injecting 
50μg DNP-KLH s.c. without adjuvant. Blood was drawn via tail vein nick on days 0 (pre-
immunization), 14 (pre-boost), and day 21 at time of sacrifice. Serum was collected by 
placing blood samples on ice for 1hr. and then spinning at 660.8xg for 5 min. and 
removing serum to new tube for storage at –20ºC until use. 
B. Heat-Killed Brucella Abortus Immunization.  
 Heat-killed Brucella abortus was a generous gift of Dr. Fred Finkelman. Stock 
solution (10% wet weight) was diluted to a 1:25. 200μl of the 1:25 dilution was injected 
i.p. into groups of either WT C57BL/6 or Lck W97A C57BL/6 mice. Blood was taken at 
days 4, 7, and 10 following immunization via tail vein nick (cardiac stick on day 10). 
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Blood was allowed to coagulate 30min-1 hour on ice and spun at 660.8xg for 5 minutes. 
Serum was collected and stored at –20°C until analysis by ELISA. 
C. In vitro Antigen Re-Stimulation. 
LN cells were isolated from DNP-KLH immunized animals following sacrifice on 
day 21 (see above). 200x105 lymphocytes were resuspended in 0.1ml media complete in a 
96 well flat-bottom plate (Falcon 96 well plate, BD Labware, Franklin Lakes, NJ, Cat#35-
3072). Various doses of DNP-KLH were added (0, 1μg, 10μg, 100μg/ml) and incubated 
for 48 hours at 37ºC, 7.5%CO2. After 48 hours incubation, 1μCi of [H3]-thymidine (Perkin 
Elmer, Waltham, MA) in complete media was added/well and allowed to incorporate for 
18 hours. Plates were then harvested using a Filtermate cell harvester onto GFC plates. 
Assays were read using a Topcount Plate Counter (Perkin Elmer, Waltham, MA). 
 
IX. Helminth Infection. 
A. Nippostringylus brasiliensis Infection. 
Lck W97A mice 4-8 weeks of age, sex- and age-matched with Jackson laboratories 
C57BL/6 WT mice were injected with 500-700 Nippostrongylus brasiliensis L3 larvae s.c. 
on day 0. Blood was drawn via tail vein nick on days 0 (pre-infection), 8, 11, 14, 18, and 
21 at time of sacrifice. Nippostrongylus brasiliensis L3 larvae were generously provided 
by Dr. Dan Conrad and Dr. Joe Urban. 
B. In vivo Cytokine Capture Assay.  
In vivo cytokine capture assay (IVCCA) was performed on days 5, 7, 10 and 12 of 
Nippostrongylus brasiliensis infection. To capture IL-4 for serum analysis, 10μg biotin-
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BVD4-1D11 anti-IL-4 antibody was prepared in a 2% autologous serum and injected i.p. 
Mice were bled 3-4 hours post injection and IL-4-biotin-anti-IL4 complexes were detected 
by coating microtiter ELISA plates with BVD6-24G2.3 and analyzed by luminescent 
ELISA as previously described (Urban’98). The IVCCA, and analysis of the same was 
generously provided and performed by Dr. Fred Finkelman’s laboratory. 
 
X. ELISAs. 
A. Ig ELISAs. For Ig analysis, mouse serum was collected on days 0, 14, and 21 
following DNP-KLH immunization or at days, 0, 8, 11, 14, 18, 21 following 
Nippostrongylus brasiliensis infection. 
     1. Total IgE ELISA. For total IgE ELISAs, 96 well microtiter plates were 
coated with 10μg/ml BIE3 (Generous gift of Dr. Dan Conrad) in BBS (to 350ml deionized 
H2O add: 41.2g Boric Acid (H2BO4), 29.2g NaCl, q.s 4L and pH 8.5) O/N at 4°C 
(50μl/well). Plates were washed twice with deionized water and blocked (1/100 dilution of 
10mM Hepes, 2%FCS, in 1xPBS) for 1hr. at 37degC (70μl/well). Plates were washed 
twice in deionized water and standards (starting at 1,000ng/ml) and serum (at various 
dilutions) were added for 2 hrs. at 37ºC (50μl/well). Plates were washed twice with water, 
twice with 1xPBS/0/02% Tween-20, and then twice with water and biot-R1E4 (Generous 
gift of Dr. Dan Conrad) was allowed to bind for 1 hr. at 37ºC (50μl/well) when plates were 
washed as previously described. A 1/400 dilution of StreptAvidin –AP (Southern Biotech, 
Birmingham, AL, Cat#7100-04) was allowed to bind for 1 hr. at 37ºC (50μl/well). Plates 
   48 
 
were washed as above, and developed using 100μl/well substrate solution (into 300ml H2O 
add: 0.1g MgCl2•6H2O, 0.2g NaN3, 50ml Diethanolamine, q.s. to 500ml and pH to 9.8. 
Add 1 P-Nitrophenyl Phosphate Disodium Salt substrate tablets (Sigma, St. Louis, MO, 
Cat#S0942-200Tab) Tablet/5ml solution for a final concentration of 1mg/ml. Plates were 
read at OD 405/650 on an ELISA reader. 
     2. Ag-Specific ELISA. For Ag-specific Ig ELISAs, microtiter plates were 
coated with 5μg/ml DNP in BBS, or 5μg/ml unlabeled isotype specific goat anti-mouse 
IgG1, IgG3, or IgG2b O/N at 4degC (Southern Biotech, Birmingham, AL, Cat #1070-01, 
1100-01, 1090-01, respectively, 50μl/well). Plates were washed twice with deionized water 
and blocked for 1 hr. RT. Plates were washed as before and standards and samples were 
diluted in block buffer and plated for 1hr. at 37ºC (50μl/well). Plates were washed 2x 
water, 2x PBS/Tween-20, 2x water and goat anti-mouse isotype specific Ap-tagged Abs 
(Southern Biotech, Birmingham, AL, Cat# 1070-04, 1100-04, 1090-04, respectively) were 
used at a 1/400 dilution for 45min. at 37ºC (50μl/well). Plates were washed as before and 
developed using 50μl/well substrate (as described previously). Plates were then read at OD 
405/650 on an ELISA reader. 
 B. IFN-γ ELISA. Blood was collected from experimental mice via tail vein nick on 
days 4, 7, and 10 following immunization with heat-killed Brucella abortus. Serum was 
collected and analyzed using BD Biosciences BD OptEIA Mouse IFN-γ (AN-18) kit (BD 
Biosciences-Pharmingen, San Diego, CA, Cat# 551866) per manufacturer’s recommended 
protocol. 
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XI. In vitro T-Cell Differentiation. 
In vitro studies were performed by Jane Hu-Li of the Bill Paul Laboratory, NIAID. 
Briefly, primary murine CD4+ T-cells were negatively purified using a selection of biot-
fluorochromes (BD PharMingen) and biot-microbeads using a MACS column. 
Specifically, FITC-conjugated fluorochromes were used for: anti-CD8 (53-6.7; 
Cat#553031), anti-CD45R/B220 (RA3-6B2; Cat#553088), anti-I-Ab (AF6-120.1; 
Cat#553551- for C56BL/6), anti-CD16/32 (2.4G2; Cat#553144), anti-CD24 (M1/69; 
Cat#553261), anti-NK1.1 (PK136; Cat#553164-not on BalbC), anti-CD11b (M1/70; 
Cat#553310), anti-CD49b/Pan NK cells (DX5; Cat#553857), and anti-Ly-6G (Gr-1) and 
Ly-6C (RB6-8C5; Cat#553127). Cells were then cultured in 24-well plates/1ml volume 
media with or without 5ng/ml IL-2, and cytokines were added at final concentrations as 
follows: 
For Th1 Differentiation: anti-IL-4 (10μg/ml), Mouse IL-12 (10ng/ml), anti-CD3 
(1μg/ml), and/or anti-CD28 (1μg/ml). 
For Th2 Differentiation: IL-4 (2ng/ml), anti-IFN-γ1 (10μg/ml), Anti-IL-12 
(10μg/ml), anti-CD3 (1μg/ml), and/or anti-CD28 (1μg/ml). 
If the cells grew quickly, new reagents should be added (minus the anti-CD3 and 
anti-CD28 stimulations). Cells were cultured until days 4 or 5 and washed with HBSS. 
Cells were then resuspended in fresh medium containing 5ng/ml human IL-2 for 2-3 days, 
re-stimulated with 10ng/ml PMA and 1μM Ionomycin 4-6 hours, and treated with 
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Monensin (golgi block) before being analyzed for intracellular IL-4 or IFN-γ by FACS 
analysis. 
 
XII. Mosquito Salivary Gland Preparation. 
Harvest mosquitos by placing in 70%ETOH. Wash by performing two subsequent 
washes in 1xPBS solution. Use micro-wire tweezers to dissect mosquito in a drop of 
1xPBS on a glass slide under a microscope. Quickly dislocate head from thorax and tweeze 
salivary glands from body cavity. Place glands in small microcentrifuge tube containing 
1xPBS. When desired glands have been collected, freeze at –20ºC.  Thaw at later time and 
sonicate by 100% 2sec.ON/2sec.OFF pulsing for 20min. Keep on ice. Spin at 1116.75xg 
for 15min. at 4ºC. Remove and store supernatant at-20ºC until use. 
 
XIII. Ozaki Method for Harvesting Sporozoites from Mosquitos. 
Place mosquitos in 70%ETOH. Line mosquitos on the lid of a Petri dish and cut off 
heads with scalpel. Using tweezers, place heads in a double-barrel centrifuge tube (small 
porous inner tube contained within a 1.5ml centrifuge tube) containing wool. Cover with 
parafilm and add 300μl complete media to the top and spin at 951.55xg for 10min. at 4ºC. 
A pellet will form in the bottom of the tube. Remove the media from the flow through and 
place back into the top of the tube. Spin at 1295.17xg for 10min. at 4ºC and resuspend the 
pellet and transfer to a clean tube. Add to Petri counting grid and allow sporozoites to 
settle 15-30min. before counting. 
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XIV. Dendritic Cell Differentiation. 
Harvest bone marrow from both femurs of a mouse in media complete (flush bone 
with media three times). Culture marrow in a large Petri dish, undisturbed, at a 
concentration of 1x106 cells/3ml media supplemented with GMCSF. Alternatively, culture 
in a 24 well plate in 1.5ml media at a concentration of 0.5x106 cells/well. Change the 
media every 2 days or as necessary by removing/replacing 1ml media. Cells should 
“cluster”. Use cells on day 7 for O/N or same day experiments. Harvest by flushing the 
wells, do not use a scraper or ice to detach cells.  
 
XV. Harvesting of Peritoneal Macrophages. 
Intraperitoneal injection of 1.5ml thioglycolate with Resazurin (BioRad, Cat# 
6D0384) to enhance infusion of peritoneal macrophages. Harvest via peritoneal lavage on 
day 5 by injecting 3-4 ml of complete media into euthanized mouse, agitating belly and 
inverting mouse, and removal via p1000pipette. Add one more ml of media into mouse 
using pipette and mixing with the pipette in vivo to ensure efficient harvest. Cells will be 
slightly activated, so it may be necessary to rest cells at 37ºC for 24 hours to get cells back 
to a baseline level of activation. 
 
XVI. Microsphere Uptake and Activation of Dendritic Cells and Macrophages. 
Peritoneal cells were plated at 1x106cells/well in a 24 well tissue culture plate in a 
volume of ~100-200μl of media complete for 2-3 hours. The media was then removed and 
100-200μl media complete was re-administered. 5-10 salivary gland pairs were added 
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concomitant with 0.1-1μg/ml LPS (positive control for macrophage activation) O/N at 
37ºC. Cultures of macrophages were also used without the addition of LPS with the 
addition of 4ul of a 1:10 dilution in media of FITC-fluoresbrite carbocylate microspheres 
(Biovalley Polysciences, Cat#15700, 0.5μYG, diameter 0.496μ) for 1hr. Culture plates 
were placed on ice for exactly 10min. to loosen macrophage attachment to plates. Plates 
were scraped gently with plate scrapers and stained with M5 for MHCII (anti-mouse I-
A/I/E M5/114.15.2, BD for C57BL/6 mice, rat IgG2bk), CDllb (Mac-1, M1/70, 
cat#557396), CD80 (activation marker), CD86 (B7-2, activation marker), and CD40 
(activation marker). Cells were analyzed by FACS for presence and intensity of 
fluorescence or by fluorescent microscope for visual analysis of microsphere uptake. 
 
XVII. Circumsporozoite (CS) Staining. 
Co-culture macrophages and sporozoites on a culture microscope tray and incubate 
for desired amount of time (10min.-3hrs.) in complete media at 37ºC. Add a 4% PAF 
solution (Heat 450ml 0.1M Phosphate Buffer, after reaching 45ºC, add 20g 
paraformaldehyde and stir. When solution clears, remove from heat. Do not let solution go 
above 60ºC. Cool and filter. Add buffer to make 500ml. Store in refridgerator and use cold. 
Use within 48 hours or freeze.) for 20min. Remove and wash 2 times with 1xPBS, 
resuspend in 1xPBS and store O/N at 4ºC (if desired). Permeabilize cells by adding 
0.5%Triton at RT for 5min. Wash 3x with 1xPBS. Alternatively, cells were not 
permeabilized and were washed 3times with 1xPBS. Then, 1xpBS/2%BSA was added for 
15min. RT to block and washed 3 times with 1xPBS. Anti-CS-PE Ab was added to the 
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culture slide for 1 hr. at RT and then washed 3x with 1xPBS to detect the levels of CS on 
the surface of the macrophages using fluorescent microscopy. 
 
XVIII. HepG2 Cell Line and Primary Murine Hepatocyte Analysis for the Presence 
of Lck. 
In order to determine if Lck was present in the HepG2 liver cell line as well as in 
primary murine hepatocytes, western blot analsysis was performed. 
HepG2 cells were cultured and harvested and used at a concentration of 
10x106cells/0.5ml. Cells were spun at 7.86xg for 5’ and gently aspirated. Cells were 
resuspended in 1ml 1% NP-40 lysis buffer with inhibitors (see biochemistry protocol 
above) and incubated for one hour on ice with intermittent vortexing. HepG2 cells were 
generously provided by the laboratory of Dr. Phil Hylemon, VCU. Bradford analysis of 
protein content indicated an average of 6,380μg/ml protein. 
 Primary murine hepatocytes were used following mouse perfusion with saline 
solution. Primary hepatocyte lysates were made as per HepG2 lysates above, but with a 
total volume of lysis buffer being 1ml (not 0.5ml). Mouse perfusion performed by the 
laboratory of Dr. Phil Hylemon, VCU. Bradford analysis of protein content indicated an 
average of 8,400μg/ml protein. 
 Both HepG2 and primary murine hepatocyte lysates were run on a 10.5% 
polyacrylamide gel (see Western blotting protocol above). Membranes were blocked in 
3%BSA/PBS solution and probed with anti-Lck COOH polyclonal Ab (see Western 
blotting protocol for Ab information).








I. Lck W97A Murine Phenotype. 
The T-lymphocyte subset of immune effector cells is essential for the formation of 
a functional adaptive immune response. The development of thymocytes and subsequent 
activation of naive T-cells relies on signals received via the T-cell antigen receptor (TCR) 
(Kane, Love, Werlen). A role for the proximal TCR signaling protein, p56Lck, in T-cell 
development has been implicated (Hernandez-Hoyos, Legname, Molina, van Oers) as well 
as for T-lymphocyte differentiation and activation (Zamoyska). 
Thymocyte development is known to be regulated by the nature of signaling 
through the TCR, however, much less is known about how TCR signals influence the 
differentiation and effector function of mature T-lymphocytes. Independent work has 
implicated the MAP kinase pathway as a critical regulatory pathway for T-cell 
differentiation (Jorritsma, Yamashita‘99), although it is unclear how modifying TCR 
signals can specifically regulate MAPK pathway activity to determine the outcome of T-
lymphocyte differentiation. 
In order to examine the particular roles that Lck has in T-cell development and 
function, it was necessary to isolate specific interactions of Lck and determine how these 
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relationships were involved in the processes that lead to thymic development and, 
ultimately, T-cell activation and function in the periphery. The reliance of Lck on its 
unique domain for localization within the cell, the role of the SH2 domain for initial T-cell 
signaling (via binding to the TCR and ZAP-70), as well as the critical importance of the 
kinase domain for the phospho-tyrosine function of the protein are relatively well-studied. 
However, the specific binding partners for the Lck SH3 domain, as well as their role and 
function in T-cell development and activation, are not well understood. 
To further examine the role of the Lck SH3 domain in vivo, a murine line was 
created by our laboratory. This was accomplished by using a targeting construct with 
genomic lck sequences of the 129 mouse line. The genomic sequence encompassed 3kb 
upstream of the lck gene into exon 8. A neomycin resistance cassette was introduced at 
exon 3 and flanked by lox sites. PCR was used to create a critical tryptophan to alanine 
point mutation in exon three. This particular mutation has previously been shown in cell 
line data to ablate ligand binding to the SH3 domain of Lck, and creates an Lck SH3 
domain null phenotype (Denny’99, Patel). Neomycin-resistant embryonic stem (ES) cell 
clones were selected and correctly targeted clones were detected by Southern blotting with 
a probe recognizing a region of exon 3, 3’to the targeted/modified sequence. Blastocysts 
were injected, and animals containing the mutation were backcrossed onto the C57BL/6 
murine line. Mating with Jackson Laboratory Tek-Cre mice subsequently removed the 
neomycin resistance cassette. Reverse-transcription (RT)-PCR sequencing of the entire 
Lck coding region of thymocyte RNA confirmed the lckW97A allele mutation, as well as 
assured that no other mutations were introduced into the construct (Rudd’06). 
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Mice containing the Lck W97A mutation were backcrossed to the F8 generation 
with the Jackson Laboratory C57BL/6 line. Initial investigation of thymic development in 
these mice identified reduced CD4+ and CD8+ thymocyte population development and 
maturation. There was also a noticeable reduction in MAPK pathway induction (Erk) 
independent of initial TCR signaling events, which were found to be unaltered in Lck 
W97A thymocytes compared to WT. (Rudd’06). This work showed for the first time that 
Lck had the potential to play a role in downstream pathways critical for T-cell activation, 
irrespective of the role for Lck in initial TCR signaling events, and that this process was 
mediated by the action(s) of the Lck SH3 domain. 
Rudd et al. further showed that there were approximately half the total thymocyte 
numbers in Lck W97A mice compared to WT, and that these mice had two-fold reductions 
in double-positive thymocytes, possibly as a result of a block in development involving the 
β-selection step. There was also a two- to three-fold reduction in the number of CD4+ and 
CD8+ thymocytes, indicating defective positive selection in Lck W97A mice. Single-
positive T-cells were found in the periphery of Lck W97A mice. 
p56Lck is essential for the activation and differentiation of T-lymphocytes, 
however, it is unclear if Lck is able to act via specific mechanisms in order to regulate this 
process (Palacois, Molina, Mosmann). It is also unknown to what extent this mutation 
affects T-cell activation and function in the periphery following thymic exodus. An 
investigation into the phenotype and characteristics of the peripheral T-cell populations in 
Lck W97A mice is investigated here. 
A. Phenotypic Characterization of Primary Lck W97A T-lymphocytes. 
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 As with all new animal models, it is important to note general appearances 
and behavioral effects that may arise due to the knocking-in or –out of a gene of interest. 
With regards to the Lck W97A mice, no gross physiological abnormalities have been 
observed. The mice are fertile and healthy. 
     1. Similar Lck W97A Total Cell Counts Compared to WT. In order to 
examine more subtle phenotypic differences in Lck W97A mice, total cell counts from two 
major secondary lymphoid structures, the lymph node and spleen, were each analyzed in 
Lck W97A mice. Although thymic data from these mice suggested there might be 
differences in total numbers of T-cells in the periphery as a result of reduced thymic 
numbers (Rudd ’06), analysis of secondary lymph structures did not indicate any 
substantial differences in total numbers of cells compared to WT (Fig. 4). It is possible that 
homeostatic proliferation of thymic SP T-cells occurs following thymic exodus to elevate 
the number of Lck W97A T-cells to a more “normal” physiological level in the periphery. 
If this were the case, one would expect these T-lymphocytes to have slightly elevated 
levels of activation, compared to WT, as a result of their heightened proliferation. 
     2. Lck W97A Animals Have a Reduced TCRβ Population. A closer look at 
the T-cell population in Lck W97A animals does, however, demonstrate a significantly 
reduced percentage (5-15% reduction) of TCRβ+ cells, with the total number of TCRβ+ 
being only slightly reduced compared to WT (Fig. 5). As the cumulative data shown is 
comprised of only five individual mice, is possible that with further examination of the 
total number of TCRβ+ cells in the Lck W97A murine population, this value may in fact 
be significant, reflecting the observed reductions in the percent TCRβ+ population of total 
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cell counts from the lymph node and spleen. Alternatively, there could be another 
population of cells that have expanded in these secondary lymphoid organs to compensate 
for reduced T-cell numbers, and analysis of different cell population numbers should be 
examined. This finding led us to examine the specific T-cell compartments within the 
lymph node and spleen in Lck W97A mice in order to determine if there were differential 
requirements for the Lck SH3 domain in T-cell differentiation and/or survival in the 
periphery. 
     3. Reduced Numbers of Lck W97A CD8+ T-Cells. Analysis of the different 
T-cell compartments within the lymph node and spleen indicates significantly reduced 
numbers of CD8+ T-cells in Lck W97A animals, with the CD4+ T-cell compartment being 
only slightly reduced (Fig. 6). This significant reduction in numbers of CD8+ T-cells helps 
to explain reductions in the percent TCRβ population in Lck W97A mice, and also 
indicates that the Lck SH3 domain may play a differential role in T-cell subset 
development and/or survival in the periphery. 
Aside from total numbers of cells, and understanding what percentage of the T-cell 
population expresses the unique co-receptor markers, it is also important to examine co-
receptor expression differences between WT and Lck W97A T-cells.  
     4. Reduced CD4 Co-Receptor Expression in Lck W97A Peripheral T-Cells. 
Co-receptor and TCRβ surface expression on peripheral T-cells from Lck W97A and 
C57BL/6 WT mice was examined from both LN and spleen. CD8 and TCRβ cell surface 
expression levels were normal in Lck W97A mice with CD4 expression being modestly 
reduced (Fig. 7). These data, taken together with the distribution data previously described,  
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suggest that the SH3 domain of Lck is important for the establishment of proper T-cell 
population numbers as well as normal CD4 expression in primary T-lymphocytes. 
5. Basal Levels of the Activation Markers CD44 and CD62L in Lck W97A T-
Cells are Significantly Different. The concept that Lck W97A T-cells may be 
proliferating in an attempt to regain homeostatic balance as a result of reduced thymic 
output, it was important to look at basal expression of markers known to be involved in the 
activation-induced proliferation that accompanies homeostatic proliferation, specifically 
CD44hi and CD62low expression. This ability of T-cells to fill a lymphopoenic “void” is not 
well understood. It is believed that T-lymphocytes are able to sense “space”, potentially as 
a result of decreased competition for cytokines, such as IL-7, IL-12 and IL-15, as well as 
the more controversial MHC/self-peptide interactions (Cho, Goldrath). For this study, we 
examined the total T-cell compartment, as well as the unique CD4+ and CD8+ 
compartments, in order to determine if there were inherent differences between these two 
subsets. We found that there are significant 10-15% increases in the percentage of Lck 
W97A lymphocyte populations expressing CD44, a marker of activation and memory, and 
those of WT (Fig. 8a). There is also a significant 10-20% increase in the expression of 
CD44 between WT and Lck W97A T-cells. Lck W97A T-lymphocytes have a significantly 
higher MFI expression of CD44 on both CD4+ and CD8+ cells in the lymph node and 
splenic compartments compared to WT (Fig. 8b). This elevated level of CD44 expression 
on Lck W97A T-cells could indicate a higher level of activation, or be indicative of a 
memory T-cell phenotype. 
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We also notice significantly reduced numbers of the Lck W97A CD4+ lymphocyte 
population expressing CD62L (L-selectin) (~10%) (Fig. 9a). It is possible that there are 
significant reductions in the percent CD62L+ CD8+ T-cell population in Lck W97A mice, 
however, the standard deviation and error are too great from these experiments to be able 
to draw firm conclusions. Although there was no significant reduction in the MFI 
expression of CD62L in Lck W97A T-lymphocytes, it is also possible with larger sample 
size, the trend observed that the Lck W97A mice have slightly reduced CD62L expression 
could become significant (Fig. 9b). This data, taken together, could indicate that these cells 
are indeed slightly more activated in response to homeostatic proliferation in order to fill a 
T-cell “void” in the periphery- as they would classically have elevated levels of CD44 
expression and reduced levels of CD62L. Furthermore, this heightened state of activation 
could also negatively affect the degree to which Lck W97A T-cells can be activated in 
response to stimuli. 
 
II. T-Cell Activation in Lck W97A T-Lymphocytes. 
A. Ab-Induced Proliferation and IL-2 Production. T-lymphocyte activation is 
the result of TCR ligation and subsequent induction of intracellular signaling pathways, 
such as the MAPK and PI pathways. TCR signaling relies on non-receptor tyrosine kinases 
to link receptor engagement with activation of intracellular signaling pathways 
(Mosmann). The Src-family of protein tyrosine kinases (PTKs), in particular, Lck, are 
important for TCR and ZAP-70 phosphorylation which leads to the regulation and  
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recruitment of PI and MAPK pathway activators in T-lymphocytes (Chan, Iwashima, 
Lovatt, Palacios, Straus’92, Zamoyska).  
As p56Lck is known to be important for T-cell activation, and differences in the 
expression of activation markers were observed in Lck W97A peripheral T-cells (Figs. 8-
9), potential defects due to loss of function of the Lck SH3 domain in Lck W97A mice 
were examined by observing outcomes of T-lymphocyte activation. We assessed 
proliferation, cytokine production and early activation marker expression in T-cells from 
Lck W97A mice using anti-CD3 to stimulate Lck W97A T-cells ex vivo in order to 
examine potential differences in Lck W97A T-cell activation compared to WT. 
Proliferation studies were performed by staining LN cells with CFSE and 
stimulating with the anti-CD3 mAb, 2C11. Lck W97A T-lymphocytes show a consistent 3-
4.5 fold reduction in the number of T-cells that are able to respond to TCR ligation 
compared to WT. This difference is observed with either high or low doses of anti-CD3, 
although higher levels of anti-CD3 stimulates greater proliferation of Lck W97A T-cells, 
and cells that do respond undergo the same number of divisions as WT (Fig. 10). To 
confirm our studies on the activation induced proliferation defect observed in Lck W97A 
T-cells, we examined the levels of secreted IL-2 in stimulation cultures. IL-2 is commonly 
used as readout of T-cell activation (Irving). Analysis by ELISA indicated a 10-fold 
reduction in the level of IL-2 in Lck W97A culture supernatants compared to WT at 24 
hours following 1μg/ml anti-TCR stimulation (Fig. 11). These findings indicate that Lck 
W97A T-cells have significantly impaired activational responses compared to WT, and  
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though higher Ab stimulations appear to improve Lck W97A T-cell proliferation, there 
remain significant defects in proliferation, as well as in the production of IL-2. 
B. Co-Stimulation With CD28 Modestly Improves Lck W97A T-Cell 
Proliferation. T-cell activation, as well as T-dependant B-cell responses, is assisted by 
signaling via co-stimulatory molecules such as CD28 (Acuto). It has been shown that Lck 
binds to CD28 via the SH3 domain of Lck, and that this interaction may assist TCR 
signaling for complete T-cell activation (Holdorf). We wished to examine the potential 
effects on activation of Lck W97A T-cells with co-stimulation of CD28 in order to 
determine the role that Lck, and, in particular, the SH3 domain of Lck, facilitates the 
intracellular signaling cascades involved downstream of proximal TCR signaling leading 
to T-cell activation. The CD28 co-receptor is known to bind the SH3 domain of p56Lck, 
suggesting that mutation of the p56Lck SH3 domain might lead to a reduction in co-
stimulatory signal transduction efficacy (Mosmann). Surprisingly, we found that CD28 
receptor engagement concomitant with TCR ligation in Lck W97A T-lymphocytes 
strongly stimulated proliferation so that there were approximately 1-1.5 fold more T-cells 
able to respond to stimulation (Fig. 12). As with activation-induced proliferation following 
anti-CD3 stimulation (Fig. 10), higher doses of anti-CD3 appear to improve the ability of 
Lck W97A T-cells to respond to stimulation with the addition of anti-CD28 co-ligation 
(Fig. 12). However, the population of undivided cells still remains increased roughly 3-fold 
in Lck W97A T-cells (Fig. 12) notwithstanding CD28 co-receptor engagement when 
compared to WT. In order to examine the potential effect of the Lck W97A mutation on 
CD28 signaling in isolation from that of the T-cell receptor, the cellular response to CD28  
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and PMA was examined. The p56Lck SH3 domain makes little contribution to CD28 
signals that are independent of pathways stimulated by PMA (Fig. 12). These studies 
indicate that Lck SH3 domain function is required for proper T-lymphocyte activation, and 
that the Lck SH3 domain appears to be primarily involved in mediating signaling through 
the TCR rather than CD28. 
C. Activation Marker Induction Following Ab-Induced Activation is Reduced 
in Lck W97A Peripheral T-cells. Following our observations that Lck W97A T-cells 
appear to have significant defects in activational responses, we wanted to further examine 
parameters of cell activation, including investigation of induction of the early activation 
markers CD69 and CD25 (IL-2Rα).  CD69 induction following 2C11 stimulation is 
significantly reduced by 10-30 percent in Lck W97A mice using various doses of anti-CD3 
(Fig. 13a). Although the level of expression on responding cells is comparable with that on 
WT T-lymphocytes, the percentage of T-cells able to induce CD69 is significantly reduced 
(Fig. 13a). These data indicate a defect in the activation of Lck W97A T-cells following 
anti-TCR specific stimulation resulting from a loss of Lck SH3 domain function. 
Preliminary analysis of CD25 expression on Lck W97A T-cells, another marker of early 
activation, indicates that this marker is elevated to a greater degree basally, and remains 
modestly elevated over a period of 4-31 hours following stimulation with anti-CD3 
antibody, compared to WT (Fig. 13b). Further investigation into this phenomenon will be 
required to get a clear picture of these differences in CD25 expression. However, it appears 
that Lck W97A T-cells do have defective CD69 induction, which correlates to the  
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observed reductions activational responses as examined by both proliferation and IL-2 
production following Ab-induced activation. 
D. Ag-Induced Activation is Modestly Reduced in Lck W97A Peripheral T-
Cells. Observing the importance of the Lck SH3 domain in MAPK pathway induction and 
T-cell activation following TCR-specific ligation, as indicated by reduced activation-
induced expression of CD69 (Fig. 13), proliferation (Fig. 10) and IL-2 production (Fig. 
11), even with the assistance of the co-stimulatory molecule CD28 (Fig. 12), we wanted to 
investigate the importance of multiple co-stimulatory signals on the activation state of Lck 
W97A T-cells to determine if multiple signals could assist in overcoming these observed 
activational defects. In order to examine complex co-stimulation, in vitro, p56Lck W97A 
mice were backcrossed onto mice expressing the OT-I transgenic (Tg) T-cell receptor 
(restricted for Kb/SIINFEKL peptide) for three generations. Peripheral T-cells were 
stimulated in an antigen-dependent fashion to determine differences in proliferation and 
cytokine production. 
Various doses of SIINFEKL peptide were used to examine potential differences in 
the responses of Lck W97A T-cells to antigen presentation compared to WT. Ag-induced 
proliferation of Lck W97A OT-I T-cells was modestly reduced (approx. 2-fold) at lower 
concentrations of SIINFEKL peptide, compared to WT, with higher peptide doses 
mitigating proliferation and IL-2 production to a similar level with that of WT (Fig. 14). 
The Lck W97A T-cells appear to be able to have similar rounds of division when 
compared with that of WT, but the percentage of cells that undergo this proliferation is 
severely reduced, especially at later rounds of division (Fig. 14). This is only a preliminary  
   89 
 
   90 
 
   91 
 
investigation into the ability of Lck W97A T-cells to respond to Ag-specific stimulation 
and should be repeated with various doses of SIINFEKL as well as kinetic analysis 
performed to determine whether the Lck W97A T-lymphocytes peak at different times 
following stimulation compared to WT. The observed decrease in reliance of Lck SH3 
domain for T-cell activation with Ag in vitro, especially with stronger Ag stimulation, led 
us to examine if there were any potential differences in T-effector function and immunity 
in vivo.  
 
III. T-Cell Signaling in Lck W97A T-Lymphocytes. 
To understand the basis for defective activation of T-lymphocytes from Lck W97A 
mice, regulatory pathways critical for cellular activation downstream of TCR signaling 
were examined. In particular, we wished to examine the MAP kinase pathway, which we 
have previously found to be regulated by Lck SH3 domain function in thymocytes 
(Rudd’06). 
 A. Reduced Phospho-Tyrosine Induction in Lck W97A Peripheral T-Cells. To 
analyze signaling, we purified peripheral LN T-cells from Lck W97A and WT mice using 
negative selection (to eliminate any basal levels of activation that positive sorting might 
incur) and stimulated with anti-CD3. Western analysis of lysates probed with anti-
phosphotyrosine (PY) antibodies did not indicate substantial differences in the levels of 
tyrosine phosphorylation in anti-CD3 stimulated Lck W97A peripheral T-cells (Fig. 15). 
Although the pattern of PY induction appears similar between groups and treatments, 
several proteins have slightly reduced levels, as indicated by lower phospho-tyrosine  
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induction, following 2C11 stimulation in Lck W97A peripheral T-cells (Fig. 15). It is 
possible that several of these proteins may represent activation defects of signaling 
proteins known to bind the Lck SH3 domain and be activated by Lck, or are downstream 
targets of Lck SH3 domain function. 
 B. Adaptor Molecules in Lck W97A T-Cells Appear Differentially Regulated. 
 Our interest in various bands that appear differentially regulated in PY immunoblot 
analysis of Lck W97A T-cells following anti-CD3 stimulation (Fig. 15) led us to examine 
several proteins known to interact with Lck or Lck binding partners that are about the 
observed sizes noted in the anti-PY immunoblot analysis. Preliminary data, as analyzed by 
Western immunoblot, suggests that activation of the adaptor molecule, LAT, is 
significantly reduced in peripheral Lck W97A T-cells following anti-CD3 Ab-induced 
activation (Fig. 16). This protein runs about 38kDa, and correlates to a major band that 
appears reduced on the PY immunoblot (Fig. 15). LAT is an important adaptor molecule, 
acting as a scaffolding protein for various signaling proteins near the TCR. Moreover, data 
from our lab in Lck W97A thymocytes has also indicated that there is reduced 
phosphorylation of LAT following anti-TCR stimulation (Rudd ‘06), indicating that the 
Lck SH3 domain may play a role in the activity and function of LAT following TCR 
ligation. This result will need to be further investigated in order to discern if this is a 
representative finding. A control blot recording total LAT levels will also be required to 
confirm that this finding is truly reflective of a difference in activation of this molecule, 
and not a result of different levels of total LAT in Lck W97A T-cells. 
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Another molecule of interest is SLP-76. This adaptor molecule is believed to be a part of 
the LAT complex proximal to the TCR following TCR ligation and, thus, has been 
implicated in MAPK/Erk pathway induction. Furthermore, SLP-76 has been shown to bind 
the Lck SH3 domain in vitro (Sanzenbacher), and was of interest to us as we have 
previously shown defects in MAPK/Erk pathway induction in thymocytes (Rudd ‘06). 
Preliminary immunoblot analysis indicates only modest reduction in total SLP-76  
levels (Fig. 17). Further examination of total SLP-76, as well as potential differences in 
phosphorylated levels of SLP-76 will be of critical interest with regards to differential 
functionality in Lck W97A T-cells and SLP-76 activity in peripheral T-cells. Of ultimate 
importance is the effect on binding between SLP-76 and Lck having a mutated SH3 
domain (W97A). Future work, including immunoprecipitation of SLP-76 and Lck 
(W97A), will determine if there is reduced binding between these proteins due to the 
ablation of Lck SH3 domain binding capability. 
 C. Normal ZAP-70 Induction Following Ab-Induced Activation of Lck W97A 
T-Cells Compared with WT. In order to rule out differences in early activation events 
following TCR ligation that may lead to the observed activational differences observed in 
Lck W97A T-cells, immunoblot analysis of purified T-cells from both WT and Lck W97A 
mice was examined for differences in ZAP-70 activation. ZAP-70 is an early mediator of 
TCR signaling and is directly activated by Lck for downstream cascade activation of the 
MAPK pathway. Preliminary immunoblot analysis indicates higher basal levels of P-ZAP-
70 and similar levels of induction of the early signaling molecule, ZAP-70, following anti- 
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TCR ligation in Lck W97A T-cells (Fig. 18). This data corroborates previous analysis in 
Lck W97A thymocytes from our lab (Rudd ‘06). 
D. Reduced MAPK Pathway Induction in Lck W97A Peripheral T-Cells. Next, 
we wanted to investigate proteins of the MAPK pathway, as this pathway has previously 
been shown to be affected by the Lck W97A mutation. Recent work has shown Lck is also 
directly involved in regulation of the MAPK pathway downstream and independent of 
initial phosphorylation of the TCR and ZAP-70, and that this role in MAPK pathway 
induction selectively requires the p56Lck SH3 domain (Rudd’06, Denny’00, Li).    
 Activation of the MAPK pathway proteins Erk1/2, was significantly reduced in Lck 
W97A peripheral T-cells following anti-CD3 stimulation (Fig. 19a). P-Erk 2 appears 
moredramatically reduced in Lck W97A T lymphocytes (4 fold reduction) when compared 
to P-Erk 1 (2 fold) between Lck W97A and WT mice using densitometric analysis to 
determine fold inductions from basal levels of Erk following anti-CD3 stimualtion. Total 
levels of Erk1/2 are comparable between Lck W97A T-cell and WT cells (Fig. 19b). 
Analysis of total Lck was examined to confirm that lysates from both WT and Lck W97A 
mice had equal levels of Lck, ensuring that differences in Erk activation were not due to 
differences in the levels of Lck, but rather, its activity (Fig. 19). Furthermore, the defect in 
Erk induction in Lck W97A T-cells does not appear to be due to an issue of kinetics, as 
Erk induction is never restored in Lck W97A peripheral T-cells even after fifteen minutes 
following initial anti-TCR-induced activation (Fig. 20). 
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E. Similar Levels of PLC-γ1 and Calcium Mobilization in Lck W97A T-cells 
Compared to WT. The Lck SH3 domain has been shown to interact with Tec kinases, 
which are known to play a role in normal phosphorylation of PLC gamma and activation of 
the PI pathway.  Therefore, we wanted to examine PI pathway function in Lck W97A 
peripheral T-cells. 
Immunoblot analysis of lysates with anti-phospho-PLC-γ1 antibody revealed that 
P-PLCγ1 induction was similar in T-lymphocytes purified from Lck W97A and WT mice 
(Fig. 21). These results appear to suggest that induction of the phosphoinositol (PI) 
pathway does not require the Lck SH3 domain. With little change in overall 
phosphorylation or PLC-γ1 activation following TCR stimulation, the Lck SH3 domain 
appears to be selectively required for MAPK pathway activation, which may help explain 
the role of the Lck SH3 domain in the activation of T-lymphocytes. 
As Lck, and not Fyn, has been shown to regulate the activation of PLCγ and PKC 
to mobilize intracellular calcium (Lovatt), we wanted to further confirm that the Lck 
W97A mutation does not affect the PI pathway and calcium mobilization. Lck W97A and 
WT T-lymphocytes were stained with the ratiometric dye Fura-2 in order to examine 
potential differences in calcium mobilization following anti-CD3 cross-linking. 
Ionomycin, a calcium ionophore was used as a positive control to ensure that the Fura-2 
stain was able to measure calcium mobilization, and that both WT and Lck W97A T-cells 
were able to mobilize calcium in response to such a strong stimuli. Examination of calcium 
flux reveals that although the ability of Lck W97A peripheral T-cells to mobilize calcium 
is not differentially regulated compared with WT following anti-CD3 ligation, there do  
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appear to be reduced calcium stores in Lck W97A T-lymphocytes as indicated by the 
reduced maximum mobilization with Ionomycin compared with WT (Fig. 22). 
There are signaling molecules which are affected by the release of calcium, 
including the Ca2+/calmodulin-dependent protein kinase II (CaMKII). CaMKII is activated 
by released stores of calcium and acts to antagonize TCR signaling via SHP-2. It has also 
been shown that CaMKII can act to impair positive selection of thymocytes, and is 
involved in the activation of Erk/2. Therefore, it was of interest for us to determine if 
activity of this protein might be regulated by the Lck SH3 domain with regards to both PI 
and MAPK pathway function, or that alternative regulation of CAMKII might potentially 
lead to altered Lck activity and downstream Erk induction. Furthermore, calcium-induced 
activation of Erk has been shown to require activation of CaMKII and that this is followed 
by activation of Lck (Franklin), though the mechanisms behind the relationship between 
CamKII and Lck has not been elucidated. Preliminary examination of CaMKII appears to 
indicate a slightly elevated (3-5 fold) induction of CaMKII in Lck W97A T-cells (Fig. 23). 
This study requires further investigation into reproducibility of this finding. Potentially, 
increased levels of CaMKII could mean that the activity of the Src homology 2 domain-
containing phosphatase 2 (SHP-2) is altered, and may thus be an alternative pathway (aside 
from Ras/Raf activation) regulated by the Lck SH3 domain, further acting to dampen Erk/2 
activation. 
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F. P38 Activation is Potentially Induced Earlier But Not to a Greater Degree at Later 
Time-Points Following Ab-Induced Activation in Lck W97A T-Cells. To further 
examine how alternative signals at the TCR could result in defective cell activation and 
induction of the MAPK/Erk pathway, we examined the induction of p38. It has been 
shown that p38 activity can be regulated by the membrane-associated guanylate kinase 
(MAGUK) family member, Dlgh1. Dlgh1 has also been shown to interact with the SH3 
domain of Lck, enabling proper membrane targeting and function of Dlgh1. Therefore, 
potential differences in Lck SH3 domain interactions with Dlgh1 could ultimately affect 
p38 activation and function for proper NFAT activity. Immunoblot analysis indicates that 
P-p38 induction appears to be significantly elevated basally, and earlier (30min.), in Lck 
W97A T-cells, but does not surpass the level of activation in WT T-cells at one hour post 
stimulation with anti-CD3 (Fig. 24). This finding indicates that while there may be 
differences early on in p38 activation as a result of the Lck W97A mutation, the effects on 
this pathway are not significantly impacted at later points during activation. This enhanced 
early p38 induction could result from heightened basal Lck activity, as p38 has been shown 
to be activated downstream of Lck activation of ZAP-70 (Salvador), and may not be a 
result of stress-induced responses. Dlgh1 has also been shown to be involved in 
TCR/CD28 signal transduction. As TCR/CD28 co-stimulation appears to somewhat 
recover activation-induced defects in TCR-specific activation (Fig. 12), it is unlikely that 
there are significant defects in Lck SH3/Dlgh1 interactions that would result in defective 
p38 activation.  
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IV. Lck SH3 Domain and T-Cell Function. 
In order to determine if the differences between Lck W97A and WT T-cell 
activation might affect T-lymphocyte effector function and immunity, we examined 
several different immunization and infection protocols to observe if and how these immune 
processes were differently affected between these groups. 
A. Conjugation Between Lck W97A T-Cells and B-Lymphocytes is Similar to 
that of WT. Proper differentiation and effector function of T-lymphocytes, particularly the 
T-helper subset, is critical for host survival and regulation of immune responses to 
pathogens (Mosmann’86, Syrbe). Two major components of T-cell subset function are 
cytotoxic killing (CD8+ T-cells) and B-cell help (CD4+ T-cells). Primed effector CD8+ T-
cells that recognize antigenic peptides concomitant with MHC molecules on a 
target/infected cell, are able to release the cytotoxins perforin and granulysin via exquisite 
specificity to target and destroy infected cells. CD28, a co-stimulatory molecule on T-
lymphocytes, binds the CD80 or CD86 receptors on antigen presenting cells (APCs) to 
assist the interaction of the cytotoxic T-cell and infected cell. Lck is believed to play a role 
in CD28 signaling, and, more specifically, this interaction has been proposed be facilitated 
by the Lck SH3 domain (Holdorf). Potential defects in the ability of CD28 to assist the 
engagement of CD8+ effector T-cells could be expected as a result of the Lck W97A 
mutation in peripheral T-cells, and was investigated here. Ag-dependant contact between 
B-cells and CD4+ T-cells relies on the interaction between Ag/ MHC II and CD4 receptors 
on T-cells as well as via the interaction of CD40 on T-cells and CD40 ligand (CD40L) on 
B-cells. Cd40/CD40L interactions facilitate the transduction of activation signals enabling 
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B-cell growth, and differentiation leading to the production and secretion of IgE (Noelle, 
Rousset, Jabara). 
In order to examine potential differences in peripheral Lck W97A T-cell function, 
we examined the role of the Lck SH3 domain on the ability of T-lymphocytes to carry out 
their effector function both in vitro and in vivo. For ex vivo investigation of T-effector 
function, we examined the ability of Lck W97A T-cells to properly form conjugates with 
B-cells following Ag-induced activation. This cell-to-cell interaction is critical for the 
ability of T-cells to activate the B-lymphocyte group of the immune system during host 
infection or immunization and provide a productive adaptive immune response. 
Preliminary evidence indicates that Lck W97A T-cells are able to form proper 
conjugates with B-lymphocytes (Fig. 25). Whereas the induction of conjugate formation is 
modestly increased with WT T-cells following the addition of the OT-II-specific Ag 
ligand, ovalbumin (ova), to cell cultures, Lck W97A OT-II T-cells appear to have a 
generally higher basal level of conjugate formation, which is also increased to a greater 
degree following Ag-specific activation (Fig. 25). As with OT-1 Ag-induced activation of 
Lck W97A T-cells, it would be interesting to see if conjugate formation was also 
effected/altered by varying the dose of ova peptide. 
B. Lck W97A Animals Have a Significant Defect in Th2 Ag-Specific 
Immunity. In order to examine potential differences in the effector CD4+ T-cell 
population, we examined several immunization and infection strategies. 
CD4+ T-cells are further subdivided into Th0, Th1, Th2, Th17, and T-regulatory T-
cells, which have specific roles in immunity. Of particular interest are Th1 T-cell clones,  
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which are characterized by the production of IL-2, IFN-γ and TNF-β, and Th2 T-cells, 
which secrete IL-4, IL-5, IL-6, IL-9, IL-10, and IL-13 (Mosmann’86). Moreover, Lck has 
been implicated in Th2 differentiation, as T-cells from dominant negative Lck transgenic 
mice have selective defects in Th2 T-cell differentiation both in vitro and in vivo 
(Yamashita’98).  
Thus, understanding the outcomes of alterations in components of TCR signaling 
pathways and how they regulate this immune process is of clinical interest for the control 
of immune responses to antigen immunity and pathogen infections. It is known that 
altering the strength of TCR signaling can regulate differentiation of T-lymphocytes 
(Brogdon). Initial studies showed that T-cell differentiation was influenced by altering 
antigen concentration (Constant, Reudl). More recent studies have shown that mutations in 
early TCR signaling components also modify differentiation (Yamashita’98, Schaeffer, 
Marsland, Sommers). It was the purpose of these experiments to determine the initial 
effects of the Lck W97A mutation on basic T-cell functions such as conjugation and the 
ultimate effect that the Lck W97A mutation had on the ability of Lck W97A animals to 
mount immune responses to antigen immunization and parasite infections. 
Given the defects in MAPK pathway induction in Lck W97A T-cells, and evidence 
supporting an essential role for this pathway in Th2 immunity (So,Yamashita‘99), we 
examined the ability of Lck W97A mice to respond to immunization with DNP-KLH 
antigen/adjuvant. 
     1. Ig Isotype Analysis. Immune responses were determined by monitoring Ag-
specific (anti-DNP) Ig serum levels in Lck W97A and WT mice. Baseline serum analysis 
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did not reveal any difference in the overall levels of Ig isotypes between Lck W97A and 
WT mice (Fig. 26a,c). However, we found significantly reduced levels of DNP specific 
IgG1 in Lck W97A compared to WT mice following immunization (Fig. 26a). In contrast 
Ag-specific IgG2b and IgG3 isotypes were found to be comparable between both groups 
throughout the immunization (Fig. 26b-c). The particular deficit in IgG1 suggests defective 
Th2 immunity in Lck W97A mice. 
     2. Ag Re-Stimulation. In order to rule out the possibility that Lck W97A T-
cells are simply unable to proliferate in response to activating Ag-stimulation, re-
stimulation of T-lymphocytes from Lck W97A and WT animals following immunization 
with DNP-KLH was examined. Re-stimulation data does not indicate defects in the ability 
of T-cells from immunized animals to proliferate in response to Ag re-exposure (Fig. 27). 
On the contrary, preliminary investigations into the ability of T-cells from Lck W97A mice 
immunized with DNP-KLH appear to be slightly better responders to re-stimulation than 
their WT counterparts (Fig. 27). Though this type of experiment has only been performed 
several times, it does indicate that the lack of Lck W97A T-cell responsiveness in vivo is 
not a result of their inability to proliferate, or that they are not initially primed by exposure 
to the immunogen. It is also of note that the levels of proliferation as cpm in the figure 
shown are somewhat low (expected cpm for ag re-stim are anywhere from 5-20,000 cpm) 
compared to similar antigen re-stimulation experiments. This could be due to several 
parameter variables, including the strength of Ag re-stimulation, the time at which the 
tritium was added to the stimulated culture, and/or the length of time the tritium was  
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allowed to incorporate. Further optimization will need to be performed in order to examine 
re-stimulation of Lck W97A T-lymphocytes more effectively 
3. Th1 Immunity is not Impaired in Lck W97A Mice. In order to further 
determine if the defect in Lck W97A immunity was limited to alterations in the IgG1 
isotype specific response to immunization, or was indicative of a more general defect in 
the Th2 immune responses in these mice, a parasite infection model was utilized. In order 
to further confirm that there is not a defect in Th1 immunity, and that the observed IgG1 
deficit in Lck W97A mice following Ag- immunization truly reflects a defect in Th2-
specific immunity, a heat-killed Brucella abortus was utilized as an immunogen to induce 
a robust Th1 response. IFN-γ, an inflammatory cytokine associated with robust Th1 
responses, was used as a readout for Th1 immunity following immunization with the heat-
killed Brucella abortus. Serum was analyzed at days 4, 7, and 10 during infection, and 
IFN-γ was measured by ELISA. Analysis does not indicate significant defects in IFN-γ 
production by Lck W97A mice at days 7 and 10 during infection, which would indicate 
defective T-cell responsiveness in Lck W97A mice (Fig. 28). However, there does appear 
to be a large deficit in IFN-γ production in Lck W97A mice around day 4, indicating a 
potential defect in the innate immune responsiveness to the immunogen (Fig. 28). This 
data suggests that Lck W97A mice are indeed able to mount a productive Th1 immune 
response. To further examine the parameters of the defective Th2 immune response in Lck 
W97A mice, a helminth model of infection was utilized, which should induce a robust Th2 
immune response in mice. 
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4. Lck W97A Animals Have a Significantly Reduced Th2 Immunity to Infection. 
 Nippostrongylus brasiliensis, a well-studied model of helminth infection, and a 
strong inducer of Th2 immunity, was used to further examine potential differences in Th 
immunity in Lck W97A mice. Mice were infected with L3 stage parasites and total serum 
IgE and IL-4 levels were examined during the course of infection. 
     i. IgE Serum Levels Are Significantly Reduced Following Helminth 
Infection in Lck W97A Mice. IgE, a robust immunoglobulin characteristic of a Th2 
immune response, was examined during the course of infection as a readout of Th2 
immunity in Lck W97A and WT mice. Lck W97A mice have significant reductions in 
serum levels of IgE compared to C57BL/6 WT mice after day 8 of infection and 
continuing throughout the course of the study (day 21) (Fig. 29). There is a maximum 
defect in serum IgE on day 14 in Lck W97A mice, amounting to a roughly 6 fold reduction 
in levels compared to WT mice (Fig. 29), with only nominal inductions noted for IgE in 
Lck W97A mice. These results indicate that the SH3 domain of Lck acts in a critical 
fashion in peripheral T-lymphocytes to determine the outcome of Th2 specific immune 
responses in C57BL/6 mice following both Ag immunization and helminth infection. 
     ii. IL-4 Serum Levels Are Significantly Reduced Following Helminth 
Infection in Lck W97A Mice. IL-4 is a critical cytokine for maintaining Th2 immunity 
and regulating IgE levels, as well as the propagation of functional T-helper type 2 T-cells 
during parasite infection in mice (Finkelman’91, Gros, Jorritsma, Kopf, Mora, Urban’98). 
To investigate whether deficient IL-4 production could explain the observed deficit in IgE 
levels in Lck W97A mice following Nippostrongylus brasiliensis infection, serum levels of  
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IL-4 were examined on days 5-12 during the course of infection (Fig. 30). To assess IL-4, 
we used an in vivo cytokine capture assay (IVCCA), which enabled retention of IL-4 in the 
serum for improved isolation and characterization by fluorometric analysis. Lck W97A 
mice appear to have roughly half the available serum IL-4 during the height of the IL-4 
response in vivo compared to WT (Fig. 30). This data demonstrates a significant defect in 
the ability of Lck W97A mice to maintain Th2 immunity and cytokine production during 
an immune response to parasite infection. 
Lck W97A animals, therefore, have a specific and significant reduction in Th2 
immunity as demonstrated by reduced levels of IgG1, IgE, and serum levels of IL-4 
following either immunization (DNP-KLH) or infection with the helminth Nippostrongylus 
brasiliensis. Thus, the SH3 domain of Lck plays a critical role in the function of Lck as 
regards the Th2-specific immune response in vivo. 
     iii. Th1/Th2 in vitro Differentiation Indicates Slightly Elevated Levels of 
IFN-γ. In order to determine if Lck W97A T-cells were able to properly differentiate into 
either Th1 or Th2 T-cells, an in vitro differentiation experiment was performed. CD4+ T-
lymphocytes were purified from either WT or Lck W97A mice and cultured in the 
presence of cytokines and neutralizing Ab to direct cell fate to either Th1 or that of Th2 
specificity. Analysis of 3 experiments indicates that there are increased levels of IFN-γ 
produced with either anti-CD3 or anti-CD3/anti-CD28 stimulation under Th2-
differentiating conditions (Fig. 31a,c). This trend is also observed with the addition of IL-
2, and under direction to the Th1 phenotype (Fig 31). Some significance is noted for 
enhanced production of IL-4 with anti-CD3 +IL-2 stimulation, indicating that mutation of  
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the Lck SH3 domain does not preclude the differentiation into cells that are able to produce 
IL-4 (Fig. 31b). This trend is also seen without the addition of IL-2 (Fig. 31a). These data 
indicate that Lck W97A T-cells are able to differentiate into Th2 cells, as indicated by 
intracellular staining of IL-4. Furthermore, Lck W97A T-cells produce significantly 
increased levels of IFN-γ, which may act in vivo to inhibit IgE synthesis, and Th2 
immunity as a whole. These results indicate a role for the Lck SH3 domain in Th2 
immunity and Th2 effector T-cell function. 
 When looking at the expression levels of IL-4 and IFN-γ, although there are some 
nuances between groups, the expression levels are similar between WT and Lck W97A 
CD4+ T-cells following Th1 and Th2 in vitro differentiating conditions. Under Th1 
conditions, without the addition of IL-2, there is a clear enhancement of the numbers of 
cells producing IFN-γ as well as its expression in both the WT and Lck W97A T-cells 
following co-stimulation with anti-CD28 compared with anti-CD3 stimulation alone (Fig. 
32). When IL-2 is added, there appears to be a reduction in the number of cells having 
higher IFN-γ expression so that expression between anti-CD3 and anti-CD3/anti-CD28 
stimulations is equivalent. (Fig. 32). Under Th2 differentiating conditions, there is a 
consistent and comparable level of IL-4 expression, irrespective of the addition of IL-2 or 
co-stimulation with anti-CD28 (Fig. 32). There is also a slightly higher WT population of 
cells without IL-2 and with anti-CD28 co-stimulation producing IL-4 (Fig. 32). These data 
indicate that the expression of IL-4 and IFN-γ is similar between WT and Lck W97A 
CD4+ T-cells following in vitro differentiation. 
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V. Plasmodium, Mosquitos, and the Immune System. 
 I had the priveledge and honor to perform an internship in the laboratory of Dr. 
Salaheddine Mecheri at the Institut Pasteur, Paris, France during the course of my studies. 
In a seemingly unrelated project tangent, I studied the effects of Anopheles mosquito saliva 
on the innate immune system. Recent evidence, however, has made an intruiging link 
between Plasmodium pathogenesis and the SH3 domain of Lck. 
Plasmodium, the causative agent of malaria, is one of the deadliest maladies on 
Earth. As the quest for an efficient vaccine continues, so do we gain new insights into the 
parameters affecting its pathogenesis. A relatively new piece to the puzzle is the role 
vector salivary proteins play in the innate and adaptive immune responses to Plasmodium 
protists. The role of saliva from Anopheles mosquitos, the only vector for human malaria, 
with regard to cells of the innate immune system remains unclear. It was the purpose of 
this project and internship to examine some of the early interactions that occur between 
vector, protist, and murine host during infection with Plasmodium berghei. 
A. Anopheles stephensi Saliva Increases Macrophage Activation.  
In order to examine how mosquito salivary proteins could be affecting cells of the 
innate immune system, I first examined the activation state of macrophages in response to 
co-culture with salivary proteins extracted from the salivary glands of the Anopheles 
stephensi mosquito. Elevated expression of MCHII expression on the surface of 
macrophages is an accepted measure of macrophage activation. LPS is a known activator 
of macrophages, and was used in vitro as a positive control for activation of peritoneal 
macrophages from C57BL/6 mice. Primary peritoneal macrophages were co-cultured in 
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vitro with LPS and various doses of salivary gland pairs excised from A. stephensi 
mosquitoes to examine the potential regulatory effects of salivary proteins from A. 
stephensi on macrophage activation (Fig. 33). Mosquito saliva was found to slightly 
increase the activation of macrophages when compared to the activation of macrophages 
induced with LPS alone (Fig. 33). A characteristic function of macrophages resulting from 
activation is increased levels of phagocytosis. In order to determine if the slight observed 
increase in macrophage activation was physiologically important, a novel and efficient 
method to examine changes in phagocytosis was utilized here with the addition of 
fluorescent microspheres to in vitro macrophage cultures to determine differences in 
macrophage phagocytosis. In this experiment, salivary gland pairs were used without the 
co-stimulation of LPS. While pre-incubation of macrophages with saliva significantly 
increased microsphere uptake, co-incubation of saliva and microspheres resulted in even 
greater activation and phagocytosis compared to macrophages incubated in the absence of 
salivary proteins (Fig. 34). Therefore, macrophages are activated by A. stephensi salivary 
gland proteins. This is an important finding, as it indicates that salivary gland proteins 
alone can encourage the activation of macrophages, and, perhaps pathogen uptake 
following mosquito probing and pathogen introduction to the host. There are inherent 
limitations to using microbeads as a true “pathogen” uptake. However, vaccinology 
frequently uses polymer and latex beads to encourage phagocytosis and uptake of bound 
Ag for vaccine efficacy with regards to cross-presentation and a specific resulting immune 
response. 
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 B. Macrophage Infection by Sporozoites. In order to determine the extent to 
which macrophages are potentially infected by sporozoites, tissue culture microscopy was 
performed using freshly isolated GFP-tagged sporozoites from A. stephensi mosquitoes in 
complete media. Macrophages were co-cultured with sporozoites for various times (5min.-
30min.) and stained for the presence of circumsporozoite protein (PE-tagged CS). 
Fluorescence microscopy was utilized to determine the location of the sporozoites (green) 
and the CS protein, which would remain on the surface of cells infected by the sporozoite. 
Observation at all time points indicate 100% CS positive cells, and the absence of 
sporozoites in the culture (data not shown). The addition of sporozoites into the cultured 
macrophages with real-time imaging confirmed that sporozoites rapidly traverse 
macrophages, leaving CS protein on the surface of the cell, and are quickly relieved of 
their GFP tag upon phagocytosis by the macrophages. This is, to my knowledge, this first 
example of this type of rapid traversal and CS shedding by sporozoites and macrophages. 
Further investigation of alternative tagging and imaging will be required to examine the 
process of sporozoite infection of macrophages, and the ultimate fate of the sporozoites 
following phagocytosis. 
 C. Anopheles stephensi Saliva Modestly Decreases Dendritic Cell Activation. 
Aside from macrophages, dendritic cells are robust antigen presenting cells (APC) 
of the innate immune system, and were examined for their potential role as APCs for 
sporozoite Ag. Bone-marrow derived dendritic cells (DC) from C57BL/6 mice were 
cultured for 7-8 days in supplemented media. On day 7 or 8 the cells were treated with 
various doses of LPS, a known activator of DCs, with or without the addition of salivary 
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proteins, in order to determine the effect of mosquito saliva on DC activation. The addition 
of mosquito saliva exhibited modest inhibitory effects on DC activation at both high and 
low doses of LPS stimulation (Fig. 35). Whereas macrophage activation is associated with 
increased phagocytic function, DC activation results in decreased phagocytic capacity and 
increased levels of cytokine production. To measure physiologically relevant levels of 
activation by salivary gland proteins on dendritic cell activity, micropshere uptake by DCs 
was measured in vitro in the presence of salivary gland proteins and/or LPS. Salivary 
proteins were able to enhance the level of microsphere uptake by DCs in vitro (Fig. 36). 
Higher doses of saliva appear to increase DC activation, as indicated by reduced 
phagocytosis of the microspheres, but continued to have a lower levels of activation than 
with LPS alone (Fig. 36). This data, taken together with the effects of saliva on 
macrophage activity, indicates that mosquito saliva is able to enhance the phagocytic 
capacity of both macrophages and dendritic cells. When contemplating the use of a vaccine 
strategy for enhancing the activity of cells of the innate immune system, vector salivary 
gland proteins should be taken under consideration for efficacy of Ag presentation. 
D. Increased T-Cell Proliferation in Response to Anopheles stephensi-Pulsed 
Macrophages. The next step in the progression of this work is to determine if these effects 
of salivary gland proteins on macrophages and dendritic cells correlate to their Ag-
presentation to adaptive immune cells, such as T-lymphocytes. To this end, peritoneal 
macrophages were pulsed with saliva and co-cultured with CFSE labeled primary T-
lymphocytes in vitro (Fig. 37). Pre-incubation of macrophages with 10salivary gland pairs 
(SGP) and ova significantly increased the activation of peripheral T-cells as determined by 
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significantly increased proliferation (~4 fold enhancement) (Fig. 37). To further investigate 
the increased ability of macrophages to activate T-cells in response to mosquito salivary 
proteins, C57BL/6 OT-II mice were either probed, or not, with mosquitoes for 5 minutes 
(abdominal and footpad exposure, mice were shifted before the mosquitoes were able to 
take a blood meal, to increase probing, and thus, saliva deposition), and then injected with 
ovalbumin (ova). Draining lymph nodes (DLN) were harvested three days later and re-
stimulated in vitro with various doses of ova to determine differences in T-cell 
responsiveness as a result of exposure to salivary gland proteins delivered via the mosquito 
vector. Significant increases in the proliferative response by T-cells exposed to salivary 
gland proteins was observed (data not shown), indicating the in vivo relevance of increased 
T-cell priming by cells of the innate immune system following exposure to vector saliva, 
as proposed by our earlier in vitro studies with dendritic cells and macrophages. 
 E. Plasmodium and p56Lck. 
 In order to verify recent work claiming that the Src family PTK, Lck, is present in 
hepatocytes, and that it is involved in the localization of sporozoites within hepatocytes to 
create a productive infection (Akhouri), I proposed to confirm/disprove this hypothesis by 
examining the HepG2 liver cell line and primary murine hepatocytes for the presence of 
Lck. 
1. Lck is Present in the HepG2 Cell Line and in Primary Murine Hepatocytes. 
Cells from both the HepG2 liver cell line and primary murine hepatocytes were analyzed 
by Western immunoblot for the presence of Lck. Lck was found in both the pure 
hepatocyte line, HepG2, and in the primary hepatocytes of C57BL/6 mice (Fig. 38).  
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These results give credence to the claim that Lck is found in hepatocytes. The 
presence of Lck in primary murine hepatocytes also encourages the hypothesis that the Lck 
SH3 is present in these cells, and may potentially act to facilitate sporozoite infection of 
hepatocytes. 
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T-cell mediated immunity is of vital interest for the improvement of immuno-
therapies and vaccines for a variety of diseases ranging from cancer and autoimmunity to 
parasite infection. In order to improve and boost immune responsiveness and vaccine 
efficacy, it is important to understand and be able to control the activation, differentiation 
and effector function of T-lymphocytes. However, the mechanisms that regulate the 
outcome of T lymphocyte differentiation, activation and effector function are not well 
understood. 
In order to elucidate the mechanisms for these processes, it is important to 
understand the regulation of these processes, and the function of signaling molecules 
within the cell that control them. The Src-family protein tyrosine kinase, p56Lck, is one of 
the first signaling molecules downstream of the TCR, and is responsible for initiating TCR 
signaling cascades following TCR ligation. There is a conserved domain homology 
between the Src family members, including a conserved SH2, SH3, kinase domain and 
carboxy tail. The unique domain and amino terminus are unique between the Src PTKs and 
are responsible for directing the specific location of the proteins within the cell. Lck is 
located mostly at the cell surface membrane. The Lck SH2 domain has been shown to be 
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important for the initial processes in T-cell activation as a result of TCR engagement, 
particularly by facilitating the binding of Lck to the TCR zeta chains and the recruitment 
and activation of ZAP-70 (Straus ’96), and is responsible for a variety of proein-protein 
interactions downstream of proximal signaling events. The role of the SH3 domain, 
however, and its role in regulating the function of Lck activity are not as well understood. 
Several binding partners have been identified for the Lck SH3 domain, including the co-
stimulatory molecules CD28 (Holdorf) and CD2 (Bell, Holdorf), c-Cbl (Hawash), and PI3-
K. Binding to the co-stimulatory molecules CD28 and CD2 enables further recruitment of 
Lck to the TCR signaling complex during TCR engagement. We have performed 
experiments here, utilizing a knock-in mouse model containing a mutant lck allele 
containing an alanine substitution of a critical tryptophan residue within the SH3 domain 
(W97A), in order to examine the role of the Lck SH3 domain in mature T-cell function and 
immunity, and to examine some of the particular Lck SH3 domain binding partners with 
regard to these processes.  This W97A mutation is known to disrupt normal ligand binding 
to the SH3 domain (Denny’99, Patel). We have shown in this work that Lck SH3 domain 
binding to CD28 is not critical for CD28 signaling, as indicated by similar levels of 
proliferation between WT and Lck W97A T-cells following CD28/PMA stimulation (Fig. 
12). The closely related Src family kinase, Fyn, has also been shown to bind CD28 via its 
SH3 domain (Ong), and whereas this interaction is critical for co-stimulation in 
thymocytes, it may also be able to compensate for defective Lck in peripheral lymph node 
T-cells. CD2 co-stimulation is assicated with cell adhesion and has been shown to activate 
Lck via Lck SH3 domain interactions (Holdorf). However, as preliminary investigation 
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into cell adhesion (T-/B-cell conjugation, Fig. 25) does not indicate a defect in the ability 
of Lck W97A T-cells to adhere to B-cells, it is unlikely that even if there were defective 
CD2/Lck interactions, this interaction is not critical for T-/B-cell adhesion (under these 
conditions). The ability to control the strength of response to TCR ligation is provided, in 
part, by the binding of Lck to c-Cbl, an ubiquitin ligase, which induces a negative feedback 
mechanism by binding and degrading Lck. Using Lck W97A T-lymphocytes we 
demonstrate that there is significantly reduced T-cell activation following TCR-specific 
ligation. Thus, while binding of c-Cbl to Lck may be defective in Lck W97A T-cells, 
defective negative regulation of Lck it is not going to be apparent under these conditions. 
With regards to PI3-K, while binding of the Lck SH3 domain to PI-3K has been 
demonstrated, it has also been shown that the Lck SH2 domain is able to bind PI3-K 
(Susa). As there are no apparent defects in calcium mobilization, and only very slight 
reductions in PLC-γ1 in Lck W97A T-cells following TCR ligation, it is likely that the Lck 
SH2 domain is able to compensate for binding to PI3-K. Also, it has been shown that Fyn 
is also able to bind PI3-K via its SH3 domain, thus this interaction could also be able to 
compensate for defective Lck SH3 domain binding. 
Evidence is presented here that function of the SH3 domain of Lck is necessary for 
normal T-cell activation and Th2 immunity. Defects in TCR-induced Lck W97A T-cell 
activation correlate with the selective requirement for Lck SH3 domain function for the 
proper induction of the MAP Kinase pathway following antigen receptor stimulation. 
Moreover, defects in Th2 immunity of Lck W97A mice indicate a critical role for the Lck 
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SH3 domain in the functional response of T-lymphocytes to immunization and helminth 
infection. 
These findings indicate that the Lck SH3 domain provides an important mechanism 
linking the antigen receptor to intracellular signaling pathways that determine the outcome 
of T-lymphocyte activation and demonstrate a novel role for the Lck SH3 domain in Th2 
differentiation and immunity in an animal model. This is, to my knowledge, the first paper 
to show a role for the Lck SH3 domain in an infection model with regards to Th2 
differentiation and immunity, and to elucidate a potential mechanism for this defect by the 
dysregulation of the MAPK pathway protein, Erk. 
 
I. Lck SH3 Domain Regulates T-Lymphocyte Phenotype. 
We show that in Lck W97A mice there are modest changes in T-cell numbers, 
particularly the CD8+ T-lymphocyte subset (two- to three-fold reductions), as well as 
slightly lower CD4 expression on Lck W97A T-cells (Figs. 5-7). While there are only 
modest reductions in the total number of TCRβ peripheral T-cells in Lck W97A mice, 
there are significantly reduced percentages (10-15% reduction) of these cells within the 
lymph node and splenic compartments (Figs. 4,5). Rudd et al. showed significantly 
reduced numbers of thymocytes in Lck W97A mice, and two- to three-fold reductions in 
the numbers of CD4+ and CD8+ thymocytes, indicating defective positive selection in Lck 
W97A mice. The recovery of CD4+ T-cell numbers following T-cell exodus from the 
thymus can potentially be explained by the finding that although Lck is necessary during 
thymic selection and maturation of both CD4+ and CD8+ T-cells, the maintenance of 
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peripheral CD8+ T-cells in vivo does not require Lck (Tewari). It is therefore possible that 
differential requirements exist for Lck signaling necessary for the maintenance of 
peripheral CD4+ and CD8+ T-cells, and that this process is mediated by the Lck SH3 
domain. It is also possible that the Lck SH3 domain plays a differential role in CD4+ T-
cells, as Lck has previously been shown to have a biased role in CD4+ T-cell survival, 
sensitivity to apoptosis, and ability to proliferate in response to a lymphopenic 
environment compared with CD8+ T-cells (Ferreira). Furthermore, we show that CD4 
expression is reduced in Lck W97A mice (Fig. 7). Wiest et al have shown that when you 
have continued engagement of CD4, and thus activation of Lck, Lck disengages from CD4 
and CD4 is subsequently internalized. If our Lck SH3 domain mutant is more basally 
active than WT (due to loss of inactive conformation stability between SH3-linker region 
binding), it is possible that there is greater disengagement of Lck from CD4 and more 
sequestering of CD4 from the cell surface. 
Thymic data from these mice has indicated that Lck W97A mice are lymphopenic 
(Rudd), however, peripheral T-cell numbers show only modest reductions in the number of 
TCRβ cells in the periphery (Fig. 5). The ability of T-cells to proliferate in response to a 
lymphopenic environment is termed homeostatic-driven proliferation. Homeostatic 
proliferation induces a memory-like phenotype in T-cells, where conventional memory T-
cell markers are expressed, including CD44 (Cho, Goldrath, Murali-Krishna). Seddon et al. 
have shown that Lck is of critical importance for homeostatic-driven proliferation of T-
lymphoctes in vivo, but not for long-term survival. It is possible that the Lck SH3 domain 
may be involved in this process, and that Lck W97A T-cells might be more at risk for not 
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being able to proliferate in response to lymphopenic conditions that the ability to survive in 
the periphery. CD44 expression was examined on Lck W97A T-lymphocytes and was 
found to be significantly higher on naïve Lck W97A compared with WT T-cells (Fig. 8). It 
is possible that Lck W97A T-cells may be more activated that WT T-lymphocytes as a 
result of homeostatic proliferation in response to the reduced thymic output and resulting 
lymphopoeinic environment in Lck W97A mice. The phenomenon of homeostatic 
proliferation, and the role that the Lck SH3 domain plays in this phenomenon, could be 
further examined by introducing Lck W97A T-cells into lymphopoeinic hosts, such as 
RAG mice, which lack both B and T lymphocytes, in order to delineate differences in this 
type of proliferative expansion between Lck W97A and WT T-cells. 
Furthermore, the CD4+ T-cell population in Lck W97A mice have a slightly 
reduced CD62L+ (L-selectin) population (Fig. 9) and supports the hypothesis that Lck 
W97A T-lymphocytes have a more activated phenotype compared to WT, and may 
indicate homeostatic-driven proliferation in Lck W97A mice, although conflicting data has 
also been reported that reduced CD62L expression is not a requirement for this process 
(Murali-Krishna). It is interesting to note that although Lck W97A T-lymphocytes appear 
to be slightly more activated than their WT counterparts, they have reduced activation as a 
result of TCR-specific stimulation. Homeostatic-driven proliferation of CD4+ and CD8+ 
T-cells is believed to result, in part, from reduced competition for several of the γ common 
chain (γc) cytokines (cytokines that bind receptors having a γc chain), specifically, IL-7, IL-
12 (CD8+ T-cells) and IL-15 (Tan, Kieper) which act to promote homeostatic-driven 
proliferation. γc chain cytokines regulate cell growth via activation of signal transducers 
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and activators of transcription (STATs) downstream of janus family kinases (JAKs), 
especially JAK3 (Suzuki), independent of TCR signaling. Moreover, it has been shown 
that low affinity for the self-MHC/peptides that mediate positive selection in the thymus 
are utilized to assist homeostatic proliferation of naïve CD4+ and CD8+ T-cells in the 
periphery (Ernst). As preliminary evidence using Lck W97A T-cells stimulated with Ag 
result in enhanced activation compared to anti-CD3-sepcific stimulation alone (Fig. 14), it 
is logical that homeostatic proliferation involving MHC/peptide/TCR engagement would 
not be as defective as a TCR-specific stimulation. This is confirmed to the extent that Lck 
W97A T-cells appear to be involved in the process of homeostatic-driven proliferation as 
they have elevated levels of CD44 expression (Fig. 8b), although there remain significantly 
fewer CD8+ T-cells in the periphery of Lck W97A mice. Seddon et. al have reported that 
Lck is required for TCR-driven homoestatic proliferation using an inducible Lck-deficient 
mouse model. It is interesting to note that homeostatic proliferation is defective in Lck 
W97A mice, but that there are indications, such as enhanced CD44 expression, of 
homeostatic proliferation. Thus, the Lck SH3 domain must be involved downstream of 
TCR-induced homeostatic proliferation, and is involved in the regulation of this process 
via an unknown mechanism.  
To further examine the phenotype of Lck W97A T-cells, and to examine potential 
activation differences, which are observed in Lck W97A thymocytes (Rudd), we examined 
T-cell activation following Ab and Ag stimulation in vitro, as measured by analysis of 
proliferation, activation marker induction, and IL-2 production. 
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II. Lck SH3 Domain Regulates T-Lymphocyte Activation. 
Our analysis of Lck W97A T-cell activation indicates substantial alterations of in 
vitro activation of LckW97A T-cells, as indicated by fewer cells undergoing proliferation, 
reduced induction of the activation marker, CD69, as well as reduced IL-2 production 
following anti-CD3 TCR-specific stimulation. However, higher doses of anti-TCR 
stimulation and/or the addition of co-stimulation via CD28 ligation, were both able to 
enhance the proliferation of Lck W97A T-cells when compared to low-dose stimulation. 
Once a T-lymphocyte has received an activation signal via its TCR, the induction 
of the early activation marker CD69 is transiently observed on the cell surface. IL-2 
production, also a marker of early T-cell activation, is a common readout for proper and 
complete activation of T-cells following ligation with activating stimuli. Activation-
induced clonal expansion of naïve T-cells, as with the production of secreted IL-2, is 
another indicator of complete T-lymphocyte activation in response to activation stimuli. 
We found a significant increase (~2- fold) in the number of Lck W97A T-cells that could 
proliferate in response to anti-TCR specific Ab stimulation at higher concentrations 
(1μg/ml) of anti-CD3 compared to that of low-dose stimulation (0.1μg/ml) (Fig. 10), 
especially with the addition of CD28 co-stimulation (~5-6- fold) (Fig. 12). IL-2 levels, 
however, were significantly lower in Lck W97A T-cell cultures stimulated with 1μg/ml 
anti-CD3 compared to WT (Fig. 11), even though proliferation was mildly mitigated at this 
concentration. 
It is interesting to note that a significant number of Lck W97A T-lymphocytes 
could be activated, particularly with the addition of CD28 co-stimulatory signals. Lck has 
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been proposed to play an important role in co-stimulatory signaling through SH3 domain 
binding to CD28.  This conclusion is based on the observations that a proline-rich region in 
the cytoplasmic region of CD28 is critical for its co-stimulatory function, Lck can bind to 
this region, and SH3 domain function of p56Lck is important for CD28 signaling in cell 
lines (Friend, Holdorf’99).  Based on this, we expected that co-stimulation of LckW97A T-
cells would be defective, but surprisingly we found that stimulation of CD28 effectively 
augmented anti-CD3 induced proliferation.  Furthermore, stimulation with CD28 and 
phorbol-12-myristate-13-acetate (PMA: a PKC activator) failed to reveal any defect in the 
response of Lck W97A T-cells (Fig. 12).  These findings indicate that SH3 domain 
recruitment of Lck to CD28 is not necessary for co-stimulatory function, although it is 
possible that PMA treatment induced intracellular signals that might otherwise require Lck 
SH3 domain function, or that the closely related Fyn kinase is able to compensate for the 
loss of Lck SH3 domain function. Alternatively, since binding of Lck to the CD28 proline 
rich region enhances Lck catalytic activity by relieving the conformation of the protein to 
the open or active form (Holdorf’99), it is possible that the modest increase in catalytic 
activity that accompanies mutation of the SH3 domain may replace the role of CD28 
binding. 
To further examine activation defects in Lck W97A T-cells, examination of the 
early activation markers CD69 and CD25 (IL-2α) were analyzed. Lck W97A T-cells have 
a consistently higher basal level of CD25 expression, indicating slightly higher levels of 
basal activation (Fig. 13). This finding corresponds to previous data involving the ablation 
of SH3 domain function, where mutation of the Lck SH3 domain reduces stability of the 
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inactive form of the protein and yields a more basally activated Lck protein compared to 
WT. Lck W97A CD25 expression remains at modestly elevated levels over a period of 31 
hours following stimulation with anti-CD3 antibody, when compared to WT (Fig.13). 
However, the requirements for induction of CD25 and CD69 must be intrinsically 
different, as T-cell activation downstream of TCR ligation is defective in inducing CD69, 
even at high doses of stimulation (20-30% reduced induction at 0.3-5μg/ml 2C11)  (Fig. 
13). It could be said that although Lck W97A T-cells appear to have a higher basal level of 
activation, or even because they have a higher basal activity, they are not able to become 
activated to the same degree as WT T-lymphocytes following TCR-specific stimulation by 
inducing some level of tolerance or even, potentially activation-induced cell death (AICD). 
I tend not to believe AICD is responsible for the observed differences in cell activation, as 
indicated by reduced proliferation, etc., as propidium iodide, a stain for dead cells, does not 
indicate significant differences in mortality between WT and Lck W97A following anti-
CD3 stimulation (data not shown). 
Although we have examined the levels of TCRβ expression on the surface of Lck 
W97A T-cells and have found the level of expression to be similar to that of WT (Fig. 7), 
it might also be of importance to examine the levels of CD3 on the surface of Lck W97A 
T-cells. Even though a differential level of expression between TCRβ and CD3 has not, to 
my knowledge, been reported in primary peripheral T-lymphocytes, Wiest et al. have 
reported differential expression of CD3 in thymocytes (Wiest ’94). Reduced CD3 
expression could affect the magnitude of TCR engagement with anti-CD3 stimulation, and 
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thus potentially affect the strength of signal required for the signal threshold for T-
lymphocyte activation.  
Therefore, although Lck W97A T-cells have defective activation following TCR-
specific Ab-induced activation, they are not anergic or unable to respond to activating 
signals. These findings indicate that Lck SH3 domain function is important for normal T-
cell activation, though not absolutely essential. 
We next examined TCR signaling function in LckW97A T-cells to understand the 
basis for the observed changes in the response to receptor stimulation. Thymocyte data 
does not indicate any defects in ZAP-70 induction in Lck W97A thymocytes following 
anti-TCR stimulation (Rudd ’06). We examine ZAP-70 induction in purified peripheral T-
cells and confirmed that this early signaling event does not seem affected in Lck W97A T-
cells following immunoblot analysis (Fig. 18). As this proximal TCR signaling event is not 
regulated by the Lck SH3 domain, it was important to examine other signaling molecules 
downstream of this process in order to understand the mechanism behind the defects in 
Lck W97A T-lymphocyte activation. 
The anti-phosphotyrosine (PY) Ab, 4G10, was used in biochemical studies to 
examine the induction of phosphorylated tyrosine residues following stimulation of Lck 
W97A T-lymphocytes with anti-CD3 mAb (2C11). Overall basal levels of tyrosine 
phosphorylation were slightly enhanced, and induced tyrosine phosphorylation of select 
proteins was reduced following anti-TCR specific stimulation (Fig. 15). As the Lck SH3 
domain plays a role in stabilization of the closed, or inactive conformation of the protein, 
this heightened basal level of phosphotyrosine induction was expected, and corroborates 
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thymocyte data (Rudd ’06). A major band around 35 kDa was significantly reduced in Lck 
W97A T-cells following TCR ligation (Fig. 15). The scaffold protein LAT, which is 
approximately 38 kDa, is known to interact with Lck and to play an important role in T-
cell activation downstream of ZAP-70 activation. Preliminary analysis of LAT induction in 
Lck W97A T-cells following stimulation with 2C11 indicates a significant reduction (~5- 
fold reduced) compared to WT (Fig. 16). This is only a single experiment, and total LAT 
levels were not examined, so it is not possible to draw any concrete conclusions from this 
data. However, differences in LAT activation could potentially affect the ability of LAT to 
form signaling clusters with critical upstream regulators of the MAPK pathway including 
Grb2/SOS and RAS, as well as bind PLC-γ, a PI pathway protein, leading to differences in 
either or both of these pathways. As PLC-γ levels and calcium mobilization appear very 
similar between Lck W97A and WT T-lymphocytes (Figs. 21-22), it is unlikely that this 
difference, if it is reproducible, is physiologically critical for PI pathway induction and the 
mobilization of calcium following TCR-specific stimulation. It is possible that the 
association of SLP-76 with Lck and PLCγ may be able to compensate for diminished LAT 
activity, and maintain relatively normal levels of PLCγ activation (Qi). LAT is known to 
be important for T-lymphocyte development, as LAT-deficient mice have a severe block in 
T-cell development at the DN stage (Zhang). If our data showing reduced P-LAT in Lck 
W97A T-cells is reproducible, a defect in LAT activity downstream of Lck, or as a result 
of reduced Lck binding may contribute to the thymic developmental issues noted in Lck 
W97A mice (Rudd). LAT is known to bind the Lck SH2 domain, but there may be a role 
for the Lck SH3 domain in this process as well. Immunoprecipitations following TCR-
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specific ligation would be useful to examine this interaction and the scope of the defect in 
LAT activation, if the defect is determined to be significant. 
SLP-76, an adaptor protein involved in the PI pathway downstream of ZAP-70 
activation, has a size of roughly 76 kDa. A band that could potentially correlate to this 
protein on our phosphotyrosine blot does not appear negatively affected (Fig. 15), but 
preliminary analysis of this protein was examined as it has been shown to be a binding 
partner for Lck, and is important for complete T-cell activation. Western immunoblot 
analysis of total levels of SLP-76 appear to show no differences between purified lysates 
of Lck W97A T-cells and those of WT (Fig. 17). Difficulties with our P-SLP-76 Ab have 
precluded further study of this protein at this time, but would be of interest in the future. 
Further examination of total SLP-76, as well as potential differences in phosphorylated 
levels of SLP-76 will be of critical interest with regards to differential functionality in Lck 
W97A T-cells and SLP-76 activity in peripheral T-cells. Of ultimate importance is the 
effect on binding between SLP-76 and Lck having a mutated SH3 domain (W97A). Future 
work, including immunoprecipitation of SLP-76 and Lck (W97A), will determine if there 
is reduced binding between these proteins due to the ablation of Lck SH3 domain binding 
capability. Reduced SLP-76 binding to the Lck SH3 domain and subsequent activation 
have been proposed to play a role in the prevention of activation-induced cell death 
(AICD) following CD4/TCR stimulation (Sanzenbacher). It is possible, therefore, that if 
there is reduced binding between Lck and SLP-76 as a result of the W97A mutation, there 
would be reduced AICD as a result of CD4/TCR stimulation in Lck W97A mice. This 
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process could be examined by stimulating Lck W97A T-cells ex vivo with CD4 and anti-
CD3 and examining WT andLck W97A T-cell death. 
Activation of the MAPK pathway Erk1/2 kinases is critical for complete T-cell 
activation and IL-2 production downstream of TCR signaling. Observation of Erk1/2 
induction following TCR-specific ligation indicates that activation of this protein is 
defective in Lck W97A T-cells (Fig. 19). Erk-2 appears to be more negatively impacted 
(~6- fold reduction) by the Lck SH3 domain mutation that Erk-1 (~4 fold reduction), and 
neither Erk-1 nor Erk-2 activation is recovered to WT levels at a later time (15 min.) (Figs. 
19,20). Given the key role of the MAP Kinase pathway in the control of cell proliferation 
and gene expression, our findings strongly suggest that the altered activation of peripheral 
LckW97A T cells is due to defective induction of ERK-1 and ERK-2 following stimulation 
of the antigen receptor. 
This signaling defect appears to be limited to the MAPK pathway, as phospholipase 
C-γ1 (PLC-γ1) activation, calcium mobilization, and the overall pattern of tyrosine 
phosphorylation were not substantially affected. Immunoblot analysis of P-PLC-γ1 
induction in Lck W97A T-cells following TCR-specific stimulation does not indicate 
significant differences compared to WT (Fig. 21). To further examine the PI pathway, and 
to ensure that there were not physiologically significant differences in calcium 
mobilization, Fura 2, a ratiometric dye, was used to examine calcium mobilization in vitro. 
Analysis of Fura 2 following anti-CD3 cross-linking does not indicate differences in the 
ability of the Lck W97A T-cells to mobilize stores of calcium in response to a TCR-
specific stimulation (Fig. 22). The potential for the binding of ITK and SLP-76 with Lck 
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for PLCγ activation could be interesting to examine in our Lck W97A T-lymphocytes, as 
these interactions may have the potential to compensate for losses in LAT. LAT null 
studies in vivo are diifcult to examine, as there is a severe block in T-lymphocyte 
development in these animals. The potential for SLP-76 and ITK to assist in PLCγ 
activation, therefore, would be of great interest if the reduced LAT of our preliminary 
finsdings proves a faithful representation of the signaling in Lck W97A T-cells. 
Furthermore, CaMKII, a signaling protein activated by intracellular calcium, has been 
shown to be involved in thymocyte TCR signaling and positive selection (McGargill) as 
well as calcium-dependent activation of Erk in human T-lymphocytes (Franklin). Franklin 
et al. propose that CaMKII activation may regulate Lck in a calcium-dependent manner, 
but that this regulation may not act by affecting the activation of Lck, but rather its 
localization with binding partners. I was interested in examining potential diffences in Lck 
and CaMKII interactions as not much is known about how these two proteins interact, even 
though CaMKII activity is believed to directly impact Lck function. Preliminary analysis 
of total CaMKII levels in Lck W97A peripheral T-cells indicates slightly elevated levels of 
this protein (Fig. 23). If normal levels of calcium are mobilized in Lck W97A T-cells, but 
aberrant CaMKII function is observed in thymocytes as well as peripheral T-cells, it may 
indicate a role for the Lck SH3 domain in the negative regulation of positive selection and 
TCR signaling via aberrant SHP-2 interactions or disregulation of CamKII-mediated 
localization of Lck with its binding partners following calcium mobilization. Further 
analysis of CaMKII levels in Lck W97A thymocytes is required, as well as examination of 
SHP-2 regulation in peripheral Lck W97A T-cells. Moreover, CaMKII has been shown, in 
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vascular smooth muscle cells, to regulate Erk1/2 via both focal adhesion kinase (FAK) 
dependent and independent mechanisms during cell adhesion (Lu); and Lck is known to 
phosphorylate and activate FAK (Goldmann). Thus, differential regulation of Lck binding 
to FAK could affect the interactions of FAK with CamKII resulting in aberrant cell 
adhesion. However, preliminary examination of T-/B-cell conjugation does not appear to 
be dysfunctional (Fig. 25). Further examination of cell adhesion and the effects on FAK 
activity will need to be examined to demonstrate that this interaction is not being 
negatively affected. 
The selective reduction in MAPK pathway activation in mature Lck W97A T-
lymphocytes is consistent with previous data from our lab linking Lck SH3 domain 
function to activation of the MAPK pathway in cell lines and thymocytes (Denny’00, 
Denny’99).  Although the specific target of the Lck SH3 domain that allows it to regulate 
the MAPK pathway has not been established, Li et al., have recently shown that Lck-
deficient J.CaM1.6 cells reconstituted with an LckW97A mutant are defective in activation 
of Raf-1 following receptor stimulation (Li).  Given the key role of the MAP Kinase 
pathway in the control of cell proliferation and gene expression, our findings strongly 
suggest that the altered activation of peripheral LckW97A T-cells is due to defective 
induction of ERK-1 and ERK-2 following stimulation of the antigen receptor. 
In order to examine what effect the convergence of multiple signaling pathways 
would have on the observed defects in MAPK pathway induction and activation in Lck 
W97A T-cells would have, preliminary investigation of Ag-stimulation, using the OT-1 Tg 
animal model, was performed. The transgene in these mice encodes a TCR specific for the 
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SIINFEKL sequence of ovalbumin. In vitro investigation of SIINFEKL stimulation on Lck 
W97A and WT peripheral T-cells indicates only modest reductions in the activation of Lck 
W97A T-cells compared to that of anti-TCR specific stimulation, as indicated by 
approximately half the percentage of cells that are able to proliferate in response to the 
stimulation at low dose of peptide (0.003μg/ml) and almost no difference at higher doses 
(0.03μg/ml), with IL-2 production being only slightly reduced at higher doses of peptide 
compared to WT (Fig. 14). It is interesting that higher doses of SIINFEKL, as with higher 
doses of anti-CD3 alone, appear to recover proliferation defects, and mitigate IL-2 
production (Figs. 10,14). The compensation in reduced activation of OT-I-stimulated Lck 
W97A T-cells compared to that of anti-CD3 stimulation could be facilitated by the 
combined signaling of multiple receptor engagement in T-lymphocytes employed via Ag-
induced ligation. This multi-receptor ligation could lessen the requirement for Lck-specific 
signaling, compared with that of Ab-mediated TCR-stimulation alone (Fig. 10). It has also 
been shown that Lck may negatively regulate signals received following peptide/MHC 
stimulation of T-cells (Lee), which might come in to play at certain doses of peptide 
stimulation (Criado). Moreover, at higher Ag doses, Fyn may override the importance of 
Lck for the initiation of TCR signaling (Criado, Sundberg), and may explain why 
activation would be improved following more potent Ag stimulation in Lck W97A T-cells 
compared to low peptide doses and Ab-directed stimulation (Figs. 10,14). 
In order to further examine other parameters that could affect Ag-recognition and 
subsequent effector function in response to that activating stimuli, we examined the ability 
of Lck W97A T-cells to bind and activate B-lymphocytes in response to Ag stimulation. 
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The current model for the order of events following T-cell/APC interactions includes: 1) 
the initial Ag-independent cell-cell contact that does not rely on the activity of Fyn, Lck, 
ZAP-70 or Itk. 2) If Ag is present, this initial step is followed by ligation of the TCRs 
within the contact zone and attains the threshold level of stimulation (set by Lck) and 
results in membrane ruffling and cytoskeletal reorganization, also regulated by Lck. 3) The 
signal is sustained and a more concentrated contact zone forms for improved adhesion and 
signaling. (Donnadieu, Grakoui, Monks,Wulfing). Lck-deficient T-cells, and those having 
a mutation of the Lck SH3 domain (cell line data), have significant defects in actin-
remodeling and LFA-1 recruitment during T-/B-cell conjugate formation in vitro, 
irrespective of the function of the MAPK protein, Mek1 (Morgan). In order to more fully 
understand how Lck might be modulating conjugation, the effects of Lck on cytoskeletal 
reorganization have been examined by performing T:B-cell conjugation experiments. The 
guanine nucleotide exchange factor (GEF), Vav-1, is an important regulator of Rho family 
GTPases, which are important for the process of actin remodeling. Defective Lck activity 
downstream of CD28 signaling has been implicated as having significantly negative effects 
on Vav-1-dependent Rac-1 activity and NF-AT activation, and thus, defective cytoskeletal 
remodeling and conjugate formation in vitro (Carey, Michel). Our results with in vitro 
conjugation, using Lck W97A OT-2 mice whose Tg TCR is specific for ovalbumin, do not 
indicate a role for the Lck SH3 domain in regulation of T-cell/B-cell conjugation following 
Ag stimulation, as there are no obvious reductions in the number of conjugates (double 
stained for TCRβ and B220) following co-culture of Ag-stimulated murine peripheral T- 
and B-cells (Fig. 25). This could be due to the strength of Ag stimulation, as well as the 
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role that antigen-dosing may play in the dependence on Lck for this process (Criado). 
Also, this is very preliminary work (n=2), and should be repeated. Also, confocal 
microscopy staining for anti-CD3 (T-cells) and B220 (B-cells) should be performed to 
confirm conjugate formation is unaffected. 
Although LckW97A T cells were activated in response to receptor and co-
stimulatory signals, and conjugation did not seem affected under the conditions tested, it 
remained possible that they had other functional defects, particularly in light of the reduced 
induction of the MAP kinase pathway. To examine this we assessed the in vivo immune 
response of LckW97A mice to antigen/adjuvant immunization and helminth infection. 
 
III. Lck SH3 Domain Selectively Affects Th2 Immunity.  
 Although Lck W97A T cells were activated in response to receptor and co-
stimulatory signals, it remained possible that they had functional defects, particularly in 
light of reduced induction of the MAP kinase pathway. To examine this we assessed the in 
vivo immune response of Lck W97A mice to antigen/adjuvant and bacterial immunization 
as well as infection with the helminth, Nippostrongylus brasiliensis. We found that Lck 
W97A mice have a selective defect in Th2 immunity as characterized by a significant 
reduction in the serum levels of IgG1, IgE and IL-4, which are known to be associated 
with, and critical for, the propagation and maintenance of Th2 immune responses (Figs. 
26,29,30). There was no effect observed on pre-immune serum Ig levels or the induction of 
antigen-specific IgG2b and IgG3 isotypes (Fig. 26). Moreover, immunization of Lck 
W97A mice with heat-killed Brucella abortus, a strong inducer of Th1 immunity, shows 
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no defects in IFN-γ production compared to WT (Fig. 28). Furthermore, Th1/Th2 in vitro 
differentiation studies, performed by culturing purified CD4+ T-lymphocytes in the 
presence of Th differentiating cytokines, indicate that Lck W97A CD4+ T-cells are able to 
become either Th1 or Th2-type cells at both high and low doses of 2C11 stimulation as 
characterized by similar levels of intracellular IL-4 measured compared to WT (Fig. 31). 
However, the ability of the CD4+ T-lymphocytes to properly polarize into either Th1 or 
Th2 T-cells appears defective compared to WT. In vitro differentiation shows that although 
there are no differences in the absolute number of IL-4 producing cells in Lck W97A 
cultures, the polarization is reduced, as there is a much higher percentage of IFN-γ-
producing cells under Th2 differentiating conditions compared to WT. 
These results indicate that Lck SH3 domain function contributes specifically to the 
induction of Th2 immunity, and not Th1 immune responses, and is not the result of an 
initial Ig immune bias. Other contributing factors to the observed reduced Th2 immunity 
besides a defect in the ability of Lck W97A T-lymphocytes to properly polarize in vivo, 
could include a defect in survival of Th2 cells, or a specific defect in Th2 cell effector 
function, such as a failure to provide B-cell help via CD40/L interactions. Moreover, it is 
very likely that enhanced production of inhibitory cytokines by Lck W997A mice, such as 
IFNγ, could antagonize Th2 immunity by suppressing IgE class-switching (Xu ‘94). 
 Lck has previously been implicated in Th2 cell differentiation by studies analyzing 
the effect of expressing a dominant-inhibitory Lck transgene in peripheral T cells 
(Yamashita’98).  This catalytically inactive mutant would be expected to block Lck 
functions dependent on catalytic activity.  Our results with the Lck W97A mice suggest 
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that function of the Lck SH3 domain is also required for Th2 differentiation.  Full Lck 
catalytic activity may be needed to phosphorylate a target of the SH3 domain, or it may 
provide independent functions specifically required for Th2 differentiation. 
 A substantial amount of evidence has accumulated showing that TCR signaling 
influences Th differentiation and function (Marsland). Our analysis of Lck W97A mice 
suggests that the Lck SH3 domain links TCR signaling specifically to induction of the 
MAP Kinase pathway and that this response is necessary for Th2 differentiation.  These 
results are consistent with an earlier study showing that perturbation of Ras signaling 
blocked Th2 differentiation (Yamashita‘99).  In addition to Lck, LAT, the Tec kinases Itk 
and Rlk, as well as PKCØ have been implicated in Th differentiation (Schaeffer, 
Marsland).  In contrast to our findings, these signaling molecules are proposed to influence 
Th differentiation by affecting the overall strength of TCR signaling, or by specifically 
regulating the NFAT or NFκB transcription factors that are required for IL-4 expression 
and Th2 differentiation. P38, for example, is a member of the MAPK protein family and 
has been linked with Th1 differentiation and IFN-γ production (Rincon, ’00, ’03). Direct 
activation by Lck is believed to occur at Tyr323 on P38, in an “alternative” activation 
pathway (vs. MKK activation of Thr180 and 182) that follows TCR ligation (Salvador). 
Even though our findings show that the Lck SH3 domain does not negatively impact IFN-γ 
production (intracellular) (Fig. 28), P38 activation was analyzed by western immunoblot to 
examine this pathway in Lck W97A peripheral T-cells. Purified WT and Lck W97A T-
cells were stimulated with anti-CD3 and lysates were analyzed by western immunoblot for 
P38 and P-P38 levels. W97A T-cells had higher basal levels of P-38 than WT, but 
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underwent a much less dramatic stimulation following anti-CD3 stimulation (Fig. 24). 
Control P38 lysates were run in parallel to show that basal levels of total P38 were not 
different between groups (Fig. 24). This experiment was performed twice for all time 
points with slightly variable results. Although the unstimulated and 30-minute stimulations 
did not always show elevated levels of phospho-P38 induction in the Lck W97A T-cells 
(n=3), the 60-minute time point always showed similar, if not slightly elevated levels of 
phospho-P38 induction in the mutant lymphocytes (n=2). Interestingly, although this 
demonstrates that there is not a block in P38 activation in Lck W97A T-cells, and that the 
Lck SH3 domain is not critical for this interaction, it does indicate that higher basal Lck 
activity in Lck W97A T-cells may be differentially regulating P38 activation, and might 
help to explain the heightened IFN-γ production observed following Th1/Th2 in vitro 
differentiation (Fig. 31). The reduced levels of IFN-γ early (day 4) in the immune response 
could indicate defective innate immunity in Lck W97A mice. NK cells, a cellular 
constituent of the innate immune system, are known producers of IFN-γ and contain Lck. It 
is possible that the Lck SH3 domain mutation is negatively affecting this cell population 
and is thus able to alter the early responses to immunization. Examination of serum levels 
of IFN-γ at early time points following immunization, as well as NK cell population 
statistics, should be performed to determine the magnitude of the effect that the Lck SH3 
domain has on these processes. Depletion of T-cells could be used to further examine the 
effects that the Lck W97A mutation has on the NK cell population and IFN-γ production. 
NK cells are also critical regulators of auto-immunity and can act to induce apoptosis of 
infected cells via the release of granzymes. If the Lck W97A mutation negatively impacts 
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NK cell activation, there could be increased incidence of auto-immunity and/or decreased 
killing of infected cells during an immune response. 
 The concept that the Lck W97A mutation might significantly impact the NK cell 
population, also leads to the concept that this mutation can have both direct and indirect 
effects on the innate and adaptive immune systems. If there is heightened IFN-γ production 
by Lck W97A T-cells (or NK cells) during an immune response, this can act to activate 
cells of the innate immune system, such as macrophages and neutrophils, leading to the 
secretion of TNF-α and reactive oxygen species (ROS) that further enhance the 
inflammatory responses of the host animal (DeMayer, Philip). Recent evidence also 
suggests that IFN-γ can also stimulate CD8 T-cells directly, thereby enhancing adaptive 
immunity via heightened CD8-dependent cytotoxicity during viral infections (Whitmire).  
 There are many factors involved in the proper differentiation of naïve T-cells into 
Th2 T-cells including antigen recognition, signaling through the TCR, and activation of the 
interleukin-4 receptor (IL-4R) pathway. The role of the Tec kinase, Itk, in these processes 
has been best examined using Itk deficient mice (Itk-/-) which have varied deficiencies in 
Th2 immunity, including significantly reduced levels of secreted IL-4 following infection 
with various parasites, such as Nippostrongylus brasiliensis (Fowell, Schaeffer, review: 
Schwartzberg). Itk deficient CD4+ T-lymphocytes are able to differentiate into Th2 T-
cells, but have defective IL-4 production and GATA3 transcription (Au-Yeung). As Lck is 
known to activate Itk (at position: Tyr 511) (Heyeck), it is possible that Lck SH3 domain 
mutant T-cells may have altered activation of Itk, and thus, altered Th2 effector function. 
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Furthermore, reduced IL-4 production by Lck W97A mice in vivo following 
Nippostrongylus brasiliensis infection (Fig. 30) helps to explain the reduced levels of IgE 
also noted in the serum of infected mice. As IL-4 is known to induce immunoglobulin 
class switching in B-cells for the synthesis and secretion of IgE, it is probable that defects 
in IL-4 production result in decreased synthesis of IgE and therefore, reductions in Th2 
immunity. Aside from its role downstream of TCR signaling, it is also possible that Lck 
regulates MAP Kinase activation following IL-4 receptor stimulation, or affects IL-4 
synthesis and secretion in vivo.  Previous work has shown that signaling through the IL-4R 
pathway and activation of the MAP kinase pathway is critical for subsequent propagation 
of a complete Th2 immune response (Yamashita‘99, So). In the absence of normal IL-4R 
signaling, Th2 cells are unable to proliferate and provide effective Th2 immunity (Gros, 
Kopf).  In this case, the Lck W97A mutation may not block the initial differentiation of 
Th2 cells, but may be required for IL-4R signals necessary for a proper Th2 effector 
response. Moreover, Src family members are known to bind members of the signal 
transducers and activators of transcription (STAT) family. Lck is known to bind and 
phosphorylate STAT3 (Lund). STAT6 is a regulator of IL-4 transcription and has a proline 
rich domain that may interact with the Lck SH3 domain for binding and subsequent 
activation. Investigation into STAT6 phosphorylation in Lck W97A T-cells should be 
further examined. 
Our results showing that IL-2 production is significantly impaired following TCR-
specific stimulation in Lck W97A T-lymphocytes may have a more far-reaching impact on 
immunity than we have so far explored. As IL-2 is a known activator of not only T-cells, 
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but T-regulatory T-cells and natural killer cells as well. It would be of great interest to 
further examine potential differential regulation of these immune cell subpopulations, as 
well as the effects that differential IL-2 levels may play in Lck W97A mice following 
immunization or infection. As we note that Lck W97A T-cells produce significantly less 
IL-2 following anti-TCR ligation, differences in IL-2 production early on during an 
immune response could significantly alter the establishment of efficient adaptive immunity 
via defects in T-helper, T-regulatory and natural killer cell activation and differentiation. If 
IL-2 levels were to be normalized (potentially via cytokine injection in vivo), it would be 
very interesting to see if some of the observed activation and immune deficiencies would 
still be observed. 
Taken together, our data present novel evidence that the SH3 domain of Lck is a 
critical mediator of normal Th2 immunity in vivo, and further provides for a potential 
mechanism for this defect by the regulation of Th2 cell polarization by the Lck SH3 
domain via activation of the MAP kinase protein, Erk. 
 
IV. Mosquito Saliva Affects Innate Immune responses. 
During the course of this thesis work, I was able to perform an internship at the 
Institut Pasteur, Paris, France, in the laboratory of Dr. Salaheddine Mecheri. I was able to 
study the infection models for the murine strain of malaria, plasmodium berghei. It was 
during this internship that I examined the role that vector saliva was playing in the initial 
host response to infection. 
   185 
 
The aim of this body of work was to understand if and how mosquito saliva might be 
affecting the cells of the innate immune system, and investigate these potential 
manipulations with regard to their role in Plasmodium infection of C57BL/6 mice with P. 
berghei. The activation of macrophages and bone marrow-derived dendritic cells was 
examined, as well as the ability of these innate immune cells to induce T-cell activation 
following incubation with salivary gland proteins. Several methods, both in vitro and in 
vivo were employed, as well as the opportunity to design experiments to examine new 
techniques for the study of these processes. 
 Direct analysis, included in this work, has shown that Anopheles stephensi salivary 
proteins are able to enhance the activation of dendritic cells and macrophages (Figs. 33, 
35). This, in combination with enhanced activation of T-lymphocytes by saliva-activated 
macrophages (Fig. 37), potentiates the belief that mosquito saliva may enhance the 
activation of both branches of the immune response, and may play a protective role in 
response to Plasmodium infection. 
Mosquito salivary proteins have also been implicated as exacerbating mast cell 
release of Histamine, leading to cerebral malaria infection. If there is no Histamine-
mediated mechanism during infection with Plasmodium, there is protection from cerebral 
malaria (Beghdadi). Mosquito salivary proteins, therefore, have multiple modes of immune 
modulation, and therefore, the specific mechanisms must be addressed in the development 
of an effective malaria vaccine. It is interesting, that extended prophylactic use of anti-
malarials results in skin rashes, and that the treatment of these conditions with anti-
Histamines not only rids the patient of the skin disorder, but also has been shown to protect 
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against cerebral malaria (unpublished data). If the mast cell-mediated responses to 
Anopheles salivary proteins could be blocked during vaccine trials, but the immune 
responses to the salivary proteins allowed to occur, there could, potentially, be enhanced 
vaccine efficacy. 
The next stage to understanding the relevance of these processes involving mosquito 
saliva would be to examine them in vivo, in a murine model of Plasmodium infection, and 
to determine how modulation of these responses confer host protection upon challenge 
with Plasmodium berghei. 
 
V. Lck SH3 Domain May Have a Role in Plasmodium Pathogenesis. 
 In order to examine if previous reports stating that Lck SH3 domain interactions 
with sporozoites is critical for localization and infection of hepatocytes was also true in 
vivo, ex vivo analysis of the HePG2 cell line and primary murine hepatocytes for the 
presence of Lck was first confirmed, as Lck has not previously been reported in 
hepatocytes. Although this is a preliminary investigation, western immunoblot analysis 
indicates that Lck is present in both the immortalized liver cell line (HePG2) as well as in 
primary murine hepatocytes (Fig. 38). Further analysis of immunoblots, along with PCR 
analysis for the presence of Lck in purified primary hepatocytes will be required to confirm 
this result. 
 As it appears very likely that Lck is present in hepatocytes, it is extremely 
intriguing to hypothesize that the SH3 domain of Lck is acting to bind the sporozoite 
protein TRAP, potentially activate TRAP, and assist with its localization to downstream 
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critical modulators of its function. The ultimate experiment to either confirm or deny this 
hypothesis would be to infect Lck W97A mice with infectious sporozoites and determine 
parasite load. If the mice present with protection from Plasmodium, or even decreased 
pathogenesis, it would indicate that hepatocyte infectivity was indeed affected, and would 
give further purpose to pursue the Lck SH3 domain as a target for an efficacious vaccine 
against malaria. 
 
IV. Conclusions and Significance. 
In summary, our analysis indicates that Lck SH3 domain function is necessary for 
normal peripheral T lymphocyte activation and induction of the MAP kinase pathway 
following T cell antigen receptor stimulation. Our data does not indicate a critical role for 
the Lck SH3 domain in CD28 function or co-stimulation; however, mice with a defective 
Lck SH3 domain exhibit a substantial defect in Th2 immunity. These findings suggest that 
Lck provides a key regulatory function in helper T cell development by providing a 
selective link to activation of the MAP kinase signaling pathway. 
 Future work required to better understand the specific parameters for this defect 
would include the use of inhibitors to specifically target the activity of Lck in WT mice; in 
particular, the activity of the SH3 domain in isolation. The usefulness of these findings 
would be of great importance for the management and control of known Lck SH3 domain 
interactions, specifically with regard to immunization and infection models such as the 
ability to mitigate the role of Lck in disease immunotherapy for HIV, pneumonia, and even 
T-cell cancers which have implicated roles for Lck SH3 domain function for infection and 
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pathogenesis. Current inhibitors for the repression of lck transcription (also yes and lyn), 
independent of new protein synthesis, include histone deacetylase inhibitors (HDIs), such 
as the endogenous butyrate (Hirsch). Understanding how mitigation (versus inhibition of 
total Lck) by inhibition of Lck SH3 domain function in vivo could affect T-cell 
responsiveness and function is of immense value for the potential use of Lck SH3 domain 
inhibitors for therapeutic trials. Of especial interest in current research is data indicating 
that the Nef molecule of the human immunodeficiency virus-1 (HIV-1) is able to bind the 
Lck SH3 domain and induce Lck activation (potentially via displacement of intramolecular 
inhibitory conformation by binding with the Lck SH3 domain). Thus activated, Lck is then 
able to assist in viral protein signaling for HIV-1 replication and invasion of host T-
lymphocytes. This interaction, as well as the ability of Nef to affect the association 
between Lck and the CD4 co-receptor (a target of HIV), is of great interest as a potential 
target for vaccine development (Trible). 
An improved in vivo approach to studying the Lck SH3 domain and its relevance to 
infection and immunity for “proof of theory/principle” studies would be to create a 
conditional Lck W97A knock-in mouse model. This would bypass any developmental 
issues involved with the Lck SH3 domain and thymocyte development, so that the defects 
observed in vivo would have no caveats with relation to T-cell development, such as 
abnormal positive selection as noticed in Lck W97A thymocytes (Rudd ’06). By 
circumventing the requirements for the Lck SH3 domain in T-cell development, peripheral 
T-cells will have pre-TCR and TCR signaling comparable to WT. Thus, the resulting 
population of peripheral T-lymphocytes may not have the potential variable reliance on the 
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function of the Lck SH3 domain as pertains to proximal pre-TCR and TCR signaling 
(which may be selected for during thymic development in Lck W97A T-cells). Alternative 
models could also include the creation of a tetracycline inducible system (Gossen’92, ‘95) 
in which the presence or absence of tetracycline would be able to manipulate the regulation 
of the Lck W97A phenotype. 
The Lck SH3 domain has also been implicated as a critical component for 
Plasmodium sporozoite infection of host hepatocytes, as well as sporozoite migration from 
the mid-gut to the salivary glands in the mosquito vector. Activation of the sporozoite 
protein, TRAP, a critical adhesion molecule for host invasion, and which is also required 
for localization of the sporozoite within the liver cell, has been shown to rely on Lck SH3 
domain for binding and localization within the cell. It has also been shown that Lck is able 
to activate TRAP once it is bound to the Lck SH3 domain (Akhouri, Sultan). Studies 
involving the co-infection processes involving HIV and Plasmodium are intensely 
investigating immune targets for vaccine development, which will be able to 
simultaneously interrupt/prevent infection and disease pathogenesis. The Lck SH3 domain 
presents a unique and intriguing target for new approaches to simultaneous-treatment 
vaccine development, as it has been implicated as critical for both of these life-threatening 
disease pathologies. 

















Abraham, N.,  M.C. Miceli, J.R. Parnes, and A. Veillette. 1991. Enhancement of T-cell 
responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Nature. 350:62-
66. 
Acuto, O., S. Mise-Omata, G. Mangino, F. Michel. 2003. Molecular modifiers of T cell 
antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor. 
Imm. Rev. 192:21-31. 
Akhouri, R.R., A. Sharma, P. Malhotra, and A. Sharma. 2008. Role of Plasmodium 
falciparum thrombospondin-related anonymous protein in host-cell interactions. Malaria J. 
7:63. 
Appleby, M.W., J.A. Gross, M.P. Cooke, S.D. Levin, Z. Qian, and R.M. Perlmutter. 1992. 
Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn. Cell. 
70:751-763. 
Au-Yeung, B. B., D. Shoshana, D. Katzman and D. J. Fowell. 2006. Cutting Edge: Itk-
Dependent Signals Required for CD4+ T Cells to Exert, but Not Gain, Th2 Effector 
Function. J. Immunol. 176:3895-3899. 
   192 
 
Beghdadi, W., A. Porcherie, B.S. Schneider, D. Dubayle, R. Peronet, M. Huerre, T. 
Watanabe, H. Ohtsu, J. Louis, and S. Mecheri. 2008. Inhibition of histamine-mediated 
signaling confers significant protection against severe malaria in mouse models of disease. 
J. Exp. Med. 205(2):395-408. 
Bell, G. M., J. Fargnoli, J. B. Bolen, L. Kish, J. B. Imboden. 1996. The SH3 domain of 
p56lck binds to proline-rich sequences in the cytoplasmic domain of CD2. J. Exp. Med. 
183: 169-178. 
Bjorkman, A., and A. Bhattarai. 2005. Public health impact of drug resistant Plasmodium 
falciparum malaria. Acta. Trop. 94:163-169. 
Boggon, T.J., and M.J. Eck. 2004. Structure and regulation of Src family kinases. 
Oncogene. 23:7918-7927. 
Boussiotis, V.A., G.J. Freeman, J.D. Griffin, G.S. Gray, J.G. Gribben, L.M. Nadler. 1994. 
CD2 is involved in maintenance and reversal of human alloantigen- specific clonal anergy. 
J. Exp. Med. 180: 1665-1673. 
Brdickova, N., T. Brdicka, P. Angelisova, O. Horvath, J. spicka, I. Hilgert, J. Paces, L. 
simeoni, S. Kliche, C. Merten, B. Schraven, and V. Horejsi. 2003. LIME: a new membrane 
raft-associated adaptor protein involved in CD4 and CD8 coreceptor signaling. J. Exp. 
Med. 198(10):1453-1462. 
Brogdon, J.L., D. Leitenberg, and K. Bottomly. 2002. The potency of TCR signaling 
differentially regulates NFATc/p activity and early IL-4 transcription in naïve CD4+ T 
cells. J. Immunol. 168:3825-3832. 
   193 
 
Brown, M.T., and J.A. Cooper. 1996. Regulation, substrates and functions of src. Biochim. 
Biophys. Acta., 1287:121-149. 
Cannon, J.L., C.M. Labno, G. Bosco, A. Seth, M.H.K. McGavin, K.A. Siminovitch, M.K. 
Rosen, and J.K. Burkhardt. 2001. WASP recruitment to the T cell-APC contact site occurs 
independently of Cdc42 activation. Immunity. 15:249. 
Carey, K.D., T.J. Dillon, J.M. Schmitt, A.M. Baird, A.D. Holdorf, D.B. Straus, A.S. 
Shaw, and P.J. Stork. 2000. CD28 and the tyrosine kinase lck stimulate mitogen-activated 
protein kinase activity in T cells via inhibition of the small G protein rap-1. Mol. Cell. Biol. 
20:8409. 
Carmo, A.M., M.A.A. Castro, F.A. Arosa. 1999. CD2 and CD3 associate independently 
with CD5 and differentially regulate signaling through CD5 in Jurkat T cells. J. Immunol. 
163: 4238-4245. 
Castro, M.A.A., P.A. Tavares, M.S. Almeida, R.J. Nunes, M.D. Wright, D. Mason, A. 
Moreira, A.M. Carmo. 2002. CD2 physically associates with CD5 in rat T lymphocytes 
with the involvement of both extracellular and intracellular domains. Eur. J. Immunol. 32: 
1509-1518. 
Chan, A.C., M. Dalton, R. Johnson, G.H. Wang, R. Thomas, and T. Hurosaki. 1995. 
Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for 
lymphocyte antigen receptor function. EMBO J. 14:2499-2508. 
Chen, L., P.S. Linsley, and K.E. Hellstrom. 1993. Costimulation of T cells for tumor 
immunity. Immunol. Today. 14:483-486. 
   194 
 
Chemnitz, J.M., J. Driesen, S. Classen, J.L. Riley, S. Debey, M. Beyer, A. Popov, T. 
Zander, and J.L. Schultze. 2006. Prostaglandin E2 impairs CD4+ T cell activation by 
inhibition of Lck: implications in Hodgkin’s Lymphoma. Cancer Res. 66(2):1114-1122. 
Cho, B.K., V.P. Rao, Q. Ge, H.N. Eisen, J. Chen. 2000. Homeostasis-stimulated 
proliferation drives naïve T cells to differentiatie directly into memory T cells. J. Exp. 
Med. 192:549-556. 
Constant, S., C. Pfeiffer, A. Woodard, T. Pasqualini, and K. Bottomly. 1995. Extent of T 
cell receptor ligation can determine the functional differentiation of naïve CD4+ T cells. J. 
Exp. Med. 182:1591-1596. 
Cooper, J.A., and B. Howell. 1993. The when and how of Src regulation. Cell. 73:1051-
1054. 
Criado, G., J. Madrenas. 2004. Superantigen stimulation reveals the contribution of Lck to 
negative regulation of T cell activation. J. Immunol. 172:222-230. 
Cross, A.H., T.J. Girard, K.S. Giacoletto, R.J. Evans, R.M. Keeling, R.F. Lin, J.L. Trotter, 
and R.W. Karr. 1995. Long-term inhibition of murine experimental autoimmune 
encephalomyelitis. Using CTLA-4-Fc supports a key role for CD28 costimulation. J. Clin. 
Invest. 95:2783-2789. 
Dal Porto, J.M., K. Burke, J.C. Cambier. 2004. Regulation of BCR signal transduction in 
B-1 cells requires the expression of the Src family kinase Lck. Immunity. 21(3):443-453. 
DeMayer, D.-G. 1998. The cytokine handbook, p. 491-516. In Angus W. Thomson (ed.), 
Cytokine handbook, 3rd ed. Academic Press, San Diego, Calif. 
   195 
 
Demeure, C.E., K. Brahimi, F. Hacini, F. Marchand, R. Peronet, M. Huerre, P. St.-
Mezard, J.F. Nicolas, P. Brey, G. Delespesse, and S. Mecheri. 2005. Anopheles mosquito 
bites activate cutaneous mast cells leading to a local inflammatory response and lymph 
node hyperplasia. J. Immunol. 174:3932-3940. 
Deng. L., R.A. Mariuzza. 2007. Recognition of self-peptide-MHC complexes by 
autoimmune T-cell receptors. Trends Biochem. Sci. 32(11):500-508. 
Denny, M.F., H.C. Kaufman, A.C. Chan, and D.B. Straus. 1999. The Lck SH3 domain is 
required for activation of the mitogen activated protein kinase pathway but not the 
initiation of T-cell antigen receptor signaling. J. Biol. Chem. 274(8):5146-5152. 
Denny. M.F., B. Patai, and D.B. Straus. 2000. Differential T-cell antigen receptor 
signaling mediated by the Src family kinases lck and fyn. Mol. Cell. Biol. 20(4):1426-
1435. 
Depinay, N., F. Hacini, W. Beghdadi, R. Peronet, and S. Mecheri. Mast cell-dependent 
down-redulation of antigen-specific immune responses by mosquito bites. 2006. J. 
Immunol. 176:4141-4146. 
Donnadieu, E., V. Lang, G. Bismuth, W. Ellmeier, O. Acuto, F. Michel, and A. 
Trautmann. 2001. Differential roles of Lck and Itk in T cell response to antigen recognition 
revealed by calcium imaging and electron microscopy. J. Immunol. 166:5540-5549. 
Donovan, M.J., A.S. Messmore, D.A. Scrafford, D.L. Sacks, S. Kamhawi, and M.A. 
McDowell. 2007. Uninfected mosquito bites confer protection against infection with 
malaria parasites. Infect. and Immunity. 75(5):2523-2530. 
   196 
 
Drappa, J., L.A. Kamen, E. Chan, M. Georgiev, D. Ashany, F. Marti, and P.D. King. 
2003. Impaired T cell death and lupus-like autoimmunity in T cell-specific adaptor protein-
deficient mice. J. Exp. Med. 193:1425-1430. 
Duplay, P., M. Thome, F. Herve, and O. Acuto. 1994. p56Lck interacts via its src 
Homology 2 domain with the ZAP-70 kinase. J. Exp. Med. 179:1163-1172. 
Eck, M.J., S.K. Atwell, S.E. Shoelson, and S.C. Harrison. 1994. Structure of the 
regulatory domains of the Src-family tyrosine kinase Lck. Nature. 368:764-769. 
Ernst, B., D.S. Lee, J.M. Chang, J. Sprent, C.D. Surh. 1999. The peptide ligands 
mediating positive selection in the thymus control T cell survival and homeostatic 
proliferation in the periphery. Immunity 11(2):173-81. 
Erpel, T., G. Superti-Furga, and S.A. Courtneidge. 1995. Mutational analysis of the Src 
SH3 domain: the same residues of the ligand binding surface area are important for intra- 
and intermolecular ointeractions. EMBO J. 14(4):963-975. 
Fabian, J. R., I. O. Daar, and D. K. Morrison. 1993. Critical tyrosine residues regulate the 
enzymatic and biological activity of Raf-1 kinase. Mol. Cell. Biol. 13:7170-7179. 
Feng, S., J.K. Chen, H. Yu, J.A. Simon, and S.L. Schreiber. 1994. Two binding 
orientations for peptides to the Src SH3 domain: development of a general model for SH3-
ligand interactions. Science. 266:1241-1247. 
Ferreira, C., T. Barthlott, S. Garcia, R. Zamoyska, and B. Stockinger. 2000. Differential 
survival of naïve CD4 and CD8 T cells. J. Immunol. 165:3689-3694. 
Finkelman, F.D., E.J. Pearce, J.F. Urban Jr., A. Sher. 1991. Regulation and biological 
function of helminth-induced cytokine responses. Immunol. Today 12(3)A62-6. 
   197 
 
Flanagan, K.L., M. Plebanski, P. Akinwunmi, E.A. Lee, W.H. Reece, K.J. Robson, A.V. 
Hill, M. Pinder. 1999. Broadly distributed T-cell reactivity, with no immunodominant loci, 
th the pre-erythrocyte antigen thrombospondin-related adhesive protein of Plasmodium 
falciparum in West Africans. Eur. J. Immunol. 29:1943-1854. 
Fowell, D.J., K. Shinkai, X.C. Liao, A.M. Beebe, R.L. Coffman, D.R. Littman, R.M. 
Locksley. 1999. Impaired NFATc translocation and failure of Th2 development in Itk-
deficient CD4+ T cells. Immunity. 11:399-409. 
Franklin, R.A., P.A. Atherfold, and J.A. McCubrey. 2001. Calcium-induced Erk 
activation in human T lymphocytes occurs via p56Lck and CaM-Kinase. Mol.  Immunol. 
37(11):675-683. 
Friend, L.D., D.D. Shah, C. Deppong, J. Lin, T.L. Bricker, T.I. Juehne, C.M. Rose, and 
J.M. Green. 2006. A dose-dependent requirement for the proline motif of CD28 in cellular 
and humoral immunity revealed by a targeted knockin mutant. J. Exp. Med. 203(9):2121-
2133. 
Furuta, T., T. Kikuchi, Y. Iwakura, and N. Watanabe. 2006. Protective roles of mast cells 
and mast cell-derived TNF in murine malaria. J. Immunol. 177:3294-3302. 
Germain, R.N., I. Stefanova. 1999. The dynamics of T cell receptor signaling: complex 
orchestration and the key roles of tempo and coordination. Annu. Rev. Immunol. 17:467-
522. 
Gilbert, S.C., M. Plebanski, S.J. Harris, C.E. Allsopp, R. Thomas, G.T. Layton, A.V. Hill. 
1997. A protein particle vaccine containing multiple malaria epitopes. Nat. Biotechnol. 
15:1280-1284. 
   198 
 
Glaichenhaus, N., N. Shastri, D.R. Littman, and J.M. Turner. 1991. Requirement for 
association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell. 
64:511-520. 
Goldmann, W.H. 2002. p56(lck) Controls phosphorylation of filamin and (ABP-280) and 
regulates focal adhesion kinase (pp125(FAK)). Cell Biol. Int. 26(6):567-71. 
Goldrath, A.W., L.Y. Bogatzki, M.J. Bevin. 2000. Naïve T-cells transiently acquire a 
memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 192:557-
564. 
Goldsmith, M.A., and A. Weiss. 1987. Isolation and characterization of a T-lymphocyte 
somatic mutant with altered signal transduction by the antigen receptor. Proc. Natl. Acad. 
Sci. U.S.A. 84:6879-6883. 
Good, M.F., D.C. Kaslow, L.H. Miller. 1998. Pathways and strategies for developing a 
malaria blood-stage vaccine. Annu. Rev. Immunol. 16:57-87. 
Good, M.F., D.L. Doolan. 1999. Immune effector mechanisms in malaria. Curr. Opin. 
Immunol. 11:412-419. 
Gossen, M., H. Bujard. 1992. Tight control of gene expression in mammalian cells by 
tetracycline responsive promoters. Proc. Natl. Acad. Sci. USA. 89:5547-5551. 
Gossen, M., S. Freundlieb, G. Bender, G. Muller, W. Hillen, and H. Bujard. 1995. 
Transcriptional activation by tetracycline in mammalian cells. Science 268:1766-1769. 
Grakoui, A.S., S.K. bromley, C. Sumen, M.M. Davis, A.S. Shaw, P.M. Allen, and M.L. 
Dustin. 1999. The immunological synapse: a molecular machine controlling T cell 
activation. Science. 285:221. 
   199 
 
Gros, G.L., S.Z. Ben-Sasson, R. Seder, F.D. Finkelman, and W. E. Paul. 1990. Generation 
of interleukin 4 (IL-4)-producing cells in vivo and in vitro: Il-2 and IL-4 are required for in 
vitro differentiation of IL-4-producing cells. J. Exp. Med. 172:921-929. 
Henning, S.W., and D.A. Cantrell. 1998. p56Lck signals for regulating thymocyte 
development can be distinguished by their dependency on Rho function. J. Exp. Med. 
188:931. 
Han, J., B. Das, W. Wei, L. Van Aelst, R.D. Mosteller, R. Khosravi-Far, J.K. Westwick, 
C.J. Der, and D. Broek. 1997. Lck regulates Vav activation of members of the Rho family 
of GTPases. Mol. Cell. Biol. 17:1346. 
Hashimoto, K., S.J. Sohn, S.D. Levin, T. Tada. R.M. Perlmutter, and T. Nakayama. 1996. 
Requirement for p56Lck tyrosine kinase activation in T-cell receptor-mediated thymic 
selection. J. Exp. Med. 184:931-943. 
Hawash, I.Y., K.P. Kesavan, A.I. Magee, R.L. Geahlen, and M.L. Harrison. 2002. The 
Lck SH3 domain negatively regulates localization to lipid rafts through an interaction with 
c-Cbl. J. Biol. Chem. 277:5683-5691. 
Hermiston, M.L., Z. Xu, R. Majeti, A. Weiss. 2002. Reciprocal regulation of lymphocyte 
activation by tyrosine kinases and phosphatases. J. Clin. Invest. 109:9-14. 
Herrington, D., J. Davis, E. Nardin, M. Beier, J. Cortese, H. Eddy, G. Losonsky, M. 
Hollingdale, M. Sztein, M. Levine. 1991. Successful immunization of humans with 
irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. 
Am. J. Trop. Med. Hyg. 45:539-457. 
   200 
 
Heyeck, S., Heather M. Wilcox , Stephen C. Bunnell and Leslie J. Berg. 1997. Lck 
Phosphorylates the Activation Loop Tyrosine of the Itk Kinase Domain and Activates Itk 
Kinase Activity. J. Biol. Chem. 272(40):25401-25408. 
Hirsch, C.L., E.L. Smith-Windsor, and K. Bonham. 2005. Src family members have a 
common response to histone deacetylase inhibitors in human colon cancer cells. Int. J. 
Cancer. 118:547-554. 
Holdorf, A.D., J.M. Green, S.D. Levin, M.F. Denny, D.B. Straus, V. Link, P.S. 
Changelian, and A.S. Shaw. 1999. Proline residues in CD28 and the Src homology (SH)3 
domain for Lck are required for T cell costimulation. J. Exp. Med. 190:375-384. 
Holdorf, A.D., K.H. Lee, W.R. Burack, P.M. Allen, and A.S. Shaw. 2002. Regulation of 
Lck activity by CD4 and CD28 in the immunological synapse. Nat. Immunol. 3(3):259-
264. 
Hur, E.M., M. Son, O.-H. Lee, Y.B. Choi, C. Park, H. Lee, and Y. Yun. 2003. LIME, a 
novel transmembrane adaptor protein associates with p56Lck and mediates T-cell 
activation. J. Exp. Med. 198(10):1463-1473. 
DeFranco, A.L., R.M. Locksley, M. Robertson. Immunity. 
Irving, B., and A. Weiss. 1991. The cytoplasmic domain of the T cell receptor zeta chain 
is sufficient to couple to receptor-associated signal transduction pathways. Cell. 64(5):891-
901. 
Iwashima. I., B.A. Irving, N.S. van Oers, A.C. Chan, A. Weiss. 1994. Sequential 
interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 
263(5150):1136-9. 
   201 
 
Jabara, H.H., S.M. Fu, R.S. Geha, and D. Vercelli. 1990. CD40 and IgE: synergism 
between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE 
synthesis by highly purified human B cell. J. Exp. Med. 172:1861. 
Johnson, D.R., R.S. Bhatnagar, L.J. Knoll, and J.I. Gordon. 1994. Genetic and 
biochemical studies of protein N-myristoylation. Annu. Rev. Biochem. 63:869-914. 
Jordan, M.S., A.L. Singer, and G.A. Koretzky. 2003. Adaptors as central mediators of 
signal transduction in immune cells. Nature Immunol. 4:110-116. 
Jorritsma, P.J., J.L. Brogdon, and K. Bottomly. 2003. Role of TCR-induced extracellular 
signal-related kinase activation in the regulation of early IL-4 expression in naïve CD4+ T-
cells. J. Immunol. 170:2427-2434. 
Juncadella, I.J., R. Garg, S.K. Ananthnarayanan, C.M. Yengo, and J. Anguita. 2007. T-
cell signaling pathways inhibited by the tick saliva immunosuppressor, Salp15. Immunol. 
Med. Microbiol. 49:433-438. 
Kamhawi, S., Y. Belkaid, G. Modi, E. Rowton, and D. Sacks. 2000. Protection against 
cutaneous leishmaniasis resulting from bites of uninfected sand flies. Science. 290:1351-
1354. 
Karnitz, L., S.L. Sutor, T. Torigoe, J.C. Reed, M.P. Bell, D.J. McKean, P.J. Liebson, and 
R.T. Abraham. 1992. Effects of p56Lck on the growth and cytolytic effector function of an 
interleukin-2-dependent cytotoxic T-cell line. Mol. Cell. Biol. 12:4521-4530. 
Kieper, W.C., M. Prlic, C.S. Schmidt, M.F. Mescher, and S.C. Jameson. 2001. IL-12 
Enhances CD8 T Cell Homeostatic Expansion. J. Immunol. 166: 5515-5521. 
   202 
 
Killeen, N. et al. 1992. Development and function of T cells in mice with a disrupted CD2 
gene. EMBO J. 11:4329-4336. 
Koegl, M., P. Zlatkine, S.C. Ley, S.A. Courtneidge, and A.I. Magee. 1994. Palmitoylation 
of multiple Src-family kinases at a homologous N-terminal motif. Biochem. J. 303(Pt 
3):749-753. 
Kopf, M., G.L. Gros, M. Bechmann, M.C. Lammers, H. Bluethmann, and G. Kohler. 
1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245-
248. 
Koretzky, G.A., M. Kohmetscher, and S. Ross. 1993. CD45-associated kinase activity 
requires lck but not T cell receptor expression in the Jurkat T cell line. J. Biol. Rev. 
268(12):8958-8964. 
Lanier, L.L. 1997. Natural killer cells: from no receptors to too many. Immunity. 
6(4):371-378. 
Larson, S.M., and A.R. Davidson. 2000. The identification of conserved interactions 
within SH3 domain by alignment of sequences and structures. Protein Sci. 9:2170-2180. 
Lee, J.E., M.B. Cossoy, L.A. Chau, B. Singh, and J. Madrenas. 1997. Inactivation of Lck 
and loss of TCR-mediated signaling upon persistent engagement with complexes of 
peptide:MHC molecules. J. Immunol. 159:61. 
Legname, G., B. Seddon, M. Lovatt, P. Tomlinson, N. Sarner, M. Tolaini, K. Williams, T. 
Norton, D. Kioussis, and R. Zamoyska. 2000. Inducible expression of a p56Lck transgene 
reveals a central role for Lck in the differentiation of CD4 SP thymocytes. Immunity. 
12:537-546. 
   203 
 
Lenschow, D.J., S.C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K.C. Herold, and J.A. 
Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody 
treatment on the development of diabetes in the non-obese diabetic mouse. J. Exp. Med. 
181:1145-1155. 
Levin, S.D., S.J. Anderson, K.A. Forbush, and R.M. perlmutter. 1993. A dominant-
negative transgene defines a role for p56Lck in thymopoiesis. EMBO J. 12:1671-1680. 
Ley, S.C., M. Marsh, C.R. Bebbington, K. Proudfoot, and P. Jordon. 1994. Distinct 
intracellular localization of Lck and Fyn protein tyrosine kinases in human T lymphocytes. 
J. Cell Biol. 125:639-649. 
Li, M., S.S. Ong, B. Rajwa, V.T. Thieu, R.L. Geahlen, and M.L. Harrison. 2008. The SH3 
domain of Lck modulates T-cell receptor-dependent activation of the extracellular signal-
regulated kinase through activation of Raf-1. Mol. Cell. Biol. 28(2):630-641. 
Li, R.H., N. Wong, M.D. Jabali, P. Johnson. 2001. CD44-initiated cell spreading induces 
Pyk2 phosphorylation, is mediated by Src family kinases, and is negatively regulated by 
CD45. J. Biol. Chem. 276: 28767-28773. 
Lin, K., N.S. Longo, X. Wang, J.A. Hewitt, and K.M. Abraham. 2000. Lck domains 
differentially contribute to pre-T cell receptor (TCR)- and TCR-alpha/beta-regulated 
developmental transitions. J. Exp. Med. 191:703-716. 
Lovatt, M., A. Filby, V. Parravicini, G. Werlen, E. Palmer, and R. Zamoyska. 2006. Lck 
regulates the threshold of activation in primary T cells, while both Lck and Fyn contribute 
to the magnitude of extracellular signal-related kinase response. Mol. Cell. Biol. 8655-
8665. 
   204 
 
Lu, KK., S.E. Armstrong, R. Ginnan, H.A. Singer. 2005. Adhesion-dependent activation 
of CamKII and regulation of Erk activation in vascular smooth muscle. Am. J. Physiol. 
Cell Physiol. 289(5):C1343-1350. 
Lund, T.C., C. Coleman, E. Horvath, B.M. Sefton, R. Jove, M.M. Medveczy, and P.G. 
Medveczy. 1999. The Src-family kinase Lck can induce STAT3 phosphorylation and DNA 
binding activity. Cell Signal. 11:789-796. 
Luo, K., and B.W. Sefton. 1990. Cross-linking of T-cell surface molecules CD4 and CD8 
stimulates phosphorylation of the Lck tyrosine protein kinase at the autophosphorylation 
site. Mol. Cell. Biol. 10:5305. 
Marsland, B.J., T.J. Soos, G. Spath, D.R. Littman, and M. Kopf. 2004. Protein kinase C θ 
is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. J. 
Exp. Med. 200(2):181-189. 
Marth, J.D., R. Peet, E.G. Krebs, and R.M. Perlmutter. 1985. A lymphocyte-specific 
protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell 
lymphoma LSTRA. Cell. 43:393-404. 
Marti, F., C.W. Xu, A. Selvakumar, R. Brent, B. Dupont, and P.D. King. 1998. LCK-
phosphorylated human killer cell-inhibitory receptors recruit and activate 
phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. U.S.A. 95(20):11810-11815. 
Marti, F., G.G. Garcia, P.E. Lapinski, J.N. MacGregor, and PD. King. 2006. Essential role 
of the T cell-specific adaptor protein in the activation of Lck in peripheral T-cells. J. Exp. 
Med. 203(2):281-287. 
   205 
 
McHargill, M.A., L.L. Sharp, J.D. Bui, S.M. Hedrick, and S. Calbo. 2005. Active 
Ca2+/Calmodulin-dependent protein kinase IIγB impairs positive selection of T cells by 
modulating TCR signaling. J. Immunol. 175:656-664. 
Michel, F., G. Mangino, G. Attal-Bonnefoy, L. Tuosto, A. Alcover, A. Roumier, D. Olive, 
and O. Acuto. 2000. CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT 
activation. J. Immunol. 165:3820. 
Miller, L.H., M.F. Good, D.C. Kaslow. 1998. Vaccines against the blood stages of 
falciparum malaria. Adv. Exp. Med. Biol. 452:193-205. 
Molina, T.J., K. Kishihara, D.P. Siderovski, W. van Ewijk, A. Narendran, E. Timms, A. 
Wakeham, C.J. Paige, K.U. Hartmann, A. Veillette, D. Davidson, and T.W. Mak. 1992. 
Profound block in thymocyte development in mice lacking p56Lck. Nature 357:161-164. 
Monks, C.R., B.A. Freiberg, H. Kupfer, N. Sciaky, and A. Kupfer. 1998. Three-
dimensional segregation of supramolecular activation clusters in T cells. Nature. 395:82. 
Mora, A.L., L.M. Stephenson, B. Enerson, J. Youn, A.D. Keegan, and M. Boothby. 2003. 
New programming of IL-4 receptor signal transduction in activated T-cells: stat6 induction 
and Th2 differentiation mediated by IL-4Rα lacking cytoplasmic tyrosines. J. Immunol. 
171:1891-1900. 
Moran, M., and M.C. Micelli. 1998. Engagement of GPI-linked CD48 contributes to TCR 
signals and cytoskeletal reorganization: a role for lipid rafts in T cell activation. Immunity. 
9:787. 
   206 
 
Morgan, M.M., C.M. Labno, G.A. van Seventer, M.F. Denny, D.B. Straus, and J.K. 
Burkhardt. 2001. Superantigen-induced T cell: B cell conjugation is mediated by LFA-1 
and requires signaling though Lck, but not ZAP-70. J. Immunol. 167:5708-5718. 
Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L. 1996. 
Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 
14:619-648. 
Mosmann, T.R., and S. Subdash. 1996. The expanding universe of T-cell subsets: Th1, 
Th2 and more. Immunol. Today 17(3)138-146. 
Mosmann, T.R., H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Coffman. 1986. 
Two types of murine helper T cell clone. J. Immunol. 136(7):2348-2357. 
Murali-Krishna, K., R. Ahmed. 2000. Cutting edge: naïve T cells masquerading as 
memory cells. J. Immunol. 165:1733-1737. 
Musacchio, A., M. Noble, R. Pauptit, R. Wierenga, and M. Saraste. 1992. Crystal structure 
of a Src-homology 3 (SH3) domain. Nature. 359:851-855. 
Mustelin, T., and A. Altman. 1990. Dephosphorylation and activation of the T cell 
tyrosine kinase pp56lck by the leukocyte common antigen (CD45). Oncogene. 5:809-813. 
Mustelin, T., K.M. Coggeshall, and A. Altman. 1989. Rapid activation of the T-cell 
tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase. Proc. Natl. 
Acad. Sci. U.S.A. 86:6302-6306. 
Nardin, E.H., R.S. Nussenzweig. 1993. T cell responses to pre-erythrocytic stages of 
malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu. 
Rev. Immunol. 11:687-727. 
   207 
 
Newbold, C.I., A.G. Craig, S. Kyes, A.R. Berendt, R.W. Snow, N. Peshu, K. Marsh. 1997. 
PfEMP1, polymorphism and pathogenesis. Ann. Trop. Med. Parasitol. 91:551-557. 
Nobel. 1966. Br. Med. J. 2(5520):964. 
Noble, M., A. Musacchio, M. Saraster, S.A. Courtneidge, and R.K. Wierenga. 1993. 
Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional 
structures of SH3 domains in tyrosine kinases and spectrin. EMBO J. 12:2617-2624. 
Noelle, R.J., J.A. Ledbetter, and A. Aruffo. 1992. CD40 and its ligand, an essential ligand-
receptor pair for thymus-dependent B-cell activation. Immunol. Today 13:431. 
Nunes, R.J., A.A.M. Castro, C.M. Gonçalves, M. Bamberger, C.F. Pereira, G. Bismuth, 
and A.M. Carmo. 2008. Protein Interactions between CD2 and Lck Are Required for the 
Lipid Raft Distribution of CD2. J. Immunol. 180:988-997. 
Okada, M., and H. Nakagawa. 1989. A protein tyrosine kinase involved in regulation of 
pp60c-src function. J. Biol. Chem. 264:20886-20893. 
Olszowy, M.W., P.L. Leuchtmann, A. Veillette, and A.S. Shaw. 1995. Comparison of 
p56Lck and p59Fyn protein expression in thymocytes subsets, peripheral T-cells, NK cells, 
and lymphoid cell lines. J. Immunol. 155:4236-4240. 
Omri, B., C. Blancher, B. Neron, M.C. Marty, J. Rutin, T.J. Molina, B. Pessac, and P. 
Cristani. 1998. Retinal dysplasia in mice lacking p56lck. Oncogene. 16(18):2351-2356. 
Ong, C.J., A.S. Lim, and H.S. The. 1997. CD28-induced cytokine production and 
proliferation by thymocytes are differentially regulated by the p59fyn tyrosine kinase. J. 
Immunol. 159(5):2169-2176. 
   208 
 
Owhashi, M., M. Harada, S. Suguri, H. Ohmae, A. Ishii. 2001. The role of saliva of 
anopheles stephensi in inflammatory response: identification of a high molecular weight 
neutrophil chemotactic factor. Parasitol. Res. 87:376-382. 
Paige, L.A., M.J. Nadler, M.L. Harrison, J.M. Cassidy, and R.L. Geahlen. 1993. 
Reversible palmitoylation of the protein-tyrosine kinase p56lck. J. Biol. Chem. 268:8669-
8674. 
Palacios, E.H. and A. Weiss. 2004. Function of the Src-family kinases, lck and fyn, in T-
cell development and activation. Oncogene 23:7990-8000. 
Patel, V.P., M. Moran, T.A. Low, and C. Miceli. 2001. A molecular framework for two-
step signaling: Lck Src homology 3 mutations discriminate distinctly regulated lipid raft 
reorganization events. J. Immunol. 166:754-764. 
Perrin, P.J., D. Scott, L. Quigley, P.S. Albert, O. Feder, G.S. Grey, R. Abe, C.H. June, 
and M.K. Racke. 1995. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing 
experimental allergic encephalomyelitis. J. Immunol. 154:1481-1490. 
Philip, R., and L. B. Epstein. 1986. Tumour necrosis factor as immunomodulator and 
mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. 
Nature 323:86-89. 
Plebanski, M., E.A. Lee, A.V. Hill. 1997. Immune evasionin malaria: altered peptide 
ligands of the circumsporozoite protein. Parasitology. 115:S55-S66. 
Plebanski, M., S.C. Gilbert, J. Schneider, C.M. Hannan, G. Layton, T. Blanchard, M. 
Becker, G. Smith, G. Butcher, R.E. Sinden, A.V. Hill. 1998. Protection from Plasmodium 
   209 
 
berghei infection by priming and boosting T cells to a single class-I restricted epitope with 
recombinant carriers suitable for human use. Eur. J. Immunol. 28:4345-4355. 
Plebanski, M., K.L. Flanagan, E.A. Lee, W.H. Reece, K. Hart, C. Gelder, G. Gillepsie, M. 
Pinder, A.V. Hill. 1999. Interleukin 10-mediated immunosuppression by a variant CD4 T 
cell epitope of Plasmodium falciparum. Immunity. 10:651-660. 
Popik, W., and P. M. Pitha. 1996. Binding of human immunodeficiency virus type 1 to 
CD4 induces association of Lck and Raf-1 and activates Raf-1 by a Ras-independent 
pathway. Mol. Cell. Biol. 16:6532-6541. 
Potts, W.M., A.B. Reynolds, T.J. Lansing, and T.J. Parsons. 1988. Activation of pp60c-src 
transforming potential by mutations altering the structure of an amino terminal domain 
containing residues 90-95. Oncogene Res. 3:343-355. 
Prasad, K.V.S., R. Kapeller, O. Janessen, H. Repke, J.S. Duke-Cohan, L.C. Cantley, C.E. 
Rudd. 1993. Phosphatidylinositol (PI) 3-kinase and PI 4-kinase binding to the CD4-p56lck 
complex: the p56lck SH3 domain binds to PI 3-kinase but not PI 4-kinase. Mol. Cell. Biol. 
13:7708-7717. 
Qi, Q., A. August. 2007. Keeping the (kinase) party going: SLP-76 and ITK dance to the 
beat. Sci. STKE. 2007(396):pe39. 
Rajagopal, K., C.L. Sommers, D.C. Decker, E.O. Mitchell, U. Korthauer, A.I. Sperling, 
C.A. Kozak, P.E. Love, and J.A. Bluestone. 1999. RIBP, a novel Rlk/Txk- and Itk-binding 
adaptor protein that regulates T cell activation. J. Exp. Med. 190:1657-1668. 
   210 
 
Rao, N., S. Miyake, A.L. Reddi, P. Douillard, A.K. Ghosh, I.L. Dodge, P. Zhou, N.D. 
Fernandes, and H. Band. 2002. Negative regulation of Lck by Cbl ubiquitin ligase. Proc. 
Natl. Acad. Sci. USA. 99(6):3794-3799. 
Rawlings, D.J., and O.N. wittee. 1995. The Btk subfamily of cytoplasmic tyrosine 
kinases: structure, regulation and function. Semin. Immunol. 7:237-246. 
Rhoades, R.A., R.G Pflanzer. 2002. Human Physiology (4th ed. ed.). Thomson Learning. 
Rincon, M., R.A. Flavell, and R.A. Davis. 2000. The JNK and P38 MAP kinase signaling 
pathways in T cell-mediated immune responses. Free Radic. Biol. Med. 28:1328-1337. 
Rincon, M., and G. Pedraza-Alva. 2003. JNK and P38 MAP kinases in CD4+ and CD8+ T 
cells. Immunol. Rev. 192:131-142. 
Ruedl, C., M.F. Bachmann and M. Kopf. 2000. The antigen dose determines T helper 
subset development by regulation of CD40 ligand. Eur. J. Immunol. 30:2056-2064. 
Robinson, P.J., M. Millrain, J. Antoniou, E. Simpson, and A.L. Mellor. 1989. A 
glycophospholipid anchor is required for Qa-2 mediated T cell activation. Nature. 342:85-
87. 
Round, J.L., T. Tomassian, M. Zhang, V. Patel, S.P. Schoenberger, and M.C. Micelli. 
2005. Dlgh1 coordinates actin polymerization, synaptic T cell receptor and lipid raft 
aggregation, and effector function in T cells. J. Exp. Med. 201(3):419-430. 
Roussel, L.C., S.R. Brodeur, D. Shalloway, and A.P. Laudano. 1991. Selective binding of 
activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl 
terminus of pp60c-src. Proc. Natn. Acad. Sci. U.S.A. 88:10696-10700. 
   211 
 
Rousset, F., E. Garcia, and J. Banchereau. 1991. Cytokine-induced proliferation and 
immunoglobulin production of human B lymphocytes triggered through their CD40 
antigen. J. Exp. Med. 173:705. 
Rudd, C.E., J.M. Trevillyan, J.D. Dasgupta, L.L. Wong, and S.F. Schlossman. 1988. The 
CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from 
human T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 85:5190-5194. 
Rudd, C.E., O. Janssen, Y.-C. Cai, A.J. da Silva, M. Raab, and K.V.S. Prasad. 1994. Two-
step TCRξ/CD3-CD4 and CD28 signaling in T-cells: SH2/SH3 domains, protein-tyrosine 
and lipid kinases. Immunol. Today 15:225-234. 
Rudd, M.L., A. Tua-Smith, and D.B. Straus. 2006. Lck SH3 domain function is required 
for T-cell receptor signals regulating thymocyte development. Mol. Cell. Biology. 
26(21):7892-7900. 
Salvador, J.M., et al. 2005. Alternative P38 activation pathway mediated by T-cell 
receptor-proximal tyrosine kinases. Nat. Immunol. 6:390-395. 
Sanzenbacher, R., D. Kabelitz, and O. Janssen. 1999. SLP-76 binding to p56Lck: A role 
for SLP-76 in CD4-induced desensitization of the TCR/CD3 signaling complex. J. 
Immunol. 163:3143-3152. 
Schaeffer, E.M., G.S. Yap, C.M. Lewis, M.J. Czar, D.W. McVicar, A.W. Cheever, A. 
Sher, and P.L. Schwartzberg. 2001. Mutation of Tec family kinases alters T helper cell 
differentiation. Nat. Immunol. 2(12)1183-1188. 
Schneider, J., S.C. Gilbert, T.J. Blanchard, T. Hanke, K.J. Robson, C.M. Hannan, M. 
Becker, R. Sinden, G.L. Smith, A.V. Hill. 1998. Enhanced immunogenicity for CD8+ T 
   212 
 
cell induction and complete protective efficacy of malaria DNA vaccination by boosting 
with modified vaccinia virus Ankara. Nat. Med. 4:397-402. 
Schwartzberg, P.L., L.D. Finkelstein, and J.A. Readinger. 2005. Tec-family kinases: 
regulators of T-helper-cell differentiation. Nat. rev. Immunol. 5(4):284-295. 
Seddon, B., G. Legname, P. Tomlinson, and R. Zamoyska. 2000. Long-term survival but 
impaired homeostatic proliferation of naïve T cells in the absence of p56Lck. Science. 
290:127-131. 
Seddon, B., and R. Zamoyska. 2002. TCR signals mediated by Src family kinases are 
essential for the survival of naïve T cells. J. Immunol. 169:2997-3005. 
Sedegah, M., T.R. Jones, M. Kaur, R. Hedstrom, P. Hobart, J.A. Tine, S.L. Hoffman. 
1998. Boosting with recombinant vaccinia increases immunogenicity and protective 
efficacy of malaria DNA vaccine. Proc. Natl. Acad. Sci. USA. 95:7648-7653. 
Shaw, A.S., J. Chalupny, J.A. Whitney, C. Hammond, K.E. Amrein, P. Kavathas, B.M. 
Sefton, and J.K. Rose. 1990. Short related sequences in the cytoplasmic domains of CD4 
and CD8 mediate binding to the amin-terminal domain of the p56Lck tyrosine protein 
kinase. Mol. Cell. Biol. 10:1853-1862. 
Shenoy-Scaria, A.M.,  J. Kwong, T. Fujita, M.W. Olszowy, A.S. Shaw, and D.M. Lublin. 
1992. Signal transduction through decay-accelerating factor. Interaction of glycosyl-
phosphatidylinositol anchor and protein tyrosine kinases p56Lck and p59Fyn. J. Immunol. 
149:3535-3541. 
Shenoy-Sacria, A.M., L.K. Timson Gauen, J. Kwong, A.S. Shaw, and D.M. Lublin. 1993. 
Palmitylation of an amino-terminal cysteine motif of protein tyrosine kinases p56Lck and 
   213 
 
p59Fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins. Mol. 
Cell. Biol. 13(10):6385-6392. 
Sicheri, F., I. Moarefi, and J. Kuriyan. 1997. Crystal structure of the Src family tyrosine 
kinase Hck. Nature. 385:602-609. 
Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature. 387:569. 
So, E., J. Oh, J. Jang, J. Kim, C. Lee. 2006. Ras/Erk pathway positively regulates 
Jak1/STAT6 activity and IL-4 gene expression in Jurkat T cells. Mol. Immunol. 44:3416-
3426. 
Skapenko, A., P.E. Lipsky, H.-G. Kraetsch, J.R. Kalden, and H. Schulze-Koops. 2001. 
Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 
gene expression and mitogen-activated protein kinase activation. J. Immunol. 166:4283-
4292. 
Sommers, C.L., C. Park, J. Lee, C. Feng, C.L. Fuller, A. Grinberg, J.A. Hildebrand, E. 
Lacana, R.K. Menon, E.W. Shores, L.E. Samelson, P.E. Love. 2002. A LAT mutation that 
inhibits T cell development yet induces lymphoproliferation. Science 296:2040-2043. 
Sondhi, D., W. Xu, Z. Songyang, M. Eck, and P.A. Cole. 1998. Peptide and protein 
phosphorylation by protein tyrosine kinase Csk: Insights into specificity and mechanism. 
Biochemistry. 37:165-172. 
Stehelin, D., Varmus, H. E., Bishop, J. M. & Vogt, P. K. 1976. DNA related to the 
transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 
260, 170–173. 
   214 
 
Stein, P.L., H.M. Lee, S. Rich, and P. Soriano. p59fyn mutant mice display differential 
signaling in thymocytes and peripheral T cells. Cell. 70:741-750. 
Straus, D.B.,  A.C. Chan, B. Patai, and A. Weiss. 1996. SH2 domain function is essential 
for the role of the Lck tyrosine kinase in T-cell receptor signal transduction. J. Biol. Chem. 
271(17):9976-9981. 
Straus, D.B, and A. Weiss. 1992. Genetic evidence for the involvement of the Lck 
tyrosine kinase in signal transduction through the T cell antigen receptor. Cell. 70:585-593. 
Stefanova, I., B. Hemmer, M. Vergelli, R. Martin, W.E. Biddison, R.N. Germain. 2003. 
TCR ligand discrimination is enforced by competing Erk positive and SHP-1 negative 
feedback pathways. Nat. Immunol. 4:248-254. 
Stefanova, I., J.R. Dorfman, R.N. Germain. 2002. Self-recognition promotes the foreign 
antigen sensitivity of naïve T lymphocytes. Nature. 420:429-434. 
Stein, P.L., H.-M. Lee, S. Rich, and P. Soriano. 1992. pp59Fyn mutant mice display 
differential signaling in thymocytes and peripheral T cells. Cell. 70:741-750. 
Su, B., G.L. Waneck, R.A. Flavell, and A.L.M. Bothwell. 1991. The glycosyl 
phosphatidylinositol anchor is critical for Ly-6A/E mediated T-cell activation. J. Cell. Biol. 
112:377-384. 
Sultan, A.A., V. Thathy, U. Frevet, K.J.H. Robson, A. Crisanti, V. Nussenzweig, R.S. 
Nussenzweig, R. Menard. 1997. TRAP is necessary for gliding motility and infectivity of 
Plasmodium sporozoites. Cell. 90:511-522. 
Sun, W., X. Wei, K. Kesavan, T.P. Garrington, R. Fan, J. Mei, S.M. Anderson, E.W. 
Gelfand, and G.L. Johnson. 2003. MEK kinase 2 and the adaptor protein Lad regulate 
   215 
 
extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src. Mol. 
Cell. Biol. 23:2298-2308. 
Sundberg, E.J., Y. Li, and R.A. Mariuzza. 2002. So many ways of getting in the way: 
diversity in the molecular architecture of superantigen-dependent T-cell signaling 
complexes. Curr. Opin. Immunol. 14:36. 
Superti-Furga, G., S. Fumagalli, M. Koegl, S.A. Courtneidge, and G. Draetta. 1993. Csk 
inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. EMBO J. 
12:2625-2634. 
Susa, M., D. Rohner, and S. Bichsel. 1996. Differences in binding of PI3-K to the Src-
homology  domains 2 and 3 of p56 lck and p59 lyn. Biochem. And Biophys. Res. Comm. 
220(3):729-734. 
Suzuki, K., H. Nakajima, Y. Saito, T. Saito, W.J. Leonard, I. Iwamoto. 2000. Janus kinase 
3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent 
signaling: comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-
deficient mice. Int. Immunol. 12(2):123-132. 
Syrbe, U., J. Siveke, A. Hamann. 1999. Th1/Th2 subsets: distinct differences in homing 
and chemokine receptor expression? Springer Semin. Immunopathol. 21:263-285. 
Taher, T.E.I., L. Smit, A.W. Griffioen, E.J.M. Schilder-Tol, J. Borst, S.T. Pals. 1996. 
Signaling through CD44 is mediated by tyrosine kinases: association with p56lck in T 
lymphocytes. J. Biol. Chem. 271: 2863-2867. 
   216 
 
Takemoto, Y., M. Furuta, X. Li, W.J. Strong-Sparks, and Y. Hashimoto. 1995. LckBP1, a 
praline-rich protein expressed in haematopoietic lineage cells, directly associates with the 
SH3 domain of protein tyrosine kinase p56Lck. EMBO J. 14(14):3403-3414. 
Tan, J.T., E. Dudl, E. LeRoy, R. Murray, J. Sprent, K.I. Weinberg, and C.D. Surh. 2001. 
IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. 
Sci. USA. 98:8732–8737 
Taniuchi, I., D. Kitamura, Y. Maekawa, T. Fukuda, H. Kishi, and T. Watanabe. 1995. 
Antigen-receptor induced Clonal expansion and deletion of lymphocytes are impaired in 
mice lacking HS1 protein, a substrate of the antigen-receptor-coupled tyrosine kinases. 
EMBO J. 14:3664. 
Tavano, R., G. Gri, B. Molon, B. Marinari, C.E. Rudd, L. Tuosto, and A. Viola. 2004. 
CD28 and lipid rafts coordinate recruitment of Lck to the immunological synapse of 
human T lymphocytes. J. Immunol. 173:5392-5397. 
Teh, S.J., N. Killeen, A. Tarakhovsky, D.R. Littman, H.S. Teh. 1997. CD2 regulates the 
positive selection and function of antigen-specific CD4–CD8+ T cells. Blood 89: 1308-
1318. 
Tewari, K., J. Walent, J. Svaren, R. Zamoyska, and M. Suresh. 2006. Differential 
requirement for Lck during primary and memory CD8+ T cell responses. Proc. Natl. Acad. 
Sci. USA. 103:16388-16393. 
Theus, M.H., L. Wei, K. Francis, and S.P. Yu. 2006. Critical roles of Src family tyrosine 
kinases in excitory neuronal differentiation of cultured embryonic stem cells. Exp. Cell 
Res. 312(16): 3096-3107. 
   217 
 
Thomas, Sheila M., and Joan S. Brugge. 1997. Cellular functions regulated by Src family     
kinases. Annu. Rev. Cell Dev. Biol. 13:513-609. 
Titus, R.G., J.V. Bishop, and J.S. Mejia. 2006. The immunomodulatory factors of 
arthropod saliva and the potential for these factors to serve as vaccine targets to prevent 
pathogen transmission. Parasite Immunol. 28:131-141. 
Trible, R.P., L. Emert-Sedlak, T.E. Smithgall. 2006. HIV-1 Nef selectively activates Src 
family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction. J. Biol. Chem. 
281(37):27029-27038. 
Turka, L.A., P.S. Linsley, H. Lin, W. Brady, J.M. Leiden, R.Q. Wei, M.L. Gibson, X.G. 
Zheng, S. Myrdal, D. Gordon, et al. 1992. T cell activation by the CD28-ligand B7 is 
required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA. 89:11102-
11105. 
Turner, J.M.,  M.H. Brodsky, B.A. Irving, S.D. Levin, R.M. Perlmutter, and D.R. 
Littman. 1990. Interaction of the unique N-terminal region of tyrosine kinase p56lck with 
cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell 60:755-765. 
Urban, J.F., N. Noben-Trauth, D.D. Donaldson, K.B. Madden, S.C. Morris, M. Collins, 
and F. Finkelman. 1998. IL-13, Il-4Rα, and stat6 are required for the expulsion of the 
gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 8:255-264. 
Van Oers, N.S., N. Killeen, and A. Weiss. 1996. Lck regulates the tyrosine 
phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes. J. Exp. 
Med. 183:1053-1062. 
   218 
 
Van Oers, N.S., B. Lowin-Kropf, D. Finlay, K. Connolly, and A. Weiss. 1996b. αβT cell 
development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. 
Immunity. 5:429-436. 
Vaughan, J.A., L.F. Scheller, R.A. Wirtz, and A.F. Azad. 1999. Infectivity of plasmodium 
berghei sporozoites delivered by intravenous inoculation versus mosquito bite: 
implications for sporozoite vaccine trials. Infect. and Immun. 67(8):4285-4289. 
Veillette, A., M.A. Bookman, E.M. Horak, and J.B. Bolen. 1988. The CD4 and CD8 T cell 
surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. 
Cell 55:301-308. 
Veillette, A., M.A. Bookman, E.M. Horak, L.E. Samelson, and J.B. Bolen. (1989a). 
Signal transduction through the CD4 receptor involves the activation of the internal 
membrane tyrosine-protein kinase p56lck. Nature. 338:257-259. 
Veillette, A., J.B. Bolen, and M.A. Bookman. 1989(b). Alterations in tyrosine 
phosphorylation induced by antibody-mediated cross-linking of the CD4 receptor of T 
lymphocytes. Mol. Cell. Biol. 9:4441. 
Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by the T cell receptor 
number and tunable thresholds. Science. 273:104-106. 
Viola, A., S. Schroeder, Y. Sakakibara, and A. Lanzavecchia. 1999. T lymphocyte 
costimulation mediated by reorganization of membrane microdomains. Science. 283:680. 
Vogel, L.B., and D. Fujita. 1993. The SH3 domain of p56Lck is involved in binding to 
phosphatidylinositol 3’-kinase from T lymphocytes. Mol. Cell. Biol. 13(12):7408-7417. 
   219 
 
Wanasen, N., R.H. Nussenzveig, D.E. Champagne, L. Soong, and S. Higgs. 2004. 
Diffewrential modulation of murine host immune response by salivary gland extracts from 
the mosquitoes Aedes aegypti and Culex quinquefasciatus. 18:191-199. 
Wang, J.H., A. Smolyar, K. Tan, J.H. Liu, M. Kim, Z.Y. Sun, G. Wagner, E.L. Reinherz. 
1999. Structure of a heterophilic adhesion complex between the human CD2 and CD58 
(LFA-3) counterreceptors. Cell 97: 791-803. 
Wang, R., D.L. Doolan, T.P. Le, R.C. Hedstrom, K.M. Coonan, Y. Charoenvit, T.R. 
Jones, P. Hobart, M. Margalith, J. Ng, et al. 1998. Induction of antigen-specific cytotoxic T 
lymphocytes in humans by a malaria DNA vaccine. Science. 282:476-480. 
Wange, R.L., S.N. Malek, S. Desiderio, and L.E. Samelson. 1993. Tandem SH2 domains 
of ZAP-70 bind to T cell antigen receptor ξ and CD3ε from activated Jurkat T cells. J. 
Biol. Chem. 268:19797-19801. 
Wardenburg, J.B., et al. 1996. Phosphorylation of SLP-76 by the ZAP-70 protein-
tyrosine kinase is required for T-cell receptor function. J. Biol. Chem. 271:19641-19644. 
Wasserman, H.A., s. Singh, and D.E. Champagne. 2004. Saliva of the yellow fever 
mosquito, Aedes aegypti, modulates murine lymphocyte function. Parasite Immunol. 
26:295-306. 
Weber, J.R., G.M. Bell, M.Y. Han, T. Pawson, and J.B. Imboden. 1992. Association of 
the tyrosine kinase Lck with phospholipase C-γ1 after stimulation of the T cell antigen 
receptor. J. Exp. Med. 176:373-379. 
Weiss, A., and D.R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. 
Cell 76:263-274. 
   220 
 
Whitmire, J.K., J.T. Tan, J.L. Whitton. 2005. Interferon-gamma acts directly on CD8+ T 
cells to increase their abundance during virus infection. J. Exp. Med. 2005 201(7):1053-9 
Wiest, D.L.,  L Yuan, J Jefferson, P Benveniste, M Tsokos, RD Klausner, LH Glimcher, 
LE Samelson and A Singer. 1993. Regulation of T cell receptor expression in immature 
CD4+CD8+ thymocytes by p56lck tyrosine kinase: basis for differential signaling by CD4 
and CD8 in immature thymocytes expressing both coreceptor molecules. J. Exp. Med. 178: 
1701-1712. 
Wiest, D.L., K.P. Kearse, E.W. Shores, A. Singer. 1994. Developmentally regulated 
expression of CD3 components independent of clonotypic T cell antigen receptor 
complexes on immature thymocytes. J. Exp. Med. 180(4):1375-1382. 
Wikel, S.K., R.N. Ramachandra, D.K. Bergman, T.R. Burkot, and J. Piesman. 1997. 
Infestation with pathogen-free nymphs of the tick Ixodes scapularis induces host resistance 
to transmission of Borrelia burgdorferi by ticks. Infect. Immun. 65:335-338. 
Williams, J.C., A. Weijland, S. Gonfloni, A. Thomson, S.A. Courtneidge, G. Superti-
Furga, and R.K. Wierenga. 1997. The 2.35 A crystal structure of the inactivated form of 
chicken Src: a dynamic molecule with multiple regulatory interactions. J. Mol. Biol. 
274:757-775. 
Williams, J. C., R.K. Wierenga, M. Saraste. 1998. Insights into Src kinase functions - 
structural comparisons. Trends Biochem. Sci. 23: 179-184. 
Wong, N.K.Y., J.C.Y. Lai, D. Birkenhead, A.S. Shaw, and P. Johnson. 2008. CD45 
Down-Regulates Lck-Mediated CD44 Signaling and Modulates Actin Rearrangement in T 
Cells. J. Immunol. 181:7033-7043. 
   221 
 
Wulfing, C., and M.M. Davis. 1998. A receptor/cytoskeletal movement triggered by 
costimulation during T cell activation. Science. 282:2266. 
Xu, L., P. Rothman. 1994. IFN-  represses germline transcription and subsequently 
down-regulates switch recombination to . Int. Immunol. 6:515. 
Xu, W., S.C. Harrison, and M.J. Eck. 1997. Three-dimensional structure of the tyrosine 
kinase c-Src. Nature. 385:595-602. 
Yablonski, D., L.P. Kane, D. Qian, and A. Weiss. 1998. A Nck-Pak1 signaling module is 
required for T-cell receptor-mediated activation of NF-AT, but not of JNK. EMBO. J. 
17:5647. 
Yamaguchi, H., W.A. Hendrickson. 1996. Structural basis for activation of human 
lymphocyte kinase Lck upon tyrosine phosphorylation. Nature. 384:484-489. 
Yamashita, M., K. Hashimoto, M. Kimura, M. Kubo, T. Tada, and T. Nakayama. 1998. 
Requirement for p56Lck tyrosine kinase activation in Th subset differentiation. Int. 
Immunol. 10(5)577-591. 
Yamashita, M., M. Kimura, M. Kubo, C. Shimizu, T. Tada, R.M. Perlmutter, and T. 
Nakayama. 1999. T cell antigen receptor-mediated activation of the Ras/mitogen-activated 
protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell 
differentiation. Proc. Natl. Acad. Sci. 96:1024-1029. 
Yu, H., M.K. Rosen, T.B. Shin, C. Seidel-Dugan, J.S. Brugge, and S.L. Schreiber. 1992. 
Solution structure of the SH3 domain of Src and identification of its ligand-binding site. 
Scxience. 258:1665-1668. 
   222 
 
Zamoyska, R., A. Basson, A. Filby, G. Legname, M. Lovatt, B. Seddon. 20003. The 
influence of the src-family kinases, lck and fyn, on T cell differentiation, survival and 
activation. Immunol. Rev. 191:107-118.








Margaret E. McCoy was born in Silver Spring, MD, USA. After graduating from 
James Madison University, where she received her B.S. in Biology with a concentration in 
Microbiology and Immunology in 2002, she worked for a year at the University of Texas 
M.D. Anderson Cancer Research Center on WW domains under Dr. Mark Bedford. From 
2003-2004 she taught English at Spanos Frontesteria, an English language school in 
Naxos, Greece. In 2004 she began her graduate studies at the Virginia Commonwealth 
University’s Medical College of Virginia, where she earned her PhD in Immunology in 
2009. During her dissertation studies she completed an internship at the Institut Pasteur 
(2007), of which her work with malaria is included in this thesis. 
M. McCoy is a member of the American Chemical Association, Tri-Beta Honors 
Society, and the Association for the Advancement of Immunologists. She has several 
papers, including:  
• McCoy, Margaret E., Fred Finkelman, David B. Straus. 2009. Th2 specific immunity 
and function of peripheral T-cells requires the p56Lck SH3 domain. In submission to J. 
Immunol.  
• Neel NF, Creasy BM, Rankin JN, Pierce EM, McCoy ME, Daner RH, Fowler JA, 
Daniel JC, Lantz CS. 2004. Absence of interleukin-3 does not affect the severity of 
local and systemic anaphylaxis but does enhance eosinophil infiltration in a mouse 
model of allergic peritonitis. Immunol. Letters. 95(1):37-4. 
   224 
 
• Christopher P. Shelburne, Margaret E. McCoy, Roland Piekorz, Veronica V. Sexl, 
Sheila R. Gillespie, Daniel P. Bailey, Anita Chase, Paria Mirmonsef, Meredith N. 
Mann, Mohit Kashyap, Harry V. Wright, Hey Jin Chong, L. Andrew Bouton, James N. 
Ihle, Carlos D. Ramirez, Chris S. Lantz, and John J. Ryan. 2003. Stat5 expression is 
critical for mast cell development and survival. Blood. 102(4):1290-7. Epub 2003 Apr 
24. 
• Christopher P. Shelburne, Margaret E. McCoy, Roland Piekorz, Veronica V. Sexl, 
Sheila R. Gillespie, Daniel P. Bailey, Anita Chase, Paria Mirmonsef, Meredith N. 
Mann, Mohit Kashyap, Harry V. Wright, Hey Jin Chong, L. Andrew Bouton, Carlos D. 
Ramirez, Chris S. Lantz, and John J. Ryan. 2002. Stat5: an essential regulator of mast 
cell biology. Mol. Immunol. 38(16-18):1187-91. 
• C.C. Hakenkenkamp, A. E. Fuller, and M. E. McCoy. 2000. Effect of corbicula 
prescence and density on native bivalves in streams. Bulletin of the North American 
Benthological Society. 17:188. 
• Hekenkamp, C.C. and M. McCoy. 2000. Effect of liming on the macroinvertebrate 
community in the St. Mary’s Watershed. Tri-State Fisheries Conference. Lexington, 
VA. 
